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Published research indicates that Giardia spp. infections in Canidae, both domestic 
and wildlife species, are caused by several different subtypes. Four different genetic 
sequences of Giardia spp., termed ‘Assemblages’ infect domestic dogs, two of which 
also infect humans.  
Currently, DNA sequencing is the only method for distinguishing between different 
types of infections and published studies concerning potential transmission remain 
inconclusive. Nevertheless, it is well established that infections primarily affect 
juveniles and immuno-compromised individuals whilst the complexity of definitive 
diagnosis of symptomatic and asymptomatic Giardia spp. infections in dogs is 
problematic.  
The focus of this research programme concerns Giardia duodenalis, which infects 
mammalian species, specifically Giardia spp. infections in Canis lupus familiaris, or 
domestic dogs. Faecal sampling was conducted from naturally infected populations 
over a three-year period, from breeding kennels and from the urban dog population in 
Perth, Western Australia. Sampling strategies used microscopy and commercially 
available immuno-antigen tests to record enteric parasites infections and to confirm the 
earliest time of infection in different breeds of puppies. Results indicated that puppies 
could be infected with Giardia spp. within three weeks after birth and that clinical signs 
were associated with enteric parasite infections. This additional information detailing 
the impact of Giardia spp. infections on the canine host is an important factor for 
accurate diagnosis and understanding pathogenesis. 
Innovative methods were developed for analysing phenotypic descriptors of Giardia 
spp. extracted from canine faecal material using proteomic tools. Results from this 
work identified novel proteins and peptides, not previously published for any parasite 
protein extracted from mammalian faecal samples. This thesis discusses those peptide 
sequences identified in the context of canine gastro-intestinal ecosystems in 
 
 v 
conjunction with host-parasite interactions, and further explores the application and 
integration of molecular genomic and proteomic data. This work supplements 
annotation of Giardia spp. genomic data and may prove pivotal in accurate 
differentiation between host genotypes.  
Finally, one protein identified during the proteomic analysis, lactoferrin, was further 
investigated using a commercially available enzyme linked immunosorbent assay 
(ELISA). Results suggest that elevated levels of faecal lactoferrin occur in dogs with 
clinical signs of infection. 
A critical analysis of the challenges facing veterinarians and medical epidemiologists in 
diagnosis of enteric parasites in humans and canines is discussed and some important 
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Chapter 1   
General introduction to Giardia duodenalis 
G. duodenalis is a unicellular parasitic organism, a pathogen of humans and other 
mammals. The vast amount of literature concerning Giardia spp. mainly pertains to G. 
duodenalis that causes human infections, however there are many key features 
common to all genetic variants. Hereafter, the term ‘G. duodenalis’ refers specifically to 
the infective pathogens of human hosts and it’s various genotypes, as described in the 
literature. Consideration of the current and accepted taxonomic nomenclature informed 
the writing of this thesis, and Giardia spp. was selected in preference over Giardia 
canis to describe infections in canines. Where detailed information about canine 
Giardia spp. is absent, facts about G. duodenalis reported in the literature, including 
aspects of the biology, life cycle and structural features are included in this introductory 
section. In addition, this introduction includes a brief summary of the findings and 
current theories associated with G. duodenalis infections in humans, including how 
infection occurs, the clinical impacts and host susceptibility. Comments on the modes 
of transmission, public health implications and cycling of asymptomatic infections in the 
absence of diagnosis are presented, together with the potential consequences for 
those individuals and communities at risk. 
1.1 Taxonomic Classification 
Giardia spp. are protozoan parasites - non-fungal eukaryotic organisms capable of 
surviving in aerobic and anaerobic conditions. Taxonomic classification is problematic 
as the nomenclature of Giardia species has been reclassified and renamed numerous 
times since the first documented discovery by Leewenhoek in 1681 (Wolfe, 1992). 
Protozoans are classified within the domain Excavata. Within this domain, parasites 
closely related to Giardia spp. are the Parabasalids (e.g. trichomonads). Classification 
categories for protozoans include apicomplexans such as coccidians which, are 
obligate intracellular protozoan parasites of the gastrointestinal tract (Levine, 1973). 
Within the classic taxonomic characterization scheme Giardia, an anaerobic flagellated 
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protozoan parasite, is classified within the eukarya kingdom excavata Domain; 
metamonada Phylum; diplomonadida Order; hexamitidae Family; Giardia Genus; 
duodenalis species (Thompson and Monis, 2011).  
The current taxonomic class for Giardia is the Hexamitidae, which comprises 
flagellated organisms. The definitive nomenclature using traditional taxonomic methods 
has been much revised in recent years and more recent attempts have been made to 
classify the protist organisms according to clades, based upon ultrastructure, 
biochemistry and genetics (Cavalier-Smith, 2004, Adl et al., 2005, Hampl et al., 2009). 
At the present time whilst different host species are susceptible to Giardia spp. 
infections the International Committee for Zoological Nomenclature has confirmed six 
different Giardia species in 2007. Host infections are known for mice, Giardia muris; 
voles and muskrats, Giardia microti; budgerigars, G. psittaci heron and ibis, G. ardeae; 
frogs, G. agilis; and most other mammals, including humans, G. duodenalis (syn. G. 
intestinalis, G. lamblia). Giardia spp. belongs to a group of unicellular protozoan 
organisms that have evolved through specialised adaptations to exist within niche 
environments (Ricklefs, 2010, Niculescu, 2014). 
1.2 Importance of parasite infections on human health  
The World Health Organization (WHO) reports estimate over 200 million reported 
gastro-intestinal infections each year which, directly cause debilitating disease and 
death and the subsequent indirect effects of missed educational and employment 
opportunities – key contributors to poverty, are particularly evident in developing 
countries (Thompson, 2004, WHO et al., 2006). Infectious parasitic diseases include 
enteric protozoan infections of the mammalian digestive system that are of particular 
concern for humans (Thompson and Smith, 2011). The protozoan parasite Giardia spp. 
is ranked eighth in the top ten parasites affecting humans in the world (Buret, 2005). 
Giardia spp. infects a diversity of host organisms, including humans, wildlife and 
domesticated livestock pets (Buret, 2008). 
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In less developed countries with large disease burdens, G. duodenalis might be 
considered by some to be relatively minor in comparison to the effects of other parasitic 
organisms, such as malaria (Nwanguma and Alumanah, 2009). However, the 
cumulative factors of poverty; conflict and politics; unstable governments and lack of 
education and health care services result in poor hygiene, untreated water supplies; 
open sewers shared by wildlife, humans, and livestock thus increase exposure to 
waterborne infectious diseases, such as G. duodenalis (Putignani and Menichella, 
2010). This is due to the wide prevalence of the disease throughout the world, but most 
significantly in countries with large population numbers but low economic status and 
poverty, poor sanitation, high child mortality and low nutritional status. 
During 2004, the number of cases of G. duodenalis infections worldwide resulted in the 
nomination of this illness as one of the world’s most neglected tropical diseases by the 
WHO (Savioli et al., 2006). 
1.3 Clinical signs of infection 
G. duodenalis infections occur when cysts are ingested, trophozoites become attached 
to the surface of the intestine and feed on the mucus secretions of the intestine 
(Eckmann, 2003).  In humans, symptoms usually appear two weeks after exposure and 
include:  diarrhoea, dehydration, stomach cramps, flatulence, and weight loss (Nash et 
al., 1987, Robertson et al., 2010). Heavy infection can hinder the body's ability to 
absorb nutrients. Acute infections are those considered to cause severe or debilitating 
symptoms in the host, such as diarrhoea, vomiting and abdominal pain (Thompson, 
2000). Nonetheless, other symptoms have been reported such as psychotic 
manifestations that responded to anti-Giardia treatment (Heap and Mumford, 1989). 
Chronic illness associated with G. duodenalis infections, have been reported in 
juveniles as failure to thrive, poor growth rates, lethargy and suppressed appetite in 
adult hosts (Eligio-Garcia et al., 2005). The clinical appearance of the host small 
intestine has been associated with loss of brush border membrane integrity and 
peripheral enzyme function (Thompson, 2004, Scott et al., 2004, Cotton et al., 2011). 
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Clinical symptoms are the result of pathogenic mechanisms occurring at the host-
parasite interface. One of the key features of Giardia spp., which contribute to its 
success as a parasite, is the ability of trophozoites to attach to epithelial cells of the 
small intestine causing pathogenic changes. 
1.4 Pathogenicity  
Pathogenic effects noted by Chin et al. (2003), Troeger et al. (2007) and Cotton et al. 
(2011) are associated with brush border of villi in the small intestine and disruption of 
tight junction of enterocytes in humans. The mechanism of attachment, both in term of 
the adhesion process, and the signalling pathways to initiate and activate attachment 
are yet to be confirmed. Trophozoites are able to attach to epithelial cells with ease. 
Only at the point when signalling occurs, either by reaching sufficient density or 
numbers; or by reaching receptor points that pathological changes occur, resulting in 
disruption of tight junctions (Scott et al., 2002) and cell leakage (Buret et al., 2002, 
Cotton et al., 2011) ultimately resulting in clinical signs in the host.  
More recently, researchers have demonstrated an impact upon cell apoptosis caused 
by different G.duodenalis isolates on enterocytes of the small intestine through 
disruption of tight junction at zona occluda (Chin et al., 2003, Koh et al., 2012). This is 
important as it may explain some of the differences between asymptomatic and 
symptomatic infections. 
1.5 Prevalence of Giardia duodenalis in a global context  
Prevalence rates of G. duodenalis infections in humans varies greatly from less than 
1% to more than 50% depending on the location of the population and prevailing mode 
of G. duodenalis transmission. Reports indicate that 50% of all diarrhoeal deaths are 
due to acute watery diarrhoea, and 35% are due to persistent diarrhoea (WHO, 1992). 
Although the mortality rate from diarrheal disease is decreasing 500 million young 
children under 5 years old living in developing countries (excluding China) are still 
expected to suffer from 1,400 million episodes of diarrhoea per year. G. duodenalis 
poses significant health implications in densely populated countries of the world such 
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as in India with prevalence rates of 3-20% (Traub et al., 2002) or reported cases in 
China exceeding 28 million annual infections in humans (Feng and Xiao, 2011). 
Variable prevalence rates of 4.8 – 9.7 % have been reported between Chinese urban 
and rural communities (Dib et al., 2008). At least 16,747 infections occur per year in 
technologically advanced countries, such as the United States of America (USA) 
(Office of Surveillance, 2013) and incidents of infection appear to be seasonal (Esch 
and Petersen, 2013). 
G. duodenalis is comprised of a genetically diverse group of isolates which infect 
humans and other mammals. These divergent Giardia spp. genotypes were first 
recognized in humans by molecular techniques and termed Assemblages A and B 
(Mayrhofer et al., 1995) and later confirmed by Cacciò et al. (2005). Phylogenetic 
groupings based upon regions of nucleotide homology using comparative DNA 
sequence data have characterized the differences between Giardia spp. isolates as 
genetic Assemblages (Monis et al., 1999, Lasek-Nesselquist et al., 2009, Thompson 
and Monis, 2012). The term ‘Assemblage’ is now widely accepted by parasitologists to 
describe the different genotypes according to phylogenetic analysis from multiple gene 
loci.  
Eight different genotypic groupings of G. duodenalis (described in 1.3) have been 
characterized according to similarity of genetic characteristics, are known to infect 
different host species and designated as genetic Assemblages A – H (Monis et al., 
2003, Caccio and Ryan, 2008) as shown in Table 1.1.  
Table 1.1 Host species and G. duodenalis genotypes 
G. duodenalis genotype Host species Proposed species nomenclature 
A (human) Giardia duodenalis 
B (human) Giardia enterica 
C and D (canine) Giardia canis 
E (ungulates) Giardia bovis 
F (feline) Giardia cati 
G (rats) Giardia simondi 
H (marine seals)  
Adapted from (Thompson and Monis, 2011) 
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Collection of evidence for a potential Australian marsupial assemblage is ongoing 
(Thompson et al., 2010). Reclassification of G. duodenalis as 6 different species, has 
been proposed to replace those currently designated as Assemblages A-G (Monis et 
al., 2008). 
Published data has reported the presence of mixed G. duodenalis assemblages after 
laboratory testing identified more than one genetic group (Caccio and Ryan, 2008, 
Lebbad et al., 2011). The increasing evidence that more than one Giardia spp. 
genotype is able to infect mammalian species, either as one genotype, or as multiple or 
mixed infections confuses genetic characterization and there is the possibility of 
transfer of genetic material (Birky, 2005, Lasek-Nesselquist et al., 2009). 
A review of molecular epidemiology of Giardia species examined global data from 
humans, wild and captive animals, including marine species, livestock, and domestic 
pets, providing further verification that giardiasis is a zoonotic disease (Feng and Xiao, 
2011). The reviewers assert that some critical omissions remain in the research, 
including perspectives on the impacts of disease originating from zoonotic parasites. 
Moreover, that evidence for transmission dynamics requires rigorous longitudinal 
studies, and clear associations between the distribution of the particular Giardia 
species responsible for infection of humans and endemicity.  
Prevalence data alone cannot extend the body of knowledge to adequately inform 
members of the public, health professionals and government institutions with the 
information necessary to appreciate the risks of such infections and prevent large-scale 
outbreaks and the spread of asymptomatic infections.  
1.6 Infection routes 
Only viable cysts are capable of survival in aquatic environments and enable infections 
to occur through direct person-to-person contact or contaminated water and food by 
the faecal-oral route. All these circumstances arise from host organisms excreting cysts 
into the environment. A specialized cell wall construction provides a stable 
arrangement to preserve cyst structure as inactive under cool, moist conditions until 
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ingestion and exposure to favourable conditions. Within another host organism 
ingested cysts develop into active trophozoites they are able to cause patent infections. 
The features of Giardia, which contribute to the successful invasion of a wide range of 
host organisms appears to depend on efficient transformation from motile trophozoite 
into a resistant impenetrable cyst. 
Mycoplasma-like structures were first shown attached to the outer surface of Giardia 
cysts (Feely et al., 1988) and trophozoites isolated from rats were discovered to be 
capable of ingesting bacteria (Sogayar and Gregorio, 1989). Intact Giardia cysts are 
ingested by other microorganisms as described for Entamoeba sp. (Logan et al., 1980) 
and may also be parasitized themselves, confirmed for Giardia lamblia virus, a 36nm 
double stranded ribonucleic acid virus (Wang and Wang, 1986, De Jonckheere and 
Gordts, 1987).  
1.7 Eukaryotic protozoan model organism 
Whilst Giardia spp. infections are rarely life threatening this eukaryotic protozoan is an 
important organism to study in more detail because 1) It has unique and complex 
structural and metabolic features. Considered as a protist, Giardia spp. lack 
mitochondria, have a simplified endoplasmic reticulum and golgi apparatus and are 
binucleated. 2) It is unicellular with a simple lifecycle, easily cultured in-vitro and can be 
used as a model for similar parasitic organisms. 3) Unanswered questions remain 
concerning the indirect effects of subclinical, or asymptomatic, Giardia spp. infections 
and failure to thrive in the host species 4) The complexity of the host interactions and 
differences between Giardia spp. infections in various host species is undocumented. 
However, these unicellular parasitic organisms may have actually always been present 
and co-evolved in parallel with other organisms in the ecosystem and adapted as the 
environmental conditions changed thus leaving migrants to the region uniquely 
vulnerable to infection (Ricklefs and Bermingham, 2002). 
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1.8 Lifecycle of G. duodenalis in mammalian species 
A recent review by (Luján and Svärd, 2011) brings together global expertise in G. 
duodenalis epidemiology and biology that details and discusses the value of G. 
duodenalis as a model organism. Detailed explanations of G. duodenalis life cycle and 
cellular metabolism have recently been reviewed (Dawson et al., 2011, Jarroll et al., 
2011). A summary of the G. duodenalis lifecycle, as it is known to occur in human 
hosts, is presented in Figure 1.2. 
1.8.1 Cellular structures 
G. duodenalis has a simple, lifecycle, with two distinctive morphological forms the non-
motile cyst and the motile, reproductive trophozoite that transition within the gastro-
intestinal tract of the host organism (Adam, 2001). Key features of unicellular Giardia 
spp. are binuclear cells and absence of mitochondria in this protozoan parasite. Giardia 
cysts are thin-walled impenetrable cysts capable of surviving in the environment for 
long periods, whilst remaining infective for up to 6 months (Deregnier et al., 1989).  
1.8.2 Giardia spp. cyst 
Cysts are excreted in the faeces, sometimes hundreds of thousands (Wallis and M., 
1986). These microscopic structures are specially adapted to be able to withstand a 
wide range of environmental conditions, subject to the limiting factor of water, as they 
are highly susceptible to desiccation (Van Herk et al., 2004). Some of the distinguishing 
biological features are explored in more detail with respect to diagnostics in Chapter 3 






Figure 1.1 Giardia spp. cyst 
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Giardia spp. cysts, clearly visible under light microscopy at X400 magnification have 
evident microtubule structure running the entire length of the cyst with paired nuclei to 
either side, as depicted in Figure 1.1. Median bodies, unique microtubule structures, 
are visible in the centre of the cyst. More detailed electron micrograph studies provide 
comprehensive descriptions of trophozoite and cyst ultrastructures (Erlandsen et al., 
1989, Benchimol and De Souza, 2011). 
The non-motile G. duodenalis cysts are 8-14µm long and 6-10µm wide, with two or four 
nuclei, axostyle and crescent shape fragment of the ventral disc structure (Smith and 
Mank, 2011). Host ingestion of Giardia cysts occurs by the faecal-oral route. Binucleate 
or tetranucleate cysts excreted in faecal samples have the potential to excyst and 
produce four daughter trophozoites in a new host. Cysts are induced into excystation 
following exposure to low pH by gastric acid to form an intermediate excyzoite 
(Bernander et al., 2001) and ultimately mature trophozoites in the proximal region of 
the small intestine Douglas et al. (1988). Encystation occurs due to conditions 
prevailing in the proximal small intestine, alkaline pH, in the presence of bile secretions 
or cholesterol depletion and (Reiner, 1995, Lauwaet et al., 2007) or in the presence of 
carbonic acid (Feely et al., 1991). The process of encystation is a key survival 
mechanism of the parasite and the specializations enable the dissemination of 
excreted cysts across a range of environmental conditions.  
1.8.3 Trophozoite (vegetative stage) 
Excystation occurs in the duodenal and jejunal portions of the small intestine. In 
general, trophozoites are seldom observed exterior to the body cavity, and if present in 
fresh faecal samples disintegrate rapidly. The free form, vegetative, anaerobic, 
trophozoite is binucleate and pyriform typically measuring 12-15µm in body length, 5-
9µm wide and 2-4µm thick (Benchimol and De Souza, 2011). The trophozoite has a 
distinctive ventral disc and eight flagella (Harris et al., 2000). A complex internal 
organization comprises four cytoskeletal components; ventral disc; median body; 
kinetosomes; flagella; and fibrils.  
Chapter 1 General Introduction 
 34 
1.8.4 In vitro culture 
The value of in vitro experiments has been and continues to be important for 
understanding species differences in trophozoite localization, and gastrointestinal 
conditions conducive to excystation or encystation. Gillin and Reiner (1982) have 
demonstrated the conditions supporting optimal in vitro growth of G. duodenalis 
(Portland strain) to include thiol reducing agents, neutral pH, 35.5 - 37oC temperature in 
the presence of serum globulins, and 200-300 mOsmol/kg ionic composition. In 
addition, some physiochemical features of the gastrointestinal tract such as polyanionic 
mucins may influence survival and pathogenicity of G. duodenalis (Hansen and 
Fletcher, 2008). 
Despite advances using in vitro culture experimentation (Davids et al., 2011) the 
majority of the information has been limited to only a few human infective strains of 
Giardia spp. There is a need to conduct comparative research using genetic variants 
isolated from other host species. Whilst the literature also poses questions about the 
long-term viability of in vitro Giardia spp. cultures and clonal lines and the encystation 
and excystation methods used (Lauwaet et al., 2007, Ratner et al., 2008, Solarczyk, 
2009). The suitability of these methods may not adequately reflect the in vivo 
conditions and interpretation of results must be carefully considered.  
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1.8.5 Life cycle 
 
Figure 1.2 Life cycle of G. duodenalis 
Different morphological forms exist as trophozoites (enteric) and cysts (environmental).  
This aspect of the lifecycle becomes important with respect to distinct structural 
features, which are discussed further in the following section and in Chapter 5.  
Additional intermediate morphological forms reported to occur during excystation and 
encystation lifecycle stages include excyzoite (Bernander et al., 2001) and encyzoite 
(Reiner, 2008). 
1.8.6 Giardia spp. life cycle transitions 
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1.8.7 Signaling pathways  
Giardia spp. signalling pathways as depicted in Table 1.2 involve a range of molecular 
types, including phosphatase and kinase enzymes (Lauwaet et al., 2007, Davids et al., 
2008). There are specialized ESV and intraflagellar (IFT) protein trafficking 
mechanisms (Hehl and Marti, 2004, Dawson and House 2010) and trophozoite 
responses to host lipid components of steroid compounds, such as cholesterol (Yichoy 
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et al., 2011). In addition, research has demonstrated similar functional proteins in G. 
duodenalis to those seen in plants and algae for Giardia cell wall protein regulation 
Ankarklev et al. (2010) and DNA binding, (Sun et al., 2006) together with calcium as a 
key regulator in synaptic vesicle recycling and fusion pore formation (Südhof, 2004).  
Within the context of the microflora of the gastro-intestinal tract, inter species signaling 
or quorum sensing may exist between Giardia spp. and other parasites, or with 
selected bacterial species. These types of factors, which may prove critical to 
establishment of active infection, are important to consider in relation to the interactions 
within the mucosal epithelium, likely biofilm composition, and Giardia secretory 
products.  
1.8.8 Cell cycle regulation and synchronisation 
The regulation of Giardia spp. cell cycle is only partially understood, and various factors 
make this a challenging and unique organism to understand. Giardia spp. is considered 
a protist possessing features of both prokaryotic and eukaryotic organisms. The results 
from in vitro culture studies shown in Table 1.2 using a DNA replication inhibitor, 
aphidicolin, has demonstrated that Giardia cell cycle regulation of genes, such as 
histone, occurs at the transcriptional level (Reiner et al., 2008). Reiner’s work has 
confirmed that DNA replication is not dependent on cell growth and that a control point 
exists at G2/M phase of DNA replication, the absence of double stranded DNA 
effectively impedes cell division. 
Flow cytometry studies of cell synchronisation suggest that G. duodenalis undergoes 
three life cycle stages, regulated by transcriptional processes, over a six hour time 
period (Troell and Svärd, 2011). Post-translational modification has been demonstrated 
to occur in cyst wall and trophozoites by mono- and poly-ubiquitinylation modifications 
at lysine residues (Nino and Wasserman, 2010). 
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1.8.9 G. duodenalis organelles and cytoskeletal structure  
The following section describes in more detail the cellular and subcellular organelles 
unique to G. duodenalis that have been investigated using in vitro culture techniques 
and worthy of closer scrutiny both from diagnostic and therapeutic perspectives 
(Aguilar-Dìaz et al., 2011). A comprehensive review published by Luján and Svärd 
(2011) contains more details. 
1.8.10  Organelles and molecular mechanisms   
Four key elements occur in the encystation process in the lower portion of the digestive 
tract; detection and triggering expression of specific genes; synthesis and transport of 
the cell wall proteins (CWPs) into ESVs (encystation-specific vesicles); (Reiner et al., 
1990) assembly of the extracellular cyst wall; and nuclear division and DNA replication 
(Hehl and Marti, 2004). The G. duodenalis cyst cell wall encloses cell contents 
comprising nuclei and other organelles. On the cyst surface variant specific proteins 
(VSP) possess unique antigenic properties for evasion of the host immune system 
(Nash et al., 1983). The cyst functions as the principle infective form of G. duodenalis 
and a later section comments on literature describing in vivo studies of artificial Giardia 
infections induced in experimental animals using Giardia spp. cysts. 
The Giardia spp. cyst wall is composed of protein and a large proportion of 
carbohydrate (40%), mainly in the form of N-acetylgalactosamine (Jarroll E.L. et 
al.,1989, Manning et al., 1992). Five enzymes catalyse construction of the G. 
duodenalis cyst wall during encystation (Macechko et al., 1992). The process is 
regulated by transcriptional factors by means of amino sugars galactosamine and 
glucosamine together with a small number of other sugars to form a filamentous 
protein-polysaccharide complex (Manning et al., 1992, Lujan et al., 1995, Gerwig et al., 
2002). 
Electron microscopy work demonstrated a fibrillar extracellular cyst matrix contained 
extensive protein–protein interactions (Erlandsen et al., 1989) and since confirmed to 
be proline and glycine amino acids within leucine rich repeats, the critical elements for 
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retaining cyst wall structure  (Lujan et al., 1995). Molecular carbohydrate interactions of 
the cyst wall coupled with protein structures contribute to providing a highly insoluble 
cyst wall structure (Gerwig et al., 2002).  
1.8.11 Cyst wall proteins 
Four cyst wall proteins have been identified. One has been identified as a lectin 
(Chatterjee et al., 2010) and is similar to other cell wall proteins (Gillin et al., 1987, 
Luján et al., 1997, Sun et al., 2003) with a structural conformation that contains leucine 
rich repeats a coding motif common in protozoans, (Lujan et al., 1995, Kedzierski et al., 
2004b). The fourth, is a cysteine rich non-variant specific protein HCNCp (Davids et al., 
2006). The cell wall matrix of G. duodenalis consists of an outer protofilamentous layer 
and an inner two-layered membrane but the final fibrillar extracellular matrix observed 
in electron microscopy points to a highly organized structure involving extensive 
protein–protein interactions (Hehl et al., 2000). Golgi type functions in ESV have been 
demonstrated by the use of epitopes and monoclonal antibodies where proteolytic 
processing of CWP 2 develops into two parallel protein sorting and secretion routes 
entailing alternate reaction kinetics (Konrad et al., 2010). Subsequent protein 
aggregation is regulated by biophysical conditions of acidic pH and calcium ions, and 
the outcome from an elaborate study depicts the molecular integration steps for 
construction of cyst cell wall, shown in Figure 1.3 (Chatterjee et al., 2010). The steps 
involved in cyst cell wall manufacture are critical for conferring cell wall integrity and it’s 
impermeable membrane. Disruption of the process would result in thicker membrane 
but lacking its impervious properties (Chatterjee et al., 2010). 
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Figure 1.3 Dismantling of G. duodenalis cell wall structure during excystation  
   From Chatterjee et al., 2010 
1.8.12 Encystation specific vesicles (ESV) 
Encystation specific vesicles (ESV) identified by (Reiner et al., 1989) are believed to 
have a specific role in synthesis and transportation of cyst wall proteins ready for 
assembly and construction of the cyst wall (Hehl et al., 2000). Visible protrusions have 
been documented on the outer surface of trophozoites at commencement of the 
encystation stage during formation of ESV (Bittencourt-Silvestre et al., 2010). These 
encystation specific vesicles package and transport proteins from the endoplasmic 
reticulum to sites for cell well construction (Marti and Hehl, 2003). Intracellular control 
of vesico-tubular transport during encystation occurs by cytosolic recognition, with Rab 
protein and cytoskeletal actin guiding newly manufactured ESV to location for synthesis 
of cyst cell walls (Castillo-Romero et al., 2010). 
The process of encystation is a key survival mechanism of the parasite and the 
organism’s specialisation enable the dissemination of cysts across a range of 
environmental conditions. Low levels of cysts can induce infections, and molecular 
genetic technologies are able to determine Giardia genotype from a single cyst 
(Ankarklev et al., 2012). G. duodenalis appears to have a minimal endomembrane 
system, with true early/late endosomes lacking, and a fused endosomal compartment 
(peripheral vacuole). Principle features of the endocytic system - are (i) multiple routes 
from the surface, (ii) several functionally differentiated endosomal structures including 
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the early endosome, the recycling endosome and late endosomes, (iii) integration with 
a degradation pathway, variously termed the lysosome or vacuole. and (iv) close 
integration with the Golgi complex and the trans-Golgi network and consequently 
exocytic traffic (Field et al., 2007, Rivero et al., 2012). The control of the endocytic 
system is partially mediated by the Rab proteins, and integrated with the protein and 
lipid kinase system (Rivero et al., 2013). There is evidence that endosomal trafficking 
indicates a specific role for phosphatidylinositol (PI) lipid kinases (Field et al., 2007). 
1.8.13 Excystation 
A Giardia specific cysteine protease, cathepsin B initiates excystation (Ward et al., 
1997). In vitro studies have successfully demonstrated excystation of G. duodenalis 
cysts, although varying results have been reported by different research groups, and 
may also be dependent upon the host species of origin, and the maturity of the cysts 
(Lauwaet et al., 2007). Excystation is dependent upon dephosphorylation of cyst wall 
proteins, Giardial acid phosphatase is one of the proteins responsible for this and 
localizes to the soluble transmembrane fraction (Slavin et al., 2002). Whilst reference 
to host proteases is proposed by (Samuelson and Robbins, 2011) the role of these 
proteins is not yet fully understood. Aguilar-Dìaz et al. (2011) compared the cyst 
structure of G. duodenalis to that of the free-living amoeba Acanthamoeba castellani 
suggesting similarities between the architecture and packaging of cyst wall structures 
and the existence of a double envelope of ectocyst and endocyst structure with an 
intervening space. The authors suggest that between the envelopes, at the point of 
contact, an ostiol exists from which an operculum can be observed for exit of 
binucleated trophozoite supporting similar observations made for encysting G. 
duodenalis trophozoites (Hirukawa et al., 1998, Midlej and Benchimol, 2009, Fouque et 
al., 2012).  
1.8.14 Trophozoite  
The free form vegetative anaerobic trophozoite has a binucleate, pyriform shape, broad 
anterior and narrow posterior typically measuring 12-18μm in body length, 6-8μm wide 
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and 2-4μm in thickness with eight flagella arranged in four lophotrichous pairs that are 
attached to basal bodies at anterior and posterior lateral positions at ventral and caudal 
positions, with all flagella arranged in the caudal direction (Nohynkova et al., 2006). 
Two nuclei are situated bilaterally to the midline in the broad anterior. The cytoplasm is 
studded with glycogen granules and peripheral vacuoles, free ribosomes and vesicles 
are present (Gillin et al., 1996). Mitochondria are absent, although mitosomes, putative 
golgi complexes and lysosomal vacuoles, all believed to form part of a transport 
mechanism, are present (Abodeely et al., 2009). Structural bodies are integral to 
differentiation process and flagella synthesis occurs at the same time as degradation 
(Dawson and House, 2010). The motile trophozoites migrate along the proximal 
duodenum as free trophozoites or attach and colonize the duodenal epithelial layer. 
Complex interactions control the Giardia spp. cell cycle and life cycle and a ubiquitin 
transfer process has been proposed to control glucosamine phosphate production 
during cyst cell wall formation (Lopez et al., 2002). Protein phosphatase 2A (PP2A) 
locates to the cell wall and is associated with loss of trophozoite motility and adhesion 
during encystation process (Lauwaet et al., 2007). In other eukaryotic organisms 
phosphatase enzymes reverse regulatory control exerted by protein kinases. (Porter 
and Sale, 2000). 
Mitosomes have been shown to play an important role in the Fe-S metallo protein 
complexes (Tovar et al., 2003) and a proteomic analysis of the mitosomal fraction of 
Giardia trophozoites supports a biosynthetic role in assembly of the iron-sulphur cluster 
assembly. The study identified 139 proteins, 44 of which could be localized by 
combining iTraQ mass spectrometry data with bioinformatic analysis. Thus, 
confirmation of redox proteins together with chaperone proteins and protein transport 
functions by ToM40 indicates the possibility of ion and metabolite exchange across the 
outer membrane. However, TIM proteins (inner membrane transport) were absent 
(Dolezal et al., 2005, Jedelsky et al., 2011). Peripheral vacuoles have lysosomal and 
endosomal functions Lanfredi-Rangel (2003) and Touz et al. (2002) have demonstrated 
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that Giardia possess a uniquely divergent transmembrane cysteine protease displaying 
homology to other eukaryotic cathepsins, which cleaves cyst wall protein 2 (CWP 2) 
disrupting cyst wall synthesis. 
A lectin-affinity chromatography approach combined with PAGE mass spectrometry to 
investigate the glycoproteins of Giardia trophozoites and cysts demonstrated that 
proteins with glycine rich repeats were more common in cysts and contained more 
unique membrane proteins in contrast to trophozoites. More endoplasmic reticulum 
(ER) folding associated proteins, lysosomal and secretory proteins with leucine rich 
repeats were present in trophozoites (Ratner et al., 2008). These differences in protein 
trafficking processes are important for understanding how-host-parasite interactions 
occur and molecular mechanisms for evasion of the host immune system. 
1.8.15 Flagella 
G. duodenalis trophozoites are tetrakonts, with four pairs of flagella, these are 
positioned as ventral; anterior; caudal and posteriolateral pairs. Flagella are composed 
of axonemes and cross linking coiled coil protein structures and similarity to myosin 
type structures were described in early studies (Holberton et al., 1988). The role of 
flagella are primarily for motility, fluidity of movement, both in terms of speed and 
specialization to interact with host digestive system and external environment, and 
survival within aqueous conditions. Paraflagellar rods are closely associated with 
flagellar structures and have been described for ventral flagella structure (Benchimol 
and De Souza, 2011) and similar dense rod structures linked to anterior and posterior 
flagella. The anterior axoneme flagellar structure has distinctive striated fibres or 
‘marginal plate’ whereas caudal flagella have distinctive microtubule structures 
described as ‘funis’ (Elmendorf et al., 2003). Since the original estimates of at least 20 
cytoskeletal proteins Holberton and Ward (1981), Crossley and Holberton (1983) the 
number of confirmed identities has increased to include 32 ventral disk associated 
proteins (Hagen et al., 2011) and 278 protein kinases (Manning et al., 2011). More 
recently, results from electron microscopy spatial 3D whole trophozoite models have 
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endorsed the work performed 40 years earlier by Crossley and Holberton (1983). This 
preliminary 3D imaging research is expected to be of importance for establishing 
localized functions for specific proteins and proteinaceous complexes (Schwartz et al., 
2012). 
1.8.16 Cell signaling – flagellar mechanisms 
Flagella are also likely to have a key biological role for signal mediation either between 
trophozoite and host, or between individual trophozoites, in addition to transition to the 
cyst form. Signaling may occur through protein trafficking by intraflagellar transport 
proteins known as ‘trains’ (Engel et al., 2009). Sloboda (2009a) used video-enhanced 
differential interference contrast (DIC) light microscopy to describe how intraflagellar 
transport complexes fall into two distinct categories, according to length and 
morphology and protein assembly.  
The role of flagella may be key in establishing Giardia infections and signaling 
responses, be they immune or pathophysiological. Importantly, flagellar development 
occurs over 3 cell cycles with eight flagella of trophozoites having chronologically 
different development stages, until reaching maturation at completion of the fourth cell 
cycle (Dawson et al., 2011). The caudal flagella signalling of G. duodenalis has been 
associated with PP2A and nek kinase, although the precise pathway remains to be 
determined, although likely to be chemotactic processes (Lauwaet et al., 2007). The 
unique organelle components of Giardia spp. basal bodies may provide an option for 
two different mechanisms of flagellar protein trafficking, for morphogenesis and 
maturation (Briggs et al., 2004).  
1.8.17 Molecular components of intraflagellar transport 
The role of deflagellation and regeneration has been investigated in green algae cells 
of Chlamydomonas reinhardtii, a bikont (flagellated organisms with 2 flagella). Cells 
were exposed to an acidic pH shock, which induces flagellar abscission (Dentler, 2005, 
Pazour et al., 2005, Engel et al., 2009). The key structural components for IFT include 
tubulin dimers, membrane proteins, and pre-assembled dynein arms and radial spokes. 
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Engel et al. (2009) used Green Fluorescent Protein (GFP) to tag IFT proteins and 
measured IFT rates as a function of flagellar length. Cytoplasmic factors limit IFT 
formation and a significant role has been proposed implicated for flagella in the 
interaction with extracellular matrix proteins. Engel (2011) reports that the size of IFT 
proteins is inversely proportional to flagellar length. This technique has been used in 
recent experiments on G. duodenalis to confirm that trophozoite attachment to 
epithelium of the small intestine is not dependent upon flagellar motility (House et al., 
2011). 
Considering that the flagellar proteome of green algae contains nearly one hundred 
proteins that have conserved homologues in humans but whose homologues have not 
yet been characterized in any organism, this highlights the need for further research on 
these type of proteins (Pazour et al., 2005). Ninety per cent of the genes examined 
were induced by deflagellation, suggesting primary functions in cilia or flagella although 
only ten percent of them have been identified (Ostrowski et al., 2002). G. duodenalis is 
a non-ciliated organism, with a unique array of eight flagella, although differences in 
associated cell structures such as the marginal groove or striated fibres have been 
documented for different Giardia species (Friend, 1966, Sogayar and Gregorio, 1989). 
Flagellar length has been noted by Binz (1996) as one significant morphological feature 
differentiating between Giardia spp. isolated from various host and geographical 
locations. Further details of recent discoveries concerning the structural components 
and specialized functions of Giardia spp. flagellar proteins have been reviewed 
(Benchimol and De Souza, 2011). O-linked glycosylation of proteins is a unique feature 
of Giardia spp. (Banerjee et al., 2009). A definitive explanation of the interactions 
between cytoplasmic or organelle proteins and structural elements of the microtubules, 
such as those described for acid phosphatase and adaptin proteins remain under 
investigation (Rivero et al., 2012). The cell differentiation and encystation processes 
are dependent upon rearrangement of microtubule structures, but it is unclear how the 
genetic information directs protein expression and trafficking to support new cell growth 
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or cyst formation.  
These mechanisms are of key importance in establishing Giardia infections through 
successful attachment to the epithelial cell wall of the small intestine. Hence, it is 
important to understand the molecular features conferring the structural and infective 
functions of cysts and trophozoites transitioning between the two life cycle stages. 
1.9 Detection of Giardia spp. infections 
Detection and characterization of G. duodenalis has been reported from all continents 
of the world (Lu et al., 1998, Leonhard et al., 2007, Caccio and Ryan, 2008). Early 
research reports the detection of Giardia using light microscopy and whilst prevalence 
rates and host species were identified, development of DNA sequencing and genetic 
characterization did not become readily available until the 1990’s (Ford, 2005). 
Attempts to understand the differences between Giardia spp. infections in humans and 
other host species commenced using isoenzyme electrophoresis (Homan et al., 1992, 
Mayrhofer et al., 1995). Genetic characterization of Giardia spp. isolates using DNA 
sequencing methods (Hopkins et al., 1997, Monis et al., 2009) have been developed as 
research tools and routine diagnostic methods remain principally faecal flotation and 
light microscopy. Diagnosis is not straightforward and an entire chapter (Chapter 2) of 
this thesis is devoted to investigating this further. 
Currently diagnostic tests for Giardia spp. are not able to alert medical practitioners or 
veterinarians to potentially zoonotic strains. Nor do the tests define or guide industry 
acceptance of what constitutes normal or acceptable levels of infection and what is 
considered a high prevalence rate within a population or severe infection levels in 
individuals, even though they may be asymptomatic. Hosts frequently experience 
recurrent bouts of infection and intermittent shedding of cysts poses challenges for 
diagnosis.  
Gastrointestinal tract infections are caused by a variety of pathogens; the clinical 
practitioner relies on patient history and clinical diagnostics to eliminate infections of 
bacterial or viral origin. In addition, the use of correct sampling and diagnostic methods 
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for investigation of intestinal protozoa, such as Giardia, Blastocystis sp.; Entaemobea 
sp.; Diaentomeba fragilis in the differential diagnosis of IBS are important (Savioli et al., 
2006, Stark et al., 2007). The routine use of light microscopy for diagnosis, based on 
the presence or absence of intact cysts or trophozoites in faecal samples is gradually 
being replaced with molecular detection methods for copro-antigenic protein. Unlike 
genetic characterization using faecal DNA fragments of Giardia, detection of Giardia 
proteins reveal phenotypic characteristics. 
1.10 Public health  
In a global context, the neglected diseases initiative provides an important focus for 
governments in the 21st century to better understand zoonoses (WHO et al., 2006). 
There is much interest in biological differences between mammalian species to better 
understand parasitic ecosystems and aspects of human health. (Pedersen and Fenton, 
2006). 
 
1.11 Giardia canis – a literature review 
The earliest reports of Giardia spp. infections in dogs can be traced back 90 years to 
Pennsylvania in the United States of America (Hegner, 1922). A comparative study 
conducted by Hegner (1922) demonstrated differences between three different Giardia 
spp. isolates from rabbit, human and canine hosts, confirming an earlier study by 
Bensen in 1908, that three isolates of Giardia spp. were discernible by morphological 
features (Grant and Woo, 1977). At this time, trophozoites from rabbit hosts were 
named Giardia duodenalis, those from humans Giardia lamblia and those from puppies 
were Giardia canis. Morphological differences in size and shape were considered as 
constant heritable characteristics after examining more than fifty specimens from each 
host. G. canis trophozoites and cysts were both slightly larger than those for G. lamblia 
specimens from human hosts. 
Differences in the morphologically distinct features of trophozoites found to infect dogs, 
have been mentioned by Barlough (1979) and Binz (1996). Given the recent 
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publication of the Giardia genome, (Hamnes et al., 2007, Morrison et al., 2007, 
Aurrecoechea et al., 2009, Jerlstrom-Hultqvist et al., 2010) it is timely to advance the 
body of knowledge to include phenotypic descriptors exclusive to one host species, 
other than human.  
1.11.1 Prevalence and epidemiology  
Tracing the origins of Giardia spp. infection is important in the understanding the 
spread of infection and potential management strategies; details of studies conducted 
in human hosts are outlined in Section 1.5. 
1.11.2  Molecular epidemiology of canine Giardia spp. infections 
The first molecular identification of Giardia spp. assemblages C and D was from dogs 
living in remote indigenous Australian communities (Monis et al., 1998) and now 
consistently referred to as host specific genotypes (Thompson et al., 2000, Eligio-
Garcia et al., 2005, Wielinga et al., 2011). Since 1998, most molecular epidemiological 
studies indicate that dogs are infected with host specific Giardia spp., although the 
ability to detect potentially zoonotic genotypes is becoming more common, both in 
dogs and in other wildlife species (Carmena et al., 2012). Subsequent studies have 
demonstrated that the majority of Giardia spp. infected dogs harbor Giardia spp. 
Assemblages C and D, confirmed by genotyping at 18srDNA and beta giardin gene loci 
(Palmer et al., 2008, Upjohn et al., 2010, Uehlinger et al., 2013).  
This concept of host specific Giardia spp. corroborates the earlier identification and 
naming of G. canis. The predominance of Giardia spp. genotypic assemblages C and 
D infections in canines is associated with both symptomatic and asymptomatic cases 
(Barutzki and Schaper, 2003, Barutzki et al., 2007, Claerebout et al., 2009, Upjohn et 
al., 2010, Uehlinger et al., 2013). The other Giardia spp. genetic isolates commonly 
isolated from dogs are assemblages A and B, both of which are known to infect 
humans (Van Der Giessen et al., 2006). Research in different laboratories around the 
world, has demonstrated the existence of four different genetic assemblages of Giardia 
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duodenalis infecting dogs (Homan et al., 1992, Mayrhofer et al., 1995, Monis et al., 
2009). However, to complicate matters further there are increasing reports of mixed 
infections in other species and the possibility of genetic changes to the organism, over 
time (O’Handley et al., 2000, Fontanarrosa et al., 2006, Ankarklev et al., 2012). 
The use of genetic tools has both strengths and weaknesses and increasingly 
researchers are reporting the need for improved genetic characterization methods, 
such as routine use of Multi Locus Genotyping (MLG) in preference to single gene loci 
(Caccio et al., 2008, Wielinga et al., 2011, Jimenez-Cardoso et al., 2012). On 
occasions, amplification of DNA from Giardia positive faecal samples misses nearly 
30% of samples containing Giardia cysts. This is problematic because the molecular 
techniques of PCR and sequencing are unable to verify the presence of mixed 
assemblages even when positive results have been confirmed by microscopy 
(Inpankaew et al., 2007, Traub et al., 2009, Covacin et al., 2011). 
1.11.3  Prevalence and geographical distribution of canine Giardia spp. 
infections 
This section summarizes the prevalence of Giardia spp. infections in canines whilst 
discrete factors of importance are addressed in more detail in section 1.2.10 for clinical 
signs of infection, in section 1.2.21 for management and husbandry and the implication 
of concurrent parasite infections is introduced briefly in section 1.2.23 and continued in 
chapter 3. The literature reviewed in this section includes reports from all continents 
based upon data collected or sourced from a variety of grouped, roaming and 
individually housed dogs and puppies from both small local studies to large cross-
border surveys. The publications reviewed used many different diagnostic methods: a 
range of dog population types, variation in sampling, transportation and storage 
procedures, and different genetic tools and genetic analysis alignment methods. Some 
of these inconsistencies are also noted by (Uehlinger et al., 2013) as potential error 
factors for comparison of canine intestinal parasite prevalence rates. The geographic 
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and demographic extent of the literature reviewed covered natural pristine wild 
environments/landscapes and bushland to urban slums.  
Reaching conclusions concerning the prevalence rates of Giardia spp. infections in 
canines presents challenges for researchers and clinicians as the figures reported are 
dependent upon the sensitivity and specificity of different diagnostic tests used (Upjohn 
et al., 2010), and their accuracy in determining the apparent or true prevalence rates 
(Geurden et al., 2008). Different criteria and approaches used in the research studies 
hinder an accurate assessment of the prevalence and epidemiology of Giardia spp. 
infections. Nevertheless, the material reviewed here provides an opportunity to 
examine infections rates in terms of chronology and trends in detection of Giardia spp. 
infection rates as well as a critical analysis of the diversity of research approaches 
required to resolve questions concerning the impact of Giardia spp. infections in dogs.  
Whilst many studies include samples from humans and other animals many are 
reported as single species (dog only) studies making this of importance to veterinarians, 
companion animal industry, breeding facilities and dog welfare agencies and working 
dog and pet owners. An indication of longitudinal variation in parasite prevalence rates, 
in published reports from Europe Australia and Asia, suggest that overall parasite 
burdens have reduced over time for Giardia spp. although an increasing rate for 
detection of other protozoan infections (Swan and Thompson, 1986, Bugg et al., 1999, 
Itoh et al., 2009 Solarczyk, 2009).  
Seven main factors are indicative of the intricacies of determining prevalence rates of 
Giardia spp. in canines and other species. (1) Consistently higher prevalence rates 
were reported in studies using copro-antigen tests for diagnosis, rather than 
microscopic detection of Giardia spp. cysts. (Carlin et al., 2006, Epe et al., 2010, Olson 
et al., 2010, Upjohn et al., 2010, Mircean et al., 2012). (2) The highest prevalence rates 
were reported for puppies and juvenile dogs up to 12 months of age, at 16%, 26%, and 
46%, 78% (Batchelor et al., 2008, Epe et al., 2010, Itoh et al., 2011, Uehlinger et al., 
2013) respectively. (3) Intensive housing situations repeatedly reported higher 
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prevalence rates with frequent detection of mixed genotype infections (Swan and 
Thompson, 1986, Traub et al., 2004, Huber et al., 2005, Claerebout et al., 2009, 
Uehlinger et al., 2013). (4) Zoonotic Infections were reported more frequently in 
densely populated settlements such as Assemblage A in Bangkok, (Traub et al., 2009) 
and Assemblages A and B, in USA (Covacin et al., 2011) although consistency in the 
methods of detection may resolve the actual published prevalence rates. (5) Difficulties 
with reliable molecular detection of Assemblage B isolates from faecal samples from 
dogs, and humans was common (Traub et al., 2003, Souza, 2007). These difficulties 
were frequently reported, despite using Multi Locus Genotyping (MLG) (Lalle et al., 
2005, Wielinga and Thompson, 2007, Volotao et al., 2007, Caccio et al., 2008, Huey et 
al., 2013). These problems have been attributed to two key factors, i) multiple 
infections and ii) allelic sequence heterogeneity  (ASH) (Caccio and Ryan, 2008). (6) In 
situations where both humans and dogs were sampled, the Giardia spp. prevalence in 
dogs was consistently higher than in humans (Capelli et al., 2003, Traub et al., 2004, 
Itagaki et al., 2005, Solarczyk, 2009, Traub et al., 2009). (7) Overall, widespread 
parasitism in dogs occurs in rural areas, with an extensive range of infecting species 
(Traub et al., 2004, Palmer et al., 2008, Himsworth et al., 2010, Mircean et al., 2012).  
1.12 Zoonoses  
The literature reports that Giardia spp. occurs in most Canidae both domestic and 
wildlife species and that several different subtypes are present (Trout et al., 2006, 
Thompson et al., 2009). The Giardia spp. genotypes confirmed in infected Canidae are 
assemblages A, B, C and D, as outlined in Section 1.5.  
Microscopically it is difficult to differentiate between the various infective forms of G. 
duodenalis. However, at a molecular level, genotyping work has demonstrated that 
different subtypes of Giardia spp. exist. The different sub-types correspond with the 
host species and have been described by Monis et al. (2009) and Thompson and 
Monis (2011). 
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Giardia spp. infects domesticated livestock, household pets and, both captive wildlife 
and those in natural environments. The rapid and high rates of transmission observed 
between individuals in a community and the fact that individual hosts respond 
differently to parasitic invasion, with asymptomatic hosts, has contributed to a proposal 
for zoonotic transfer of Giardia spp. from dogs (Thompson, 2000, Traub et al., 2004). 
Multiple reports exist proposing the zoonotic potential G. duodenalis, although this 
remains to be proven (Faubert, 1988, Bemrick and Erlandsen, 1988, Monis and 
Thompson, 2003, Ryan and Caccio, 2013).  
Determining the mode of transmission between dogs (intra species) of the different 
Giardia spp. subtypes has not been established. In addition, if the Giardia spp. 
subtypes found in dogs are capable of infecting humans (inter species transmission) 
this knowledge will be of medical and veterinary importance, because of the increased 
risk of exposure and infections in humans. The potential epidemic spread of gastro-
intestinal disease would have major implications for public health policy, animal 
management and, prophylactic measures and treatment for both humans and dogs.  
The absence of consistency in research tools or approaches impedes the direct 
analysis and comparison research results reporting prevalence rates and genetic 
characterization of Giardia spp. in dogs. 
1.13 Transmission 
Transmission cycles of G. duodenalis are still not fully understood, the fact remains 
that whilst host specific genotypes exist many non-human species are infected with 
potentially zoonotic genotypes causing public health concerns (Buret et al., 1990, Abe 
et al., 2005, Ryan and Caccio, 2013). The potentially zoonotic Giardia assemblages A 
and B that commonly infect humans have been implicated in cross species 
transmission (Thompson, 2000, Thompson et al., 2008, Palmer et al., 2008, Ballweber 
et al., 2010). This suggestion for zoonotic transmission is further supported by data 
from multi-locus genotyping Giardia spp. infected canine faecal samples with 79% 
Assemblage A Traub et al. (2009) 69% Assemblages A and B Covacin et al. (2011) 
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and 100% Assemblage A (Marangi et al., 2009, Jiménez-Cardoso et al., 2012). This 
data when considered in the context of western communities which permit dogs to lick 
human faces and share sleeping space does pose serious implications for animal 
management and the spread of infectious diseases (Westgarth et al., 2007).  
One biological interpretation proposed by Faubert (1988), is that Giardia spp. is 
zooanthroponotic. This view supported by (Snel et al., 2009) proposes that a similar 
scenario exists for Giardia spp. as previously described for Cryptosporidium sp. 
transmission where there is involvement of two transmission cycles, zoonotic by one 
species, and anthroponotic transmission by a different species, (Morgan et al., 1998). 
Other studies in wildlife species have also suggested that anthroponotic transmission 
of Giardia spp. can occur (Teichroeb et al., 2009, Johnston et al., 2010). There is a 
good indication that the sylvatic cycle is an important facet of Giardia spp. survival in a 
diverse range of environmental conditions, with the capacity to shed infective cysts in 
excrement entering water courses destined for human and domestic animal 
consumption (Thompson et al., 2009, Ash et al., 2010, Johnston et al., 2010, 
Thompson et al., 2010). The non-human host species include canines both wild and 
domestic animals (Beck et al., 2011, Levecke et al., 2011). 
Transmission mechanisms have been investigated using cross species infection and 
association with clinical signs of infection. Gerbils have been shown to be susceptible 
to the Giardia spp. isolates that infect humans, in addition to those infecting beavers, 
guinea pigs, dogs, pronghorn, rats, and sheep. Results from references studies 
examining the action of Giardia spp. in gerbils carried out by Moss et al. (1990), Moss 
et al. (1991), Mohammed and Faubert (1995), and Rivero et al. (2010) have been 
applied to other species including humans. The infective dose used for the successful 
infection of gerbils from in vitro cultures of G. duodenalis did not affect numbers of 
cysts excreted (Amorim et al., 2010) discounting the suggestion of increased cyst 
dissemination. Belosevic and Faubert (1987) demonstrated that sera from mice could 
immobilize and lyse trophozoites, although it remains unknown exactly what 
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component of sera produces this type of lethal defence mechanism. Davies and Hibler 
(1979) recommended the need for cross species transmission studies following the 
‘beaver fever’ incident that contaminated waterways in North America. A gap remains 
in the knowledge of Giardia spp. biology as this study indicated that not all mammals 
were capable of being artificially infected with Giardia spp. of beaver origin, but dogs 
and humans were, and conversely a number of animals were susceptible to artificial 
infection by Giardia spp. of human origin. The critical issue concerning the extensive 
studies conducted in mice and gerbils is that some findings are not directly transferable 
to human physiology. 
There is the possibility that the wildlife infective pool is not confined solely to Giardia 
spp. in beavers, that it could also include herbivore or rodent species in the cycle (Mills 
and Childs, 1998, Fernandez-Alvarez et al., 2013). In addition, the landmark study by 
Davies and Hibler (1979) also includes comments on the location of a dog kennels 
close to the watercourse and defecation by humans directly into the waterways. This 
suggests that Giardia spp. infections in beavers may have originated from non-wildlife 
sources.  
The general view is that Giardia spp. has a simple direct lifecycle, although mechanical 
transmission of cysts to dogs has been discussed by (Barlough, 1979) proposing that 
flies or cockroaches serve as potential mechanical vectors. This opinion is supported 
by additional evidence for transmission of Giardia spp. cysts by flies (Graczyk et al., 
2003, Szostakowska et al., 2004) even though the potential for establishing active 
infection would still requires ingestion of cysts in sufficient numbers equating to an 
infective dose (Rendtorff, 1954). Physical transfer on material objects, such as housing 
construction and bedding may also play a role in facilitating transmission of cysts due 
to the adhesive properties (Dumetre et al., 2012). The fur of dogs has been shown to 
contribute to transfer of viable Toxocara canis eggs (Overgaauw et al., 2009) and 
indirect transport of Giardia spp. cysts by rotifers or other metazoan plankton can occur 
within aquatic environments (Jurgens, 1997, Trout, 2002). Vertical transmission occurs 
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in parasitic protozoans, such as transplacental route for Toxoplasma sp. in developing 
foetus or as described in sexually transmitted diseases (STD), Trichomonas sp. or 
Candida sp. during parturition from contact with mucus membranes (Carlier et al., 
2012) and the lactogenic transmission of Toxocara canis via the mammary glands 
(Martinez-Carrasco C. et al., 2007). Since Giardia spp. trophozoites are not 
intracellular parasites, no evidence has been presented to indicate that Giardia spp. 
may be transmitted by these mechanisms, although the potential for maternal 
transmission to their puppies is high. Transmission can occur during the neonatal 
suckling period when the adhesive outer layer of infective cysts may become attached 
to the maternal fur and gain entry to the digestive tract through the nuzzling action of 
blind puppies (Overgaauw et al., 2009, Dumetre et al., 2012). Additionally there is the 
possibility that composition of the nasal secretion or maternal saliva might contain 
substances to promote cyst activation (Klein, 2004, Piña-Vázquez et al., 2012). 
1.14 Domestic dogs (Canis familiaris) as host species  
Few detailed studies have focused on the impact of Giardia spp. infection in domestic 
dogs. Most studies report on comparative prevalence rates for dogs and humans or 
other species (Berrilli et al., 2004, Lebbad et al., 2008, Minvielle et al., 2008) or as 
retrospective studies of clinical cases presenting at veterinary clinics (Batchelor et al., 
2008, Gates and Nolan, 2009). However, some early studies in indigenous 
communities were able to clearly link infections between dogs and humans (Hopkins et 
al., 1997) by grouping DNA fragment sequences detected by PCR into four groups. 
One group of faecal DNA samples included homologous DNA sequences from humans 
and dogs. Some startling results from a recent survey of canine faecal samples from 
an indigenous community revealed high levels of exposure to Giardia spp. infection. 
Environmental samples that were collected from households in several 
neighbourhoods that owned dogs, and from landfill sites, showed more than half were 
positive for Giardia with faceal cyst counts in excess of 50,000 per gram of faeces 
(Himsworth et al., 2010). This type of data has also been shown to be true for Indian 
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and Thai communities with intensive dog populations, particularly in rural areas of low 
economic living in close proximity to humans (Traub et al., 2009). 
Analysis of Giardia spp. infections in domestic dog populations, such as shelters and 
kennels, by sequencing of the 18s rRNA and beta giardin genes identified the majority 
of infections to be host specific canine assemblages C and D 76.4%, 93.5%, 98.9%, 
100%, (Upjohn et al., 2010), (Claerebout et al., 2009), (Palmer et al., 2008), (Souza et 
al., 2007) respectively. These high rates of Giardia spp. infections reported in dogs 
directly influences the likelihood of human exposure to infection, either from direct 
animal contact or from infected excrement. 
1.15 Public health implications of canine host specific infections 
Canines are known to be susceptible to Giardia infection, as reported for wolves, foxes, 
and African painted dog (Hamnes et al., 2007, Bajer, 2008, Ash et al., 2010, Sousa et 
al., 2011). There is the possibility that co-evolution of host and parasite occurred 
suggesting that different canid species are likely to be infected with similar genetic 
strains of Giardia spp. Despite the large amount of genetic data available it remains 
unclear if different species within the same family of Canidae are infected by Giardia 
spp. of the same genetic origin. 
Canines as domestic dogs (C. familiaris) are important animals in the lives of ordinary 
Australians. Pet ownership figures indicate that 36% of Australia households own a 
dog, 3.41 million dogs, one of the highest rates of ownership of companion animals in 
the world. (Australian Companion Animal Council, 2010). Some of the current public 
health concerns include dog excreta in public open space and the implications for 
transmission of pathogenic parasite infections including Giardia spp. (Rinaldi et al., 
2008, Balassiano et al., 2009, Wang A. et al., 2012). Authors of a public health review 
of the significance of Giardia spp. infections in pets, including dogs suggest that study 
design is an important factor for realizing the significance of Giardia spp. infections in 
dogs (Ballweber et al., 2010). Recommendations included the need for trifecta 
approach including biological, molecular and epidemiological datasets; together with 
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longitudinal sampling and multilocus genotyping or case control investigations 
considering spatial and temporal variations (Ballweber et al., 2010). 
1.16 Genetic predisposition of host  
The canine genome (domestic dog) is now fully published (Lindblad-Toh et al., 2005), 
the domestication and selective breeding of Canis lupus familiaris, has given rise to the 
uniquely wide phenotypic diversity of dogs known in the 21st century. Each breed is 
recognized by distinctive phenotypic traits, the results of genetic inheritance. It is now 
established that particular dog breeds selected for distinct phenotypic traits are known 
to carry genetic pre-disposition to diseases such as hip dysplasia and irritable bowel 
disorder (Famula, 2012, Simpson, 1998) or compromised innate immune receptor 
mechanisms, as reported for Boxer dogs (Simpson, 2010). 
The link between exposure to Giardia spp. infection, and occurrence of other diseases 
may be caused by a compromised immune system, in a similar manner to psoriasis 
and G. duodenalis infections in humans (Demodex sp. infections in dogs) (Singh and 
Dimri, 2014). Researchers suggest that hereditary predisposition to immune system 
dysfunction, and the ability of T-cells to recognize or react to parasite dog leucocyte 
antigen system is more commonly observed in some particular dog breeds, such as 
Labrador retrievers (It et al., 2010). Host immune system responses are discussed 
further in Section 1.2.13. The genetic basis of canine disease explains some inherited 
factors for disease attributed to the intensive and extensive selection and inbreeding 
(Akey et al., 2010, Mellersh, 2012). There is increasing suggestion that some breeds of 
dog exposed to Giardia spp. infections may be more likely to display clinical signs of 
infection (Itoh et al., 2005, Fontanarrossa et al., 2006, Hamnes et al., 2007). If this fact 
can be verified the cause of changes in pathogenicity also need to be confirmed. The 
cause of clinical signs may be attributed to host genetic deficiency in clearing Giardia 
spp. infection rather than variation in parasite genetics or the interaction between host 
and parasite (Lymbery and Thompson, 2012). 
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Research conducted in the context of the microbial ecosystem of the host 
gastrointestinal tract requires consideration of the co-evolution and adaptation 
mechanisms of both the parasite (G. duodenalis) and host (C. familaris) and the 
potential for genetic predisposition and co speciation. The phylogeny and virulence of 
mucosal bacterial gene profiles infections of gastro-intestinal tract in dogs may also 
infect humans and that lineage-specific pathoadaptation may occur (Simpson et al., 
2006). Confirmation of individual or breed specific genetic susceptibility would assist 
veterinarians to make quicker and more accurate diagnosis, and that special 
husbandry and management practices may be advised for particular breeds, possible 
anti-protozoal drugs or vaccination or oral immune boosts. 
The phylogeny and virulence of Giardia spp, infections may also be subject to 
pathoadaptation in a similar manner to bacteria of the mucosal gastro-intestinal tract. 
Studies have confirmed phenotypic differences for in vitro growth rate kinetics for 
Giardia spp. (Plutzer et al., 2010) and the variation of surface proteins is an existing 
adaptation strategy for trophozoites to evade host defences (Nash, 1985, Nash, 2013). 
1.17 Host- parasite interactions 
This review directs attention to the parasitisation of one species, Canis lupus familiaris, 
the domestic dog whilst also considering the prevalence of Giardia spp. in many wild 
canids (captive and non-captive). Dogs as the host species, whilst domesticated, have 
a close genetic relationship with critically endangered wild canids, such as African 
Painted Dogs. As such, their continued survival in the wild depends upon the 
minimization of health threats, such as introduced human pathogens (Ash et al., 2010). 
Based upon genetic analysis and taxonomy, when does one infer the point at which a 
wild animal becomes domesticated? Is this after ‘n’ reproductive generations or when 
there are observable genotypic and phenotypic alterations? Additional information is 
required concerning the phenotypic expression in terms of proteins unique to specific 
Giardia spp. genotypes. Identification of phenotypic characteristics of Giardia spp. 
isolated from dogs may produce unique identifiers assigned to Giardia spp. infections. 
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The potential for using unique phenotypic biomarkers to distinguish between zoonotic 
and host specific Giardia spp. strains and further understand the nature of symptomatic 
or asymptomatic infections dogs infected with Giardia spp. is of value for assessing the 
impact on the host. 
Veterinarians also need to be aware that many dogs harbour asymptomatic Giardia 
infections (Zajac et al., 2000, Lymbery, 2004) and understand the limitations of 
commercial copro-antigen tests. Undetected asymptomatic infections contribute to the 
spread of infection and none of the currently available tests can detect if Giardia 
infections are likely to cause clinical signs. These types of asymptomatic infections can 
only be captured if routine sampling of healthy animals is carried out, using more than 
one diagnostic tool, and further research is needed into the consequences of 
asymptomatic Giardia infections and potential reservoirs of circulating genotypes.  
1.18 High risk groups 
Giardia spp. has been identified in all continents and Giardia ssp. infections are 
common in young and immuno- compromised dogs (Feng and Xiao, 2011). Swan and 
Thompson (1986) first reported Giardia ssp. infections in dog shelters and breeding 
establishments in Australia. A pool of infectious Giardia spp. cysts may persist in 
intensive housing situations as a reservoir of disease, whether or not clinical signs 
develop. Many reports identified the incidence of Giardia spp. infection to be much 
higher in puppies under the age of 12 months (Rimhanen-Finne et al., 2007, Epe et al., 
2010, Itoh et al., 2011, Mircean et al., 2012). Unlike many bacterial or viral 
gastrointestinal diseases, Giardia spp. does not induce life-threatening conditions, but 
is easily spread and has a debilitating effect on young host organisms, especially at 
critical development stages or immuno-compromised individuals (Thompson, 2000, 
Sackey et al., 2003). Puppies and immuno-suppressed dogs become especially 
susceptible to infection, due to the immune system’s ability to respond to infectious 
challenges. Disease occurs when cysts are ingested, usually by drinking contaminated 
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water. Parasites then attach to the surface of the intestine and feed on the mucus 
secretions of the intestine. 
Discussion concerning the severity of acute Giardia spp. infections in humans and 
animals has identified that clinical signs of infection are associated with diarrhoea and 
vomiting. Conversely, chronic Giardia infections are more likely to be reported as a 
failure to thrive, slow growth and stunting and, anorexia (Thompson and Lymbery, 
1996, O'Handley et al., 1999, Berkman et al., 2002, Savioli et al., 2006, Geurden et al., 
2010, Cotton et al., 2011).  
Four main groups of dogs have been identified as being at high risk of Giardia spp. 
infection i) those under the age of one year (puppies and juveniles), (Bemrick, 1964, 
Swan and Thompson, 1986, Itoh et al., 2011, Mircean et al., 2012). Even at low 
prevalence (2.5%) higher prevalence rates were reported for puppies (6%) (Becker et 
al., 2012). ii) those dogs kept in intensive rearing or production groups, (Bugg et al., 
1999, Itagaki et al., 2005, Itoh et al., 2005, Miro et al., 2007, Katagiri and Oliveira-
Sequeira, 2008, Claerebout et al., 2009, Itoh et al., 2011) iii) stray or free-roaming dogs 
are considered to be important contributors to the spread of infectious disease, 
including Giardia spp. (Slater, 2001, Mirzaei, 2010, Mukaratirwa and Singh, 2010, 
Becker et al., 2012). iv) in situations with poor husbandry in lower economic areas with 
reduced accessibility to education (Traub et al., 2009, Gates and Nolan, 2009). A small 
number of reports are provided for incidence of Giardia infections in working dogs, 
such as assistance animals, farm or detector dogs (Papazahariadou et al., 2007, Bajer 
et al., 2011). 
Factors contributing to physiological stress include pregnancy, lactation, weaning, 
movement and rehousing, neutering, and drug interventions, such as deworming are 
likely to affect susceptibility to parasite infection, if exposed. One social survey of 
parasitism in rural households showed that 99% of all dogs tested harboured parasites 
with up to 16 different species being identified, with more than 28% of dogs having 
greater than 3 concurrent infections (Traub et al., 2002). Although the prevalence of 
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Giardia was low, there were high rates of coccidian infections. Similar results were 
reported in a survey of shelter dogs, where Giardia spp. infections were present in 46% 
of all concurrent infections (Miro et al., 2007). 
In urban areas with prophylactic anthelminthic treatments, the number of parasitic 
species reduced with less helminthes and nematodes, but increased protozoan 
infections (Bugg et al., 1999). Additionally, in urban areas, more potentially zoonotic 
genotypes are recorded from urban populations than rural ones, where host specific 
genotypes C and D predominate (Itagaki et al., 2005, Dubna et al., 2007). This 
polyparasitic type of infection is discussed further in Section 1.2.18. 
Risk factors of infection identified for dogs grouped in intensive shelter facilities were 
considered to be at risk of developing Giardia spp. infections due to communal 
housing; construction design and materials of housing facility and the quarantine policy 
and implementation (Ho et al., 2006, Mircean et al., 2012). The public health 
implications are important, from local quarantine to international policy, lack of 
adherence to policy facilitates the spread of disease, as described for importation of 
dogs in Taiwan where 16.8% were carrying parasitic infections (Ho et al., 2006). 
Therefore analysis of the intersect between the rights and responsibilities of companion 
animal and working dog owners, public health officials, wildlife conservationists and 
animal welfare staff is key to minimizing transmission of parasites, such as G. 
duodenalis. Inclusion of dog shelters and breeding facilities in parasitology research is 
important because of possible transmission to humans, particularly children, as well as 
for increasing awareness that immuno-compromised individuals may be exposed and 
succumb to seemingly benign parasite infection. Many research reports have been 
published concerning Giardia spp. infections in canines over the last decade however, 
only one study specifically addressed public education concerning dog health (Palmer 
et al., 2008). A separate article provided an assessment of professionals ability to 
accurately diagnose Giardia infections (Gates and Nolan, 2009a).  
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1.19 Clinical signs of infection in dogs 
Primary signs of acute Giardia spp. infections in dogs include; frequent bouts of 
diarrhea with blood or mucus in pale coloured or bile-stained faeces and malodorous 
stools (Barlough, 1979) with vomiting in 17% of infected cases (Olson et al., 2010). 
Secondary signs of chronic Giardia spp. infections in dogs include; deficiency of fat-
soluble vitamins and associated dry skin and poor hair coat condition (Barlough, 1979); 
weight loss and failure to gain weight (Carlin et al., 2006); anemia and change in 
leukocyte count (Rosa et al., 2007). In addition, asymptomatic infections of Giardia spp. 
may be present although not associated with any clinical or subclinical signs of 
infection (Irwin, 2002). 
The clinical signs of infection evident in dogs have been attributed to host specific G. 
duodenalis. infections with assemblages C and D (Berrilli et al., 2004, Barutzki et al., 
2007). In contrast, asymptomatic Giardia spp. infections in a survey of household dogs 
in Europe have been associated with mainly assemblage A infections (Leonhard et al., 
2007). Whilst in Brazil and Japan, the cause of diarrhoea in dogs was attributed to host 
specific G. duodenalis infections (Itagaki et al., 2005, Souza et al., 2007).  
1.20 Pathophysiology and Intestinal inflammation  
Simpson et al. (2006) established that mucosal microflora are contributing factors for 
granulomatous colitis in Boxer dogs, and it is likely that pathogenic enteric protozoa are 
capable of provoking immune responses in genetically susceptible individuals. 
Intestinal inflammation has been defined as a causative factor of clinical signs in 
Giardia spp. infections. The detailed understanding of canine digestive tract accepts 
that the canine digestive function is similar to that of humans, with the exceptions for 
essential amino acids requirements. Historically, wild canines, such as Canis lupus spp. 
the genetic ancestors of Canis familiaris were mainly carnivorous and the contradictory 
evidence for gastric pH in canines remains unexplained (Akimoto et al., 2000, Sagawa 
et al., 2009). The importance of bile secretion and digestive function is an important 
aspect of Giardia spp. metabolism (Farthing et al., 1983, Farthing et al., 1985) and its 
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role in canines might explain the disparity in genetic identification of Giardia spp. 
infections between host species. 
The microbial ecosystem of the gastrointestinal tract may play a role in enabling 
Giardia spp. populations to establish an infection although this would be influenced by 
diet and secretion of digestive juices and immune factors (Hegner, 1924, Tsuchiya, 
1931).  
A key feature of Giardia spp. is the biochemical and structural transformation from 
inactive cysts to motile, flagellated trophozoites and the subsequent ability to achieve 
attachment to host cells of the duodenal lining. The mucosal lining of the gut may have 
microclimate (or niche conditions) that is conducive to infections.  
Both anecdotal reports and earlier studies have alluded to the severity of clinical signs 
from Giardia spp. infections with other protozoan parasites, such as the coccidian’s 
Cystoisospora sp. and Sarcocystis sp. (Little et al., 2009). However there is limited 
commentary that seriously addresses the causes, interactions, and impacts of 
polyparasitism in dogs. It is apparent that the interface of host-parasite interactions is 
critical for successful infective strategy by this protozoan parasite.  
Martinez and Baquero (2002) present an evolutionary and ecological review of 
pathogenicity of bacteria by examining virulence and drug resistance mechanisms. 
Their assertion is that horizontal gene transfer can explain some of the acquired 
pathogenic characteristics developed from co-existence with the host species within an 
evolutionary context. Furthermore a range of factors are predicted to contribute to the 
evolution of virulence and the potential impacts of novel therapeutics, although 
emphasizing that hygiene approaches to reducing host-host transmission are important 
anti-virulence strategies. This type of scenario might also apply to the evolution of 
Giardia spp. infections where differences in host specificity and pathogenicity could be 
explained as the consequence of co-evolutionary processes. Linking clinical signs with 
microbial gut composition and processes is likely to be a key to understanding the 
pathogenicity of different Giardia spp. genotypes. Further research may extend our 
Chapter 1 Giardia canis 
 64 
current understanding of inflammatory processes in healthy and infected dogs. Some 
of the largest studies on Giardia spp. infections have been conducted in Europe, 
including thousands of dogs over a number of years examining both companion 
animals and breeding populations (Barutzki and Schaper, 2003, Epe et al., 2010). 
Many of the parasite prevalence rates are reported as an overall figure and as subsets 
of juvenile dogs less than 12 months of age (Batchelor et al., 2008, Epe et al., 2010). 
Alternatively, Claerebout et al. (2009) reports differences in prevalence rates for 
household pets, veterinary clinical cases and dogs in kennels although no differences 
in Giardia spp. prevalence rates were due to breed or sex. 
All the studies in Table 1.3 report on clinical signs associated with Giardia spp. 
infections in dogs and genotyping of Giardia spp. suggest that mixed infections with 
assemblage A are present in asymptomatic infections (Leonhard et al., 2007, Barutzki 
et al., 2007). Reports indicate that host specific Giardia spp. (assemblages C and D) 
are associated with the majority of symptomatic infections in dogs (Claerebout et al., 
2009). Assemblage B has been detected in canine faeces, but less frequently than 
other Assemblages except those reported from Africa and USA  (Ash, 2010, Covacin, 
2010). 
Table 1.3 Clinical signs associated with Giardia spp. infections in dogs 






Giardia spp. common parasite, 
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twice as many as 
asymptomatic cases 
Differences between countries 
25% dogs infected, most 
noticeable in young, Gender, 
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breeding and shelter facilities. 
Higher incidence in females and 
shelter dogs, under 6 months 
age. 
(Epe et al., 
2010) 
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Cystoisospora sp. 
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A, C, D (AI zoonotic) More C 
and mixed A/C in grouped 
dogs  
asymptomatic only - no B 
assemblage and more mixed 




1.21 Asymptomatic infections and failure to thrive 
A study of symptomatic dogs using a single commercial copro-antigen diagnostic test 
suggest that 43% of dogs under 12 months old are infected with Giardia spp. (Epe et 
al., 2010) although no additional information is available to assess causes of clinical 
signs. Most cases of Giardia spp. infection in dogs are confirmed in those displaying 
clinical signs, although some studies have investigated asymptomatic dogs as shown 
in Table 1.3. The consequences of asymptomatic infections in dogs may have a direct 
impact on the host with implications for transmission to other host species (Thompson, 
2004). The absence of datasets on asymptomatic infections and possible cycling of 
infection between hosts make this an important consideration for research into Giardia 
infections in canines. 
1.22 Immune function  
Reviews detailing the immune responses to G. duodenalis infections in non-canine 
host species published by Faubert (2000) and Singer (2011) supplement the 
knowledge of antigenic variation found in G. duodenalis trophozoites (Nash, 2011). The 
following section integrates information known about mammalian immune responses to 
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G. duodenalis infections together with information available in the literature that 
focuses on the canine immune system and responses to Giardia spp. infections. 
1.23 Features of the mucosal tract 
The intricate and specialized system of cells and organs of the gastrointestinal tract are 
responsible for sifting and sorting through dietary contents to harness nutrients and 
energy sources and discard waste products. The ability to recognize and respond to 
xenobiotic agents, in particular parasites is an important function. The inner surface of 
the duodenum and colon is coated with secreted mucus, and localized immunoglobulin 
secretion is predominantly IgA (Heddle and Rowley, 1975, Reinholdt and Husby, 2004). 
Mucosal immune responses in dogs have been shown to be influenced by age, genetic 
factors, diet, gut flora and weaning (Hall, 2013). Composition of the gut microflora 
directly affects host physiology (Kinross et al., 2011, Lee and Hase 2014) including 
host immune responses (Round and Mazmanian, 2009, Tang, 2011, Maynard et al., 
2012). Studies have demonstrated that molecular patterns of microbial and pathogenic 
organisms (MAMP /PAMP) invoke immune responses in colonic epithelial cells of 
canine hosts (Swerdlow et al., 2006). 
1.24 Canine immune system 
Dogs acquire immune status in two distinct phases, firstly in healthy dogs 
immunoglobulin acquisition occurs in-utero, immunoglobulin G (IgG) is transferred via 
the placenta and, IgA is present in colostrum (Snoeck et al., 2006). Schafer-Somi et al. 
(2005) reported that IgM is the first immunoglobulin to be produced as a response to 
immune challenge. Clinical data from German shepherd dogs (German et al., 2000) 
presenting with gastro-intestinal tract infection demonstrated that immunoglobulins (A, 
G and M) circulate at detectable levels in saliva and serum, regardless of age, sex or 
disease status. Nevertheless, studies indicate an apparent deficiency of IgA secreted 
from duodenal mucosal lining in some breeds of dog (German et al., 1998). Whilst 
relatively few markers have been investigated for cats and dogs differences are known 
to exist between species for intraepithelial lymphocytes and expression of surface IgM 
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(Stokes and Waly, 2006).  
1.24.1 Canine immune response mechanisms 
Whilst there is ever increasing information and understanding of the human and murine 
immune responses to injury and infectious disease as defence mechanisms there 
remains limited knowledge on other common species, such as companion animals, 
including dogs, (C. familaris) (Linde et al., 2008). A study of pyoderma in dogs using 
polyacrylamide gel electrophoresis (PAGE) identified patterns of IgG in response to 
bacterial infection (Neuber et al., 2008). Infections rarely resolved spontaneously, with 
recrudescence episodes and evidence that dogs cannot effect an appropriate immune 
response to eliminate the organism, despite forming part of normal microflora, of nares, 
oropharynx, and anal ring. This type of response has also been observed in dogs 
infected with Giardia spp. (Gates and Nolan, 2009). 
The alpha defensins, anti-microbial proteins of the human and murine immune systems 
are absent in cattle and dogs (Shanahan et al., 2011). To date, the immune systems of 
dogs are known to possess three different beta defensins, one cathelicidin (K9CATH) 
and a hormonal peptide canine hepcidin (Fry et al., 2004, Sang et al., 2005, Sang et 
al., 2007) but no published studies have yet confirmed intestinal tract AMP 
(antimicrobial peptides). In the context of Giardia spp. and its ability to infect a wide 
range of species plus frequent cross species infections a detailed understanding of 
host response mechanisms is essential. Singer, (2011) suggests further studies into 
anti-Giardia spp. effector mechanisms in humans whilst Patil et al. (2004) outlines the 
phylogenetic relationships of cross-species beta-defensins demonstrating distinct 
evolutionary lineage groupings for dog and rodent specific; primate and dog specific; 
rodent specific and dog specific defensins. This suggests that host specific infectious 
weaponry may provide a link to understanding the reasons for differences between 
host specific and cross species infections.  
Proposed mechanisms for mammalian innate immune responses to MAMP /PAMP are 
suggested to occur through membrane bound Toll receptors and cytosolic nucleotide 
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binding sites distinctive leucine rich repeats (LRR) as described by Basset et al., 
(2003), Inohara and Nunez (2003), Akira et al. (2006). These LRR are a unique feature 
of protozoan parasites, associated with immune responses (Boceta et al., 2000, 
Mcguinness et al., 2003, Kedzierski et al., 2004b, Loftus et al., 2005, Daher et al., 
2006) and form an integral component of Giardia cell wall proteins (Lujan et al., 1995, 
Luján et al., 1997). Evidence for the expression of IL-7 induced in canine cell lines is 
associated with lipopolysaccharide (LPS) of bacterial organisms (Swerdlow et al., 
2006) and host microbiota. These types of cellular and molecular processes, in 
conjunction with markers of infection and further exploration of possible health links 
may uncover implications for other gastro-intestinal diseases, such as IBD or Crohns 
Disease (Elphick and Mahida, 2005). 
1.25 Mucosal immune responses to Giardia spp. infections  
There are differing opinions regarding the ability of Giardia to cause mucosal 
inflammation, and it’s role in host defence mechanisms against the enteric parasite as 
mentioned by (Fisher et al., 2013). Responses to G. duodenalis infections have been 
attributed to a reduction in size of the microvillus, reduced enzyme expression and 
activity and the absence of mucosal inflammation (Eckmann, 2003), although infectious 
challenge stimulated production of circulating immunoglobulins, IgA, IgG, and IgM. In 
addition the B cell (humoral) and T cell (cell-mediated) responses are induced by nitric 
oxide levels; antimicrobial (parasitic) peptides and, paneth cell secretions such as 
cryptidin and defensin (Elphick and Mahida, 2005, Ankarklev, 2012).  
Are IL-6, dendritic cells or mast cells activated during Giardia infection? How do genes 
that encode VSP vary in their antigenic mechanisms? Answering these questions, 
posed by Roxstrom-Lindquist et al. (2006) concerning G. duodenalis infections in 
humans may enhance our understanding of the spread of infections and treatment 
interventions in canines. Dendritic cells are the key intermediaries within the gastro-
intestinal tract directing immune responses resulting in either oral tolerance or 
protective immunity (Mowatt, 2005). Sites for dendritic cell activity in the intestine, the 
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lamnia propria and Peyer’s patches, can initiate t-cell responses and associated 
cytokine mediation of inflammation (Cerutti et al., 2011). Functions for the host cell 
defences include host cell receptors. Pathogenic organisms can target this receptor 
molecule to gain advantage and interact with TLR signaling in the gastro-intestinal tract 
(GIT), inducing dendritic cell production and pro-inflammatory cytokines. Inhibition of 
pro-inflammatory cytokine production is one outcome from G. duodenalis infections 
(Singer, 2011). 
The consequences for hosts infected with Giardia spp. are contingent upon active 
inflammation of the gastro-intestinal wall occurring simultaneously with a Giardia spp. 
infection (Singer, 2011). The primary cause of gastrointestinal tract inflammation may 
not necessarily be induced by Giardia trophozoites. Accordingly, if Giardia spp. 
infections occur alone then tolerance is likely to be induced. However, in the presence 
of co-infections a potential exists for initiation of mechanisms for conferring protective 
immunity. Experimental immunization of mice with Giardia spp. antigens induced IL-4 
and IL-6 responses to Giardia (Singer, 2011). Intra-species genetic differences of mice 
were considered to affect host resistance to of G. duodenalis and authors assumed 
that the bacterial microflora were the most likely causative factors (Singer and Nash, 
2000). 
1.26 Tolerance or conferred immunity? 
The complexity of oral tolerance mechanisms include systemic interactions between 
the Peyer’s patches and epithelial cells of the gastric lymphoid tissue (GALT) within the 
intestinal wall. Responses to antigen presenting cells require interaction between 
mucosal immunoglobulin (secretory IgA) and systemic responses (Strobel and Mowat, 
1998). Experimental methods for boosting immune system responses to parasites 
demonstrated that oral tolerance could be induced in dogs (Deplazes et al., 1995). 
Ingestion of combined antigens extended the immune response (elevated levels of IgG 
and IgE) three fold, in comparison to ingestion of single antigen. This work reinforces 
the premise that ingested parasite proteins play a role in enhancing immune responses 
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through the production of antibodies. Olson et al. (2002) suggest that oral tolerance 
may develop in hosts experiencing signs of chronic Giardia spp. infections, due to 
Giardia spp. antigens in the gut. This concept has been used to investigate an oral 
vaccine to prevent Giardia spp. infections in dogs and as detailed immune 
characteristics of GALT are further understood they continue to be proposed as an 
effective target for oral vaccines (Kunisawa et al., 2012).  
TLR 4 mRNA, present in the canine stomach and small intestine, is responsive to 
lipopolysaccharides and peptidoglycans (Swerdlow et al., 2006, Burgener et al., 2008). 
Polymorphism of the TLR 5 gene in canines has shown hyper-responsiveness to 
flagellin and whilst inflammatory bowel disease manifestations are similar in dogs and 
humans, some differences in histopathology have been reported (Cerquetella et al., 
2010, Kathrani et al., 2012). In humans when hyper-sensitization of the gut occurs, 
such as from gluten intolerance, it can lead to coeliac disease or IBS (Powrie, 2012). 
The complexities of immune system responses remain poorly understood, and the 
increasing incidence of adverse food reactions (allergies) and relationship with gut 
microflora are under medical and veterinary investigation (German, 2001, Hooper et al., 
2002, Cobo and Chadee, 2013,  Beirão et al., 2014, Lee and Hase, 2014).  
1.27 Other immune responses  
Additional host responses to G. duodenalis infections in humans include the activity of 
lysozyme and phospholipase A, and lactoferrin as a component of the host innate 
immune system (Eckmann, 2003, Ordaz-Pichardo et al., 2013). Lacto-transferrin an 
iron-binding protein, secreted by leukocytes, is present in plasma and secretions (milk, 
mucus, bile) (Levay and Viljoen, 1995) although previously undetected in milk from 
dogs (Masson and Heremans, 1971). It is an important component of granulocytes, 
with multiple functions, including bacteriostatic action, depriving bacteria of iron 
essential for growth (Bellamy et al., 1992, Farnaud and Evans, 2003) and improves 
cellular immune responses and faecal bacterial populations (Levay and Viljoen, 1995, 
Adlerova et al., 2008, Hellweg et al., 2008,). 
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Mammalian lactoferrin receptors are understood to play a crucial role in mediating 
multiple functions of the protein and evidence of expression has been shown in the 
infant small intestine and in other tissues (Liao et al., 2007, Pang et al., 2014). A team 
of researchers recently reviewed the relationship of iron as an intermediary between 
lactoferrin and pathogenic protozoa concluding that some parasites require holo-
lactoferrin as an iron source for in vitro growth and alluded to potential immunogenic 
properties being valuable as drug targets (Ortiz-Estrada et al., 2012). Notably, 
significant differences in the immune responses between mice and humans, have been 
recently published (Snoeck et al., 2006, Merrifield et al., 2011) and investigation into 
other species such as dogs, may reveal more details of variation across mammalian 
species. Limited information is available concerning the innate immune system 
responses to Giardia spp. infection in dogs, although it is certainly worthy of further 
examination. Some researchers suggest that the initial host immune response is 
provoked by bacterial infection, and Giardia trophozoites persist, undetected, enabling 
host infection (Batt et al., 1984, Muller and Von Allmen, 2005). Increasing pH in the 
gastro-intestinal tract has been associated with bacterial infections and might affect the 
ability for Giardia spp. trophozoites to become established. Conflicting evidence 
presented in the literature concerns the capacity for Giardia spp. infection to provoke 
inflammatory responses (Kohli et al., 2008, Hanevik et al., 2011, Buret and Cotton, 
2011). The action of signalling peptides and diet have been linked to allergic dermatitis 
in dogs. (Halliwell, 2009). Understanding the concept of immunosuppression, 
particularly in grouped housing situations, such as shelters is critical to appreciation of 
the impact of Giardia and other clinical signs of the disease syndrome, such as failure 
to thrive or association with opportune infections (Thompson and Smith, 2011). 
1.28 Vaccination  
There have been several approaches to studying immune responses to Giardia spp. in 
pursuit of effective vaccine development, reviewed by (Lee et al., 2011). Although 
infective mechanisms affect the host immune system in different ways, it was initially 
Chapter 1 Giardia canis 
 72 
considered simple to produce a vaccine against Giardia spp.. Olson (1998) found 
evidence of antibody-specific reactions to Giardia cysts and trophozoite antigens. 
These findings later resulted in a commercial Giardia vaccine for dogs and cats (Olson 
et al., 2000). Vaccination may only offer protective immunity in the short term, and 
unlikely to be specific for genotypes infecting dogs. Manufacture of the vaccine was 
prepared from axenic culture of G. duodenalis originally isolated from sheep. The 
antigenic properties for Giardia spp. infections in sheep are different to those in dogs. 
In addition to vaccines trialed in dogs, researchers have also investigated vaccines 
against human Giardia infections. Most recently, Rivero et al. (2010) developed a 
human vaccine based upon blocking the production of membrane surface proteins of G. 
duodenalis trophozoites. The integral membrane proteins are cysteine-rich and 
possess varying extracellular amino-acid terminal regions. These regions of variation 
(Variant Specific Surface Protein, VSP) serve as a unique adaptive mechanism 
enabling Giardia spp. trophozoites to withstand challenges from host immune 
responses and persist to attach to the epithelium, causing infection. Infection of gerbils 
using a human isolate of Giardia established that protection could be conferred by 
vaccination with a modified live VSP vaccine including all of its 190 surface proteins, 
(Rivero et al., 2010). The host immune response thus renders the protozoan surface 
antigens ineffective in attaching to the epithelium, thereby reducing the severity of 
reaction and the likelihood of establishing infection. Whilst adaption and variation may 
be multiple and frequent, the principle mechanism for this vaccine activity is antigenic 
variation of trophozoite surface proteins and is a key defence mechanism of all Giardia 
species, including infections in canines. The VSP constitutes an extensive range of 
immune proteins that are located on the external surfaces of Giardia spp. trophozoites 
and Nash (2011) described the specific features of these proteins in more detail. 
1.29 Giardia spp. localization in the canine digestive tract  
Early studies into dietary effects on Giardia spp. infections in canine hosts, concluded 
that carnivorous hosts did not harbour Giardia spp. or protozoan infections probably 
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due to high numbers of putrefactive bacteria in the intestinal tract (Hegner, 1924). In 
contrast, rats fed on vegetarian diets were infected with Giardia spp. and other 
protozoa accompanied by high numbers of acidopholous bacterial species. Artificial 
infection of cats with Giardia spp. was unsuccessful. 
Localization of G. canis trophozoites and cysts were compared together with bacterial 
composition of gut contents at various intestinal sections from 4 puppies receiving 
protein or vegetarian diets (Tsuchiya, 1931). The results confirmed those of Hegner 
(1922) that the lower portion of small intestine and jejunum are the optimal locations for 
trophozoite development where they are both larger and fully formed than in other 
locations in the absence of bacterial species. Protein diets appeared to inhibit 
trophozoite establishment in the small intestine, with many more cysts observed in the 
ileum and bowel region. Tsuchiya (1931) suggests that it may not be diet per se but the 
chemical characteristics of food source, which may influence trophozoites to thrive, the 
intestinal conditions, such as pH, specific gravity or viscosity may be less important 
than food chemistry or bacterial species. 
1.30 Management of Giardia infections in dogs 
To the current day, Giardia spp. remains capable of infecting a wide variety of hosts on 
a global scale with limited means of control or remediation. Prevention of Giardiasis 
depends on good sanitation. Standard concentrations of chlorine for water treatment do 
not kill the infective form of Giardia (Schantz, 1991).  
1.30.1 Treatment  
Whilst veterinary pharmaceutical treatments are used to eliminate parasitic organisms 
from the gastrointestinal tract, this often occurs without full knowledge of the exact 
cause of clinical signs, either in terms of the physiology of the pathogenic organism 
and life cycle events, or specific processes occurring in the gastro-intestinal tract. The 
rationale for treating suspected or confirmed Giardia spp. infections in dogs also 
includes public health concerns, namely, prevention of potential zoonotic transmission 
(Thompson, 2000, Thompson et al., 2008).  
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Giardia spp. treatments include the use of nitroimidazoles, such as metronidazole, 
which have long been reported as effective against G. duodenalis (Barr et al., 1993, 
Barr et al., 1994, Barr et al., 1998). An alternative drug, a benzimidazole has also been 
used a treatment in dogs. Adverse effects of the benzimidazole, albendazole, led to the 
use of metronidazole, which was consistent with in vitro findings of Giardia spp. 
susceptibility (Cedillo-Rivera and Munoz, 1992, Farbey et al., 1995) to nitroimidazoles. 
However, metronidazole resistance is of increasing concern in humans, and possibly in 
dogs (Busatti et al., 2009, Tejman-Yarden et al., 2011). Some alternative therapeutic 
approaches examined bacitracin zinc, which has been found to be effective against 
Trichomonads and Giardia spp. (Andrews et al., 1994), and ethnobotanical surveys 
identified two medicinal herbs with active compounds against Giardia spp. One of 
herbs was reported to have a 98% success rate against G.muris. (Gardner and Hill, 
2001). Consistent results from an early promising use of probiotics to reduce Giardia 
cyst excretion have not been forthcoming (Simpson et al., 2009, Benyacoub et al., 
2005).  
The drugs metronidazole and tinidazole have been reported for use of as anti-
parasitics for treatment of Giardia infections in dogs by (Zajac et al., 1998, Villeneuve 
et al., 2000, Decock et al., 2003, Hamnes et al., 2007) and using fenbendazole (Payne 
et al., 2002). Fenbendazole (Febantel) is currently recommended as a preferred 
treatment method for Giardia infections in dogs (ESCCAP, 2011). The use of combined 
treatments using praziquantel and fenbendazole for control of Giardia in shelter dogs 
compared by Ortuno and Castella (2011) showed that no significant difference in 
prevalence rates was detected following treatments. In contrast, a study reporting the 
use of a similar, commercially available, product in naturally infected dogs Montoya et 
al. (2008) showed that faecal cyst excretion by infected dogs ceased after three days 
of treatment. On further investigation, Bowman (2009) demonstrated that this treatment 
only remained effective for a short time, possibly due to re-infection, and also that 
untreated dogs spontaneously ceased to shed cysts in faeces. 
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As a follow on from successful in vivo and in vitro studies published for anti-protozoal 
activity of ronidazole, against Giardia spp. in mice, the effects of this drug was studied 
in kenneled Beagle dogs (13-19 months old) naturally infected with Giardia spp. This 
research explored the effectiveness of ronidazole, a nitroimidazole drug, against 
Histomonas sp. and Trichomonas sp., as described in previous studies, in a new trial 
with dogs. The study used drug therapy combined with environmental disinfection and 
elimination of infective cysts from fur coats using shampooing (Fiechter et al., 2012). 
Unfortunately this study was inconclusive, whilst the incidence of infection was reduced 
it could not be attributed to action of therapeutic drugs when combined with chemical 
and manual methods for parasite elimination. 
Current anti-protozoal treatments reviewed by (Astelbauer and Walochnik, 2011) are 
approaching half a century of use and managing Giardia spp. infections may require 
improved efficacy for existing benzimidazole drug treatments (Miro et al., 2007). 
1.31 Animal husbandry  
An important factor for reducing infection rates, and clinical signs relies upon 
mechanical or physical methods for removal of infectious agents. Husbandry and 
management practices, such as type and frequency of manual cleaning and 
sterilisation practices using chemical or UV light disinfection or desiccation (Li et al., 
2007) are important for eradication of infective cysts from the environment. Other 
factors that need to be considered are diet, housing construction, animal movement 
and transportation (Mircean et al., 2012). 
1.31.1 Behaviour and interaction between humans and animals 
A survey conducted in the UK of dog owner behavior illustrates how management and 
husbandry practices may affect the potential for transmission of infectious parasites 
between dogs and their owners (Overgaauw et al., 2009). Results from the survey 
identified three commonly accepted pet-owner interactions including 1) dogs licking the 
face of household members (60%), 2) dogs sleeping in the bedroom (33%) and 3) 
dogs sleeping on the human’s bed (14%). These incidences of close physical contact 
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and shared sleeping space are considered conducive to the transmission of infectious 
zoonotic diseases (Westgarth et al., 2007).  
The cultural values and beliefs of dog owners are important in the way that dogs 
interact with each other, with humans and with the wider environment. Different 
nationalities religious and ethnic groups, in addition to socio-economics and 
demographics, affects the attitudes of people towards animals and in turn, behavioural 
responses of the animal, both wild and domesticated. Examples in the literature 
acknowledging this approach to understanding Giardia spp. infections include (Gates 
and Nolan, 2009, Volotao et al., 2007). In addition, Giardia infections in dogs are 
common and there are certain behavioural aspects of dogs such as coprophagy that 
may directly influence exposure to the parasite and likelihood of infection (Askew, 2003, 
Borg and Graat, 2006). 
1.31.2 Therapeutic intervention 
There is an increasing suggestion that drug treatment interventions are ineffective in 
preventing rapid re-infection, spontaneous clearing or non-responsive to treatment in 
asymptomatic infections (Saffar et al., 2005). The concept of alternative transmission 
and infection routes must be considered, as Overgaauw et al. (2009) suggest. 
Mechanical means of transmission via fur or bedding may allow dog – dog 
transmission or dog to other host organism (Overgaauw et al., 2009). 
1.31.3 Physiological stress factors 
In addition, stress factors may also increase the likelihood of Giardia spp. infection, 
either physiological stress during growth and development stages, such as weaning, in 
juveniles, and mature females during pregnancy and lactation or from increased 
exposure to infectious challenges. Appropriate changes to management practices need 
to be implemented accordingly. Approaches to solving some of these practical 
interventions and recognizing the different parasite infections include both education of 
veterinary clinic clients and pet owners, as discussed in Sections 1.12 and 1.19.  
Chapter 1 Giardia canis 
 77 
1.32 Co-infections with other enteric parasites  
It is well established that concurrent parasite infections occur in domestic dogs, and 
those previously associated with Giardia are other protozoans, such as 
cryptosporidium, coccidian’s, and nematodes. A longitudinal study of pure bred 
domestic dogs by Hamnes et al. (2007) monitored the prevalence and intensity of 
infection of two closely associated water borne parasites, Cryptosporidium sp. and 
Giardia spp. the only other parasite reported in the study was the detection of Toxocara 
canis. Patency of infection was associated with the age of the animal, although lack of 
genotyping data greatly limited any observations on the transmission dynamics.  
Prevalence data is showing increased rates of protozoal infections in dogs, including 
Giardia spp. It is important to study and know more about the impact of protozoan 
parasite infections in dogs and how they are transmitted and ecological impacts. 
The role of polyparasitic infections, predominantly protozoan infections, and the 
significance of these concurrent infections are yet to be explained. The prevalence of 
Giardia spp. co infections is discussed in chapter 3. A summary of published research 
is outlined in Chapter 3, to comment on instances where polyparasitism may actually 
mask the true cause of clinical signs or contribute to inaccurate diagnosis. 
The ability to resolve questions concerning the impact of Giardia infections in dogs, 
and importantly recognizing that knowledge of the parasite genotype alone, is 
insufficient may require a new approach. What may actually be required is a broader 
picture encompassing host-parasite interactions, phenotypic data, and ecosystem 
biology that address physiology concurrent infections. 
1.33 Importance of understanding Giardia canis infections 
Research using dogs as a model host is essential to verify the role of this domestic 
animal in the transmission of G. duodenalis. Records for cellular and immune response 
to Giardia spp. infections that occurs in different host species are incomplete. 
Developing research approaches to examine the interaction or co-location of humans 
and dogs are a key to understanding aspects of management practices that affect the 
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incidence of Giardia spp. infections. Artificial infection experiments and studies of 
naturally infected populations remain necessary for understanding and resolving 
Giardia spp. transmission routes. Findings from this type of study will help explain the 
epidemiology and potential impacts of disease outbreaks on canine and human hosts. 
Many epidemiological studies include genotyping but lack association with clinical 
signs of infection. Absent from the literature are clinical case studies on individual dogs 
infected with Giardia spp. treatment schedules, parasite clearance and frequency of re-
infection or recrudescence and associated signs (and severity) of infection.  
Studies designed to clarify the conditions that enable Giardia spp. infections to flourish 
and any synergistic effects between parasites are important. Molecular characterization 
of Giardia spp. infections which, contribute to pathogenicity and clinical signs requiring 
veterinary or medical intervention, as reports of canine protozoal infections has 
increased in affluent human settlements. Seeking answers to questions relating to the 
numbers of Giardia spp. cysts excreted and confirm any association with potential 
zoonotic transmission mechanisms.  
Studies that consider the overall microbial environment of the gut and cellular 
interactions within digestive processes are required to address episodes of chronic 
diarrhoea in dogs and possible association with impaired endocrine or digestive 
function and parasite burden. Intestinal parasites are suspected of contributing to 
inflammatory bowel disease in humans and this could be the same situation for dogs. 
Critical analysis of Giardia spp. diagnostic tests is timely and the consequences of 
asymptomatic infections remaining undiagnosed needs to be evaluated. The majority 
of published studies refer to snapshot sampling methods, but there is a need for more 
detailed longitudinal studies. Reliable molecular detection of Assemblage B, in faecal 
samples from dogs, remains problematic, despite the increased use of multi-locus 
genotyping both in terms of understanding characteristics of host specific infections 
and to understand the characteristics of Giardia spp. infections in other species.  
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Research using dogs as a model host cannot be underestimated, both in terms of 
understanding characteristics of host specific infections and the importance of this 
domestic animal in the potential transmission routes of G. duodenalis genotypes.  
1.34 Research hypothesis  
That G. duodenalis  infections in humans are the same as Giardia spp. infections 
in dogs. 
Knowledge concerning the clinical impacts and frequency of zoonotic transmission is 
undetermined, for further understanding of the impacts of Giardia infections in canines 
broad based studies are needed. Examination of the literature Giardia spp. infections 
reported in domesticated dogs and in Canid species in wild and captive wildlife 
populations raised the following specific research questions to be addressed in this 
thesis. 
1. When is the earliest time that patent Giardia spp. infections can be detected? 
How long is the pre-patent period?  
2. What tests are available for accurate diagnosis of Giardia spp. infections in 
dogs?  
3. Can Giardia spp. proteins be detected in canine faeces using proteomic 
techniques?  
4. Can novel proteins or peptides be detected in canine faeces be used to 
differentiate between different genotypes of Giardia spp.?  
5. What host-parasite interactions can be detected using proteomic techniques for 
the Giardia spp. infected canine host?  
6. Do lactoferrin levels in canine faecal samples change when clinical signs of 
parasite infection are observed? 
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Chapter 2   
Comparative diagnostics for Giardia spp. infections in canine 
faecal samples 
2.1 Introduction  
Enteric protozoan infections in dogs go largely unrecognized by the majority of pet 
owners, especially in Australia where there is a high level of pet ownership. Recent 
studies have found that parasite infection occurs in over twenty percent of dogs, the 
majority by the protozoan parasite, G. duodenalis (Palmer et al., 2008). 
Molecular studies have advanced understanding of the epidemiology of G. duodenalis 
infections, in addition to identifying some knowledge gaps in terms of transmission and 
potentially zoonotic genotypes (Thompson et al., 2008). Overall, substantial differences 
in study design and methodology have obscured taxonomic differentiation between 
host specific and cross species G. duodenalis infections in dogs. These differences 
include host population studies Eligio-Garcia L. et al., (2005) and diagnostic 
approaches, with the latter based solely on results using microscopy (Hamnes et al., 
2007, Claerebout et al., 2009, Batchelor et al., 2008) and others on copro-antigen test 
results (Epe et al., 2010, Olson et al., 2010, Rishniw et al., 2010). Epidemiological 
studies reporting G. duodenalis infections using genotyping methods are available, 
although these are not consistent in the choice of gene loci for PCR analysis (Itagaki et 
al., 2005, Lalle et al., 2005, Leonhard et al., 2007, Upjohn et al., 2010, Covacin et al., 
2011). Few studies use a combination of all three techniques for diagnosis (Barutzki et 
al., 2007, Traub et al., 2009). Veterinary clinicians have been unable to apply findings 
from molecular research work at a diagnostic level and remain reliant upon faecal 
flotation and light microscopy for routine laboratory practices, although there is 
increasing use of copro-antigen test kits (Carlin et al., 2006, Epe et al., 2010). Currently 
diagnostic G. duodenalis tests lack the precision or resolution to alert medical 
practitioners or veterinarians to potentially zoonotic strains. Nor do they define or guide 
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industry acceptance of what constitutes normal or acceptable levels of infection, 
particularly because many infections are asymptomatic.  
Research has demonstrated the existence of four genetic assemblages of G. 
duodenalis in dogs: C and D (G. canis), B (G. enterica) and A (G. duodenalis) (Monis 
et al., 2009, Thompson and Smith, 2011, Thompson and Monis, 2011).  Concurrent 
parasite infections occur in canines (polyparasitism), and those previously reported to 
be associated with G. duodenalis are other protozoans, such as Cryptosporidium sp. 
coccidians, and nematodes (Kirkpatrick, 1988, Hopkins et al., 1993, Dubey, 2009, 
Payne and Artzer, 2009). The host response to different parasites and the order of 
exposure to infection may affect host overall well-being and clinical manifestations 
(Keusch and Migasena, 1982) and virulence (Taylor et al., 1998, Wammes et al., 2010). 
There is increasing evidence that multiple sub-genotypes of Giardia spp. are able to 
infect mammalian species. Hopkins et al. (1997) and Traub et al. (2004), indicated that 
genetically similar Giardia spp. isolates occur in dogs and humans in the same 
household, whilst data from a recent study in Europe, Epe et al. (2010) does not 
support the idea that the more dogs, the higher likelihood of human infection. 
Differences between genetically distinct Giardia spp. infections of asymptomatically 
infected dogs in Germany (Leonhard et al., 2007) suggest that domestic pets are more 
likely to carry zoonotic infections when compared to dogs in shelter situations. 
Knowledge concerning the clinical impacts and frequency of zoonotic transmission is 
inconclusive, although some dogs appear to be infected with host specific types of 
Giardia spp. other have been found to be infected with genotypes considered to be of 
zoonotic potential (Barutzki and Schaper, 2003, Barutzki et al., 2007, Claerebout et al., 
2009).  
Diagnostic tests for Giardia spp. in dogs are generally performed using fresh faecal 
matter and the quality of the sample is important for consistent and reliable results. 
Some limitations of these diagnostic methods are dependent upon microscopic 
detection of excreted cysts, however, recrudescence, sporadic cyst shedding and 
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differing levels of infection can complicate when and how much sample will yield a 
positive diagnosis (Hewlett et al., 1982). In cases of asymptomatic Giardia spp. 
infection and intermittent shedding of cysts, a lack of urgency exists for diagnosis and 
even less likelihood of follow up treatment. Although undetected infections may also 
pose serious consequences (T.D.R. Diagnostics Evaluation Expert Panel, 2010).  
Reported comparative analyses of diagnostic methods with molecular techniques are 
largely confined to research studies based upon light microscopy and copro-antigen 
tests (Batchelor et al., 2008, Olson et al., 2010, Rishniw et al., 2010). Results from zinc 
sulphate floatation and light microscopy have been compared to IFAT and PCR (along 
with prevalence rate) for dogs and humans in Thailand. Different prevalence rates were 
reported, depending on the type of test used, as low as 8% using light microscopy for 
detection of Giardia spp. cysts and up to 56% in dogs detecting Giardia spp. antigen 
using ELISA (Traub et al., 2009). 
A European wide diagnostic study Epe et al. (2010) reported a prevalence rate of 25% 
from a copro-antigen test survey of more than 8000 symptomatic dogs. Results from 
this study confirmed earlier findings from a retrospective study of clinical cases of 
gastro-intestinal disease in dogs in the UK of a true prevalence rate of 21% which 
takes into account the reported sensitivity and specificity of the diagnostic test 
(Batchelor et al., 2008).   
A study of healthy Australian adult dogs using zinc sulphate centrifugal flotation and 
light microscopy for the diagnostic method indicated that 10 - 20% of dogs are infected 
with Giardia spp. with up to 42% infection rates in puppies, and higher prevalence rates 
in intensive housing situations such as kennels or shelters (Thompson et al., 2008).  
2.1.1 Host specific infections and public health implications 
The host specific assemblages C and D have been reported to be associated with 
clinical signs of infection in dogs (Berrilli et al., 2004, Claerebout et al., 2009). The 
other Giardia spp. positive samples isolated from dogs are assemblages A and B, both 
of which infect humans (Van Der Giessen et al., 2006). These potential zoonotic 
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assemblages are common in humans and have been implicated in cross species 
transmission (Thompson, 2000, Thompson et al., 2008). This suggestion for zoonotic 
transmission is further supported by data from multi-locus genotyping Giardia spp. 
infected canine faecal samples with 79% assemblage A (Traub et al., 2009), 69% 
(assemblages A and B) (Covacin et al., 2011) 100% assemblage A (Marangi et al., 
2009, Jimenez-Cardoso et al., 2012). 
Challenges for accurate diagnosis and the need for genotyping studies to contribute to 
understanding transmission dynamics in a global context were identified by Ballweber 
et al. (2010) in a public health review of the significance of Giardia spp. infections in 
pets, including dogs. The authors suggest that study design is an important factor for 
realizing the significance of Giardia spp. infections in dogs. Recommendations included 
the need for a trifactor approach including biological, molecular and epidemiological 
datasets; together with longitudinal sampling and multi-locus genotyping or case 
control investigations considering spatial and temporal variations.  
In recognition of the increasing concern of potential zoonotic reservoirs and potential 
transfer of Giardia spp. infection from dogs to humans, this study examined two 
different high-risk groups, both from high-density populations in breeding 
establishments and shelter facilities. Risk factors for infection include: neonates and 
juveniles; poor nutritional status or eating patterns and resultant gut microflora 
populations and pH; poor sanitation and hygiene conditions; poorly managed animals 
with lack of prophylactic anti-parasite programs, intensive housing situations and dogs 
during periods of physiological stress (Klein, 2004, Thompson et al., 2009, Thompson 
and Smith, 2011)  
2.1.2 Methods for diagnosis of Giardia spp. infection 
A variety of methods used by different laboratories to confirm patent Giardia spp. 
infections from faecal samples are well published. In veterinary clinics the gold 
standard for detection of Giardia spp. cysts in faecal samples is considered to be 
density gradient flotation and light microscopy following either salt flotation (Rishniw et 
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al., 2010) zinc sulphate flotation (Zajac et al., 2002) or sucrose flotation (Dryden et al., 
2006). However, others prefer to use direct smear using Lugol’s iodine or 
immunofluorescent antibody test (Cellabs, Australia). Detection of Giardia spp. antigen 
is also performed using commercially available immunochromatographic test kits and 
enzyme linked immunosorbent assay (ELISA) (Hopkins et al., 1993). For the purposes 
of this comparative study microscopy and copro-antigen tests were used to detect 
clinical cases of Giardia spp. infections. Molecular methods using PCR were used to 
confirm the presence of Giardia spp. infections and to explain the epidemiology of 
these infections occurring in dogs. 
2.1.3 Hypothesis  
That different diagnostic methods can detect Giardia spp. infections in dogs with 
equal accuracy.  
2.1.3.1 Experimental design  
The accuracy of diagnosing Giardia spp. infections was investigated in groups of dogs 
by comparing different diagnostic methods. Canine faecal sampling was conducted 
from naturally infected groups of dogs as part of a longitudinal study. Faecal samples 
were collected and examined for the presence of Giardia spp. cysts and reactivity to 
commercial copro-antigen tests. High risk groups were identified as dogs under the 
age of one year (puppies and juveniles), (Swan and Thompson, 1986) and dogs kept in 
intensive rearing or production groups (Itagaki et al., 2005, Claerebout et al., 2009, Itoh 
et al., 2009). Diagnostic tests were assessed by calculation of the negative and 
positive predictive values relative to results obtained by the light microscopy gold 
standard. 
2.1.3.2 Sampling strategy and sample collection 
Private breeding facilities and dog shelters were approached for their cooperation. One 
dog-breeding establishment was in Victoria, Australia, and all other samples originated 
from metropolitan locations in Perth, Western Australia. Samples were obtained as 
freshly voided faeces. Third party collections (labeling and dispatch) were transported 
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variable distances and times before reaching laboratory diagnostic and processing 
facilities. For the litters of puppies samples were collected on a weekly basis from the 
age of 4 weeks. Samples were pooled from litters of puppies, rather than from 
individual animals.  
2.1.3.3 Data analysis methods 
Faecal samples were collected from four different groups of dogs during this study and 
the prevalence data was determined for each study group. The group of purebred 
Labrador retrievers from Victoria Australia, were from a government owned dog 
breeding facility known to have prior and ongoing clinical signs of diarrhea and 
vomiting and confirmed diagnosis with Giardia spp. This group was considered to 
represent symptomatic infections with collection of canine faecal samples from adult 
dogs and puppies.  
The second two groups of dogs were both from privately owned dog-breeding facilities 
in Western Australia, one was Labrador retriever, and the other was miniature 
schnauzer. The majority of canine faecal samples were from puppies under 3 months 
old. 
A fourth group included canine faecal samples from dog shelter facilities owned by an 
animal welfare organization. The dogs were mainly adult dogs without clinical signs of 
gastro-intestinal infection and faecal samples were collected from new dogs entering 
the facility.  
2.2 Methods  
Faecal flotation and light microscopy is the standard diagnostic method for diagnosis of 
Giardia spp. infections in canines (Blagburn, 2006) and research publications report 
the use of light microscopy as the most frequent faecal diagnostic method performed in 
studies of Giardia spp. infections in dogs (Dryden et al., 2006). Light microscopy 
methods were considered to form the gold standard diagnostic method throughout this 
study. 
Chapter 2 Comparative Diagnostics 
 86 
2.2.1 Sample collection 
Samples were kept refrigerated at 4oC and generally arrived at the lab for processing 
within 48 hours of collection. Samples were processed on arrival and an aliquot of 0.2g 
dispensed and stored in ethanol for future DNA extraction, if required. 
2.2.2 Microscopic examination 
An adapted centrifugal zinc sulphate flotation method was used to visualize parasitic 
eggs and cysts (Bugg et al., 1999). Firstly, zinc sulphate solution was prepared by 
dissolving 330g of zinc sulphate in deionized water to make 1 litre of solution and 
mixed thoroughly before checking for a specific gravity of 1.18. Each sample was 
processed by transferring 2g of fresh canine faeces into a 10ml centrifuge tube. 
Deionized water was added to the 10ml mark and thoroughly mixed using an applicator 
stick. The faecal mixture was centrifuged at 2000 rpm for 2 minutes, and filtered 
through gauze if the fecal material contained debris and other particulates. The 
supernatant was discarded and zinc sulphate solution (1.18 SG) was added to the 
sedimented faecal material and thoroughly mixed using an applicator stick. 
The mixture was centrifuged at 2000 rpm for 2 minutes and allowed to come to rest 
without applying the brake. A sterile pipette was used to transfer 50 microlitres of liquid 
from the surface to a clean microscope slide. A coverslip was applied and immediately 
viewed under light microscope using 100x and 400x magnification for the presence of 
Giardia spp. cysts or trophozoites. 
2.2.3 Immuno-antigen tests 
Three different immuno-antigen tests were used in this study, methods are described 
for each test as follows,  
2.2.3.1 Giardia Enzyme Linked Immunosorbent Assay (ELISA) 
Standard operating procedures for a routine commercial diagnostic screening test 
made available for use in this study by Antech Diagnostics were followed to detect 
Giardia spp. antigen using spectrophotometry. Attention was paid to consistent 
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incubation time intervals and to ensuring reagents and materials reached room 
temperature prior to use. 
The principles of this test, a sandwich ELISA, used assay plates coated with primary 
immobilized antibodies against Giardia spp. cyst antigens. Dilution buffer was added to 
each well in 50µl aliquots together with 50µl of solubilized faecal samples. Each plate 
was incubated at room temperature for 60 minutes to allow Giardia spp. antigen – 
antibody binding. Then the well contents were washed five times with wash buffer 
blotted dry. A conjugated secondary antibody (anti-Giardia spp. cyst enzyme 
conjugate) was added to each well and incubated for 30 minutes. The amount of 
conjugate that was able to successfully bind to form an antibody-antigen complex was 
representative of the quantity of Giardia spp. antigen in each sample. The conjugate 
was removed by washing five times and 2 drops of chromogen was added for 
development of a colorimetric reaction that was measured using a spectrophotometer 
plate reader at 450 and 620nm wavelength. 
Positive and negative control standards were included in duplicate wells on the same 
plate for each batch of test samples. All samples were tested in duplicate. Diagnostic 
criteria for confirmation of Giardia spp. were determined based upon performance 
characteristics of the control samples. For positive confirmation control samples must 
have yellow coloration and an absorbance value greater than 0.5. The negative control 
appeared almost colorless with an absorbance value of less than 0.08. 
2.2.3.2 Copro-antigen test 1  
The copro-antigen test 1 used in this study has been developed by IDEXX laboratories 
(IDEXX Laboratories, USA) from an immunosorbent assay and requires the action of 
an enzyme conjugate. Results can be obtained within eight minutes, although to 
preserve the efficacy of the test, components must be kept refrigerated prior to use. 
The manufacturers state that the test identifies Giardia species, which infect dogs, that 
is G. duodenalis. Detection of Giardia spp. antigen in fecal samples indicates the 
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animal has ingested Giardia spp. cysts, may be actively infected, and may be shedding 
(excreting) cysts. 
Manufacturers instructions for the SNAP Giardia antigen test (IDEXX Laboratories, 
USA) were followed, as described here. A test kit swab was immersed in a fresh faecal 
sample. The faecal-coated swab was then flooded with a conjugate-bound antibody 
solution and mixed. Five drops of the solution were transferred onto a sealed test 
device, containing a secondary antibody. The solution flowed across the device until 
observed in the activation circle. Immediately the lower part of the device was pressed 
until an audible “snap” was heard. Coloured reaction spots in the results window 
determine correct operation of the test and were interpreted to confirm positive and 
negative results, in comparison to two control spots. In positive samples, where Giardia 
spp. antigen was present in the faecal sample, the reaction between the substrate 
solution and conjugate-bound antibody generated a blue colour.  
2.2.3.3 Copro-antigen test 2  
Copro-antigen test 2 used in this study is a one step immunochromatographic test 
performed at room temperature. This test has been developed by VetAll Laboratories, 
(VetAll Laboratories, Korea) from an immunochromatographic assay and is based 
upon direct sandwich binding of antigen-antibody conjugate on a nitrocellulose pad. 
Results can be obtained after 5-10 minutes, and kits remain stable at room 
temperature (2 – 30oC for 2 years). The manufacturers state that the kit contains 
antibodies with two different epitopes for specific antigen binding. A test kit swab was 
immersed in a fresh faecal sample, to collect a maximum of 30mg faeces. The faecal-
coated swab was then immersed in a buffer solution and mixed. Four drops (100µl) of 
the solution supernatant were transferred onto a sealed test device, containing a 
nitrocellulose conjugate pad, using the dropper provided. A gold colloid complex 
migrated along the pad membrane to meet a second monoclonal antibody. A red/ 
purple band appeared to confirm correct operation of the test, and a second band 
appeared if the test was positive. The results window became invalid after ten minutes. 
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2.2.4 Molecular methods 
The methods used for DNA extraction and genetic detection of Giardia spp. are 
outlined as follows, 
2.2.4.1 DNA extraction 
DNA was extracted from fresh faecal samples using the Maxwell® 16 Tissue DNA 
Purification Kit (Promega, Madison, USA) with the Maxwell® 16 SEV Instrument 
(Promega). Water, ultrapuregrade (FisherBiotechPerth, Australia), was added to 
samples to further dilute the extracts and reduce inhibiting factors.  
2.2.4.2 Genotyping methods - nested PCR gene loci 
2.2.4.2.1 Nested PCR for 18S rDNA 
This PCR technique is established as a sensitive method for genetic confirmation of 
Giardia spp. infections and is valid for epidemiological and genetic characterization 
studies (Hopkins et al., 1997, Morgan, 2000, Thompson and Monis, 2004). The 
external forward and external reverse primers,  
(RH11) 5'-CATCCGGTCGATCCTGCC-3' and  
(RH4) 5'-AGTCGAACCCTGATTCTCCGCCAGG-3', used in the primary reaction were 
developed and described by (Hopkins et al., 1997) to amplify a 292 bp region of the 
small subunit of ribosomal RNA. The secondary reaction internal forward and reverse 
primers were (GiarF) 5’-GACGCTCTCCCCAAGGAC-3’ and (GiarR) 5’-
GTCGAACCCTGATTCTCCG-3’ developed by (Read C. et al., 2002) to amplify a 130 
bp product. The PCR reaction was performed in 96 well plates along with a positive 
control and pre- and post-reaction negative controls. Each reaction consisted of 1 μl of 
extracted DNA, 2.0 mM MgCl2, 2.5 μl PCR reaction buffer (67 mM Tris-HCL, 16.6mM 
(NH4)2SO4 4.5% TritonX-100, 0.2mg/ml gelatin), 500 μl, 4 of each dNTP, 10 ρmol of 
each primer, 0.55 units of TAQ DNA polymerase (Fisher Biotec, Perth Australia), 2.4% 
cresol and 5% DMSO was added to each reaction, plus ultrapure water to a total 
volume 25 μl. The primary reaction, modified from (Hopkins et al., 1997) used the 
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following conditions, denaturing step of 95 °C for 5 min, then 40 cycles of 95 °C for 30 
s, 53 °C for 30 s and 72 °C for 45s, followed by a final extension of 72 °C for 7 min. 
The conditions for nested reaction were the same as for the primary reaction, except 
that the annealing temperature was increased to 56 °C.  
2.2.4.2.2 Nested PCR for β Giardin gene  
A 753 bp fragment was amplified using the forward primer G7 and the reverse primer 
G759, as previously described (Caccio, S. M., 2002). Secondary PCR reaction primers, 
developed to amplify a 511 bp fragment by (Lalle et al., 2005), used a forward primer of 
5’-GAACGAACGAGATCGAGGTCCG-3’ and a reverse primer of 5’-
CTCGACGAGCTTCGTGTT-3’. The PCR reaction was performed in 96 well plates 
along with a positive control and pre- and post-reaction negative controls. Each 
reaction consisted of 1 μl of extracted DNA, 2.5 mM MgCl2, 2.5 μl 1X reaction buffer 
(67 mM Tris-HCL, 16.6mM (NH4)2 SO4 4.5% TritonX-100, 0.2mg/ml gelatin), 500 μM, of 
4 dNTP, 10 ρmol of each primer, 0.55 units of TAQ DNA polymerase (Fisher Biotec, 
Perth Australia), 2.4% and 5% DMSO was added to each reaction, plus ultrapure water 
to a total volume 25 μl. 
Amplification conditions were modified from. Caccio (2002) and Lalle et al. (2005) as 
follows the primary reaction was initiated with a denaturing step of 95 °C for 5 minutes, 
then 40 cycles of 95 °C for 30 seconds, 55 °C for 30 seconds and 72 °C for 45 seconds, 
followed by a final extension of 72 °C for 7 minutes. Conditions for the nested reaction 
were the same as those in the primary reaction except that the annealing temperature 
was increased to 56 °C. 
2.2.4.2.3 Nested PCR for Glutamate Dehydrogenase (GDH) gene 
This is the third locus that was used for Giardia spp. genotyping, the amplified fragment 
is 450 bp which is larger than the more sensitive multiple copy 18S gene but is 
important for genotyping as it can distinguish between the two subgroups of 
assemblage A and B (Read et al., 2004). The Forward primers use were  
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5’TCAACGTYAAYCCYGGYTTCCGT3’ and 5’CAGTACAACTCYGCTCTCGG3’ and the 
reverse primer used was 5’GTTRTCCTTGCACATCTCC3’. 
The PCR reaction was performed in 96 well plates along with a positive control and 
pre- and post-reaction negative controls. Each reaction consisted of 1 μl of extracted 
DNA, 3.0 mM MgCl2, 2.5 μl 1X reaction buffer (67 mM Tris-HCL, 16.6mM (NH4)2SO4 
4.5% TritonX-100, 0.2mg/ml gelatin), 500 μM, of 4 dNTP, 10 ρmol of each primer, 0.55 
units of TAQ DNA polymerase (Fisher Biotec, Perth Australia), 6μl of 0.1% cresol and 
5%DMSO was added to each reaction, plus ultrapure water to a total volume 25 μl . 
Amplification conditions were modified from Read et al. (2004) and are as follows: the 
primary reaction was initiated with a denaturing step of 95 °C for 5 minutes, then 40 
cycles of 95 °C for 30 seconds, 50 °C for 30 seconds and 72 °C for 45 seconds, 
followed by a final extension of 72 °C for 7 minutes. The nested reaction was altered by 
an increase in annealing temperature to 53 °C. 
2.2.5 Visualization of gene products 
Aliquots of 10 μl of PCR product were electrophoresed in a 2% agarose gel, containing 
0.2% Sybrsafe TAE buffer (242g/l Tris, 57.1g/l ethanoic acid, 18.6g/l EDTA) for 30 
minutes or 1 hour depending upon size of the PCR product and visualized using a UV 
transilluminator. 
2.2.6 Sequencing of Giardia spp. positive canine faecal samples 
2.2.6.1 DNA sequencing method from PCR product 
PCR products from faecal samples were analysed by direct sequencing using the 
Sanger method, capillary sequencing protocol Sanger (1951) and carried out using 
Applied Biosystems (ABI) 3730 XL analyzer.  
2.2.6.2 DNA purification 
The secondary products from nested PCR reactions were purified using a commercial 
product, based upon magnetic beads AMPure. A known volume (10-15μl) of PCR 
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product was transferred to a new plate, ready for sequencing. The AMPure bead 
solution was mixed thoroughly and then 1.8 volumes were added to the PCR product. 
The solution was mixed well using a pipette and incubated for 5 minutes at room 
temperature. The entire microtitre plate was then placed on the magnetic base for 5 
minutes. The plate remained on the magnetic base whilst the supernatant was 
removed and discarded using a pipette. The DNA fragments bound to the AMPure 
beads were retained by magnetic force to sides of the wells. The next step required 
addition of 200μl of 70% ethanol to each well for 30 seconds. The ethanol was 
discarded, and 200μl of 100% ethanol was added for 30 seconds. Finally, all traces of 
ethanol were removed from the plate at room temperature for 5 minutes.  
The microtitre plate was removed from the magnetic base and wells were washed with 
40μl of ultrapure water by repeated pipette action. 
2.2.6.3 Sequencing reaction 
Sequencing was performed using both Forward and Reverse primer for each sample. 
1μl of Dye Terminator was mixed with 1.5 μl of 5X buffer and this solution was used in 
2.5μl volumes in reaction wells with 6.5μl of sample DNA template and 1μl of each 
primer. The reaction plate was sealed with film and placed in a thermocycler with the 
following conditions: 1 cycle 96oC for 2 minutes; 25 cycles (denaturation) 96oC for 10 
seconds; (annealing) 56oC for 10 seconds, (extension) 60oC for 4 minutes; 1 cycle at 
14o C and held at this temperature to complete the reaction. 
Post-reaction ethanol precipitation 
After removing the 96 well PCR plate from the thermocycler, 1μl 125mM EDTA was 
added to each well. The following solutions were added sequentially to each well 1μl of 
3M sodium acetate (pH4.6) and 25μl 100% ethanol. The plate was sealed and covered 
with aluminum foil to minimize exposure of dye terminator to UV light. The plate was 
placed on a vortex mixer for 15 seconds and then left to stand at room temperature for 
15 minutes, then centrifuged for 30 minutes at 3000g. The plate was inverted, blotted 
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dry and returned to the centrifuge for pulse spin. After removing from the centrifuge, 35 
μl of 70% ethanol was added to each well and mixed by vortex for 15 seconds. The 
plate was covered with foil, and kept on the bench for 15 minutes before centrifuging at 
1650g for 15 minutes. The plate was inverted to discard all residual ethanol and then 
stored at 4oC prior to sequencing.  
2.2.6.4 DNA sequence analysis and genotyping 
DNA sequences were viewed as chromatographs using Finch TV or Sequencher. DNA 
sequence Identity of purified product was confirmed by rapid search using NCBI 
BLAST (www.ncbi.nlight microscopy.nih.gov/BLAST/).  
The term ‘assemblage’ (Monis et al., 1999) in common usage for phylogenetically 
grouped Giardia spp. isolates has been further characterized by Wielinga and 
Thompson (2007) for Giardia spp. isolates infecting dogs, and these were imported 
from GenBank and used as reference sequences. Sequence alignment was carried out 
by Clustal W. Genotyping was confirmed by alignment of nucleotide sequences, using 
Sequencher (Gene Codes Corporation, Michigan, USA), to reference sequences. The 
differences between nucleotides at positions 60 and 120, identified by Hopkins et al. 
(1993) with SNP occurring at positions 60 and 111 Robertson et al. (2006) were 
compared to phylogenetic alignment data retrieved from GenBank and confirmed by 
(Monis et al., 1998, Wielinga and Thompson, 2007).  
Genotyping into assemblages A-E as described by Monis et al. (2003) was carried out 
according to the published method Hopkins et al. (1997) using base pair alignment 
tools to distinguish between isolates based on base pair changes of the 18S rDNA 
gene. Sequencing at the 18S gene locus was performed with the reverse primer, both 
forward and reverse primers were used for sequencing at β Giardin and GDH gene loci. 
2.3 Results 
Results for diagnosis of Giardia spp. infections in canine faecal samples are presented 
here. Giardia spp. detection by a centrifugal zinc sulphate flotation and light 
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microscopy method was considered the gold standard diagnostic, to which all other 
methods were compared. Results include prevalence rates and an analysis of the 
sensitivity and specificity of three different copro-antigen diagnostic tests. Molecular 
identification of Giardia spp. by PCR is reported for three different gene loci and 
Giardia spp. genotyping results are presented for the different groups of dogs tested, 
including Labrador retriever puppies from breeding facilities.  
2.3.1 Light microscopy Giardia diagnostic test results for Victoria and WA 
Results shown in Table 2.3.1 include all canine faecal samples tested for Giardia spp. 
infection using the centrifugal zinc sulphate flotation and light microscopy gold standard. 
In total there forty-four samples were diagnosed as positive for Giardia spp. infection 
from a Victoria Labrador retriever breeding facility. Fifty-two positive samples were 
from a Labrador retriever breeding facility, 4 positive samples from miniature 
schnauzer breeding facility and 6 positive samples were from dog shelter facilities all 
located in Western Australia.  
Table 2.3.1 Giardia diagnostic results obtained using light microscopy gold standard 
Group Location N POSITIVE NEGATIVE 
Breeder (Labrador retriever) Bulla, Victoria 155 44 111 
Breeder (Labrador retriever) Perth, Western 
Australia 
86 52 34 
Breeder (miniature schnauzer) Perth WA 22 4 18 
Shelters Perth WA 135 6 128 
It was noted that Giardia spp. infected faecal samples were easily identifiable by a 
sweet smelling odour that was not present in uninfected samples. In total three 
hundred and ninety-eight canine faecal samples were collected during from puppies 
and dogs aged 15 -1277 days of age. Some samples contained both trophozoites and 
cysts, although only cysts were detected in the majority of positive samples. 
Microscopy results confirmed that Giardia spp. Infections were frequently concurrent 
with, or preceeded by, other protozoan parasites, the significance of these concurrent 
infections is discussed further in Chapter 3.  
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2.3.2 Prevalence and infection rates 
The numbers of samples tested (N) are given for each test, and all prevalence values 
(%) were determined using the gold standard test. 
Table 2.3.2. Prevalence data 
Group N Prevalence Confidence Interval (CI) (95%) 
Labrador retrievers Victoria 155 28.4% 21.4 – 36.2 
Labrador retrievers WA 86 60% 48.9 – 70.5 
Miniature schnauzer WA 22 18.2% 6.5 -36.9 
Dog shelters WA 135 4.4% 2.0 – 8.6 
Prevalence rates shown in Table 2.3.2 were calculated from the number of Giardia spp. 
infected faecal samples using Quantitative Parasitology 3.0, which assumes a binomial 
parasite distribution. In total 20.1% (99% CI 15.07 – 25.92) of Australian dogs tested, 
from a total sample size of 398, were confirmed with Giardia spp. infections after light 
microscopy detection of cysts in faecal material. A higher prevalence of 28.4% (99% CI 
21.4 – 36.2) was recorded for a large breeding facility of Labrador retrievers in Victoria. 
High prevalence rates were recorded for puppies less than 6 months of age from 
Labrador retriever breeding facilities in Western Australia 60% (99% CI 48.9 – 70.5). A 
lower prevalence rate of 18.2% (99% CI 6.5 -36.9) was recorded for miniature 
schnauzer puppies from breeding facilities in Western Australia. In contrast, faecal 
samples collected from asymptomatic, mainly adult, dogs housed in shelter situations, 
in Perth metropolitan area of Western Australia, showed the lowest Giardia spp. 
infection rate of 4.4%, (99% CI 2.0 – 8.6). 
2.3.2.1 Longitudinal diagnostic testing for Giardia spp. infections in Labrador 
retriever puppies in Western Australia 
This study collected faecal samples from litters of puppies, over a three-year period.  
During 2011, thirty-nine pooled faecal samples were collected on a daily basis from 2 
litters of puppies aged 35-49 days old and examined using the light microscopy gold 
standard. Giardia spp. cysts were observed in twenty-nine samples, as shown in Table 
2.3.3. Results from observation of other enteric parasites were recorded and these are 
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presented in Chapter 3. Copro-antigen tests were not performed during the first year of 
data collection, due to time constraints. 
Table 2.3.3 Longitudinal diagnostic test results using light microscopy gold standard 
Year N Positive Negative Age Prevalence (95% CI) 
2011 39 29 10 35-49 73.7%    (0.569-0.866) 
2012 27 8 19 29-50 29.6%    (0.138-0.502) 
2013 20 15 5 14-85 75.0%    (0.509-0.914) 
2011-13 86 52 34 14-85 60.0%    (0.489-0.705) 
2.3.3 Comparison of diagnostic methods for different groups of dogs 
A comparative analysis of Giardia spp. diagnostic tests is presented in this section. 
Sensitivity, specificity, positive predictive value and negative predictive values were 
calculated for each diagnostic test, as described by Morgan et al., (1998). 
2.3.4 Comparison of three different diagnostic copro-antigen tests for 
Giardia spp. infections in two Labrador retriever breeding facilities  
The sensitivity of copro-antigen test 1 was determined as 0.65 and specificity of 0.82 
with a negative predictive value of 82%, for samples tested from Victoria, shown in 
Table 2.3.4. Samples from WA tested with copro-antigen test 1 gave a test sensitivity 
of 0.60 and specificity of 1.0. The positive predictive value calculated for copro-antigen 
test 1 for detection of Giardia infections indicates that 100% of all Giardia spp. 
infections in the WA breeding facility were likely to be detected. In contrast, in the 
Victorian population only 50% of infections were likely to be detected. 
 
 
Table 2.3.4 Sensitivity and specificity of three different Giardia copro-antigen diagnostic  
Location Test Sensitivity Specificity PPV NPV 
VIC Copro-antigen test 1 0.65 0.82 50% 82% 
WA Copro-antigen test 1 0.60 1.0 100% 76% 
VIC Copro-antigen test 2 0.50 0.50 60% 40% 
WA Copro-antigen test 2 0.75 0.60 82% 50% 
VIC ELISA antigen test 0.33 0.43 56% 23% 
WA ELISA antigen test 0.41 1.0 100% 24% 
Ten canine faecal samples from Victoria were tested with both copro-antigen test 1 and 
2 for the presence of Giardia spp. infections, results are shown in Table 2.3.5 
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Table 2.3.5 Comparison of individual copro-antigen test results to microscopy results 
Sample Parasites detected Microscopy Copro-antigen Test 1 
Copro-antigen 
Test 2 
1 Giardia spp.(1+) + - - 
2 Giardia spp.(<1+) + - - 
3 No parasitic organisms detected - + + 
4 Giardia spp.(1+) + + + 
5 Giardia spp.(3+) + + + 
6 Sarcocystis sp.(<1+) - + - 
7 Giardia spp.(<1+) + + + 
8 Giardia spp.(2+) + + + 
9 Giardia spp.(1+) + + - 
10 Giardia spp.(1+) + + + 
  8+ /2- 8+ /2- 6+/4- 
2.3.4.1 Giardia spp. ELISA test  
Seventy-four samples in total from a shelter population and two Labrador retriever 
breeding facilities (WA and Victoria) were tested using ELISA copro-antigen plate 
assay test. Calculated values for sensitivity and specificity, and the negative and 
positive predictive values are shown in Table 2.3.6. 
2.3.4.2 ELISA test for breeding facilities in WA and Victoria 
Twenty-six canine faecal samples from Labrador retrievers in breeding facilities were 
tested for Giardia spp. infections using a commercial ELISA test, over half of the 
samples tested gave negative results. The sensitivity and specificity values of the 
ELISA tests relative to the gold standard test shown in Table 2.3.6 indicate that the 
ELISA test has low sensitivity (0.33, 0.41) and low efficacy (23%, 24%) in detecting 
Giardia spp. negative samples for both groups of dogs tested. The specificity (1.0) and 
PPV (100%) for detection of Giardia spp. infections in samples from WA using ELISA 
were much higher than the values obtained from Victoria (0.43, 56%).  
Table 2.3.6 Sensitivity and specificity values for ELISA test relative to microscopy  
 Sensitivity Specificity PPV NPV 
Labrador retriever WA 0.41 1.0 100% 24% 
Labrador retriever VIC 0.33 0.43 56% 23% 
Shelter WA 0.17 0.65 12.5% 72% 
All Groups Tested 0.35 0.63 58% 42% 
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The sensitivity values for Giardia spp. ELISA across all the groups tested were very 
low ranging from 0.17 -0.41, shown in Table 2.3.6. Also, some of the ELISA positive 
samples were also tested positive with other Giardia spp. diagnostic tests. Fifteen 
samples produced a positive result by light microscopy, nine tested positive with copro-
antigen test 1, and 4 tested positive with both light microscopy and copro-antigen test 1. 
2.3.4.3 Longitudinal testing for Giardia spp. infections by two copro-antigen tests  
In 2012 twenty-seven canine faecal samples were tested for Giardia spp. infection, 
from puppies aged 29 - 50 days old using copro-antigen test 1, and 4 positive test 
results were recorded. Three samples that tested positive by microscopy for parasites 
were negative by copro-antigen test 1. Two of these samples were confirmed Giardia 
spp. co-infections with Cystoisospora spp. by microscopy. During 2013, nineteen 
canine faecal samples from one litter of puppies were collected from individual puppies 
over consecutive weeks between the ages of 68-85 days. Eight positive test results 
recorded using light microscopy gold standard were also tested with copro-antigen test 
1. Two positive test results and six negative test results were obtained. Sensitivity, 
specificity, negative and positive predictive values are shown in Table 2.3.7.  
Table 2.3.7 Sensitivity and specificity values for copro-antigen test 1  
Year Puppy Age 
Number 
tested Prevalence 
 (days)  Test 1 Gold Standard Sensitivity Specificity PPV NPV 
2012 29-50 27 14.8% 29.6% 0.67 1.0 100% 91% 
2013 14-85 20 42.1% 75.0% 0.53 1.0 100% 42% 
2012-13 14-85 86 26.0% 60.0% 0.60 1.0 100% 76% 
The same faecal samples were also tested with copro-antigen test 2 however, due to 
time constraints only 3 samples were tested in 2012. Fourteen samples were tested in 
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Prevalence Sensitivity Specificity PPV NPV 
Test 2 Gold Standard     
2012 29-50 3 66.7% 29.6% nc* nc nc nc 
2013 14-85 14 64.3% 75.0% 0.80 0.75 89% 60% 
2012-13 14-85 17 58.8% 60.0% 0.75 0.60 82% 50% 
*nc not calculated 
One microscopy positive sample was tested with copro-antigen test 2 and a positive 
result was obtained. Further testing of this sample produced positive results across all 
three copro-antigen tests and positive by PCR at the 18s gene locus. 
2.3.5 Molecular genetics of Giardia spp. infected faecal samples from all 
dogs tested in this study 
Three hundred and ninety eight canine fecal samples were analysed using polymerase 
chain reaction (PCR) during this study. Sixty-four (16%) of the samples were confirmed 
positive for Giardia spp. at 18s gene locus. Positive samples were further analysed by 
PCR at beta giardin and GDH gene loci. The PCR products were sequenced and the 
results are reported in Table 2.3.9 where sequencing was successful. For some 
samples the initial attempt to obtain DNA sequences were unsuccessful, and DNA 
extraction was repeated from faecal samples preserved in ethanol and sequences 
were successfully produced. Table 2.3.10 displays a summary of the results from 
genotyping Giardia spp. infected faeces based upon gene loci and Table 2.3.11 shows 
results for each individual gene locus 
Table 2.3.9 Percentage of samples successfully sequenced for each gene loci  
18s gene locus Beta giardin gene locus GDH gene locus 
Number % Number % Number % 
42 55 18 23 17 22 
In total 44% of samples were positive at only one gene locus, 39% at 2 gene loci and 
17% positive at all three gene loci tested. The majority of those samples positive using 
all three gene loci were those with host specific infections, assemblage C or D. 
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Table 2.3.10 Percentage of samples successfully sequenced at one or more gene loci. 
 1 gene locus 2 gene loci 3 gene loci 
Number 28 25 11 
% 44 39 17 
 











































































































1 +*  -   - 2 + +  - 3 A D D 
1 +  -  - 2 + +  - 3 A/C/D C D 
1 A  -  - 2 + +  - 3 D D D 
1 A  -  - 2 + +  - 3 D D D 
1 A  -  - 2 + +  - 3 D D D 
1 A  -  - 2 +  -  A 3 D D D 
1 A  -  - 2 A +  - 3 D D D 
1 A/D  -  - 2 A +  - 3 D D D 
1 C  -  - 2 A +  - 3 D D D 
1 C  -  - 2 A +  - 3 D D D 
1 C  -  - 2 A/D +  - 
1 C  -  - 2 A/D +  - 
1 C  -  - 2 A/D +  - 
1 C  -  - 2 A/D +  - 
1 C  -  - 2 A/D D  - 
1 D  -  - 2 C  - C 
1 D  -  - 2 C  -  - 
1 D  -  - 2 C  -  - 
1 D  -  - 2 D +  - 
1 D  -  - 2 D +  - 
1 D  -  - 2 D D  - 
1 D  -  - 2 D  - C 
1 D  -  - 2 D  - D 
1  - +  - 2 D  -   
1  - C  - 2  - D D 
1  - C  - 2  - D D 
1   - C  - 2  - D D 
* denotes PCR positive result, failure to obtain sequence 
Host specific Giardia assemblages were successfully genotyped at 18s, beta giardin 
and GDH gene loci. Sequencing of Giardia spp. positive PCR product using the beta 
giardin locus was unsuccessful in genotyping Giardia assemblage A, but successful 
genotyping was confirmed at 18s and GDH loci. 
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2.3.5.1 Molecular genetics of Giardia spp. in dogs from shelter facilities in Perth 
Seventeen samples were confirmed positive by PCR using the 18s gene locus and 15 
of these were successfully sequenced. Genotyping showed that 3 samples were G. 
duodenalis assemblage A, 8 samples were G. duodenalis assemblage D, 3 samples 
were G. duodenalis assemblage C and one contained mixed G. duodenalis 
assemblages A/D. 
2.3.5.2 Molecular genetics of Giardia spp. infections in breeding populations of 
Labrador retrievers 
Genotyping results for faecal samples tested from Victoria and WA breeding facilities 
by PCR at 18s, beta Giardia spp. and GDH gene loci are shown in Table 2.3.12. Forty-
four samples from Victoria were confirmed positive by microscopy. Twenty-nine 
samples that returned a positive result by PCR at any gene locus were successfully 
sequenced and genotyped. Five of these previously tested negative by light 
microscopy, as no Giardia cysts were observed. Only 7 samples were considered 
successfully genotyped using multi-locus genotyping (at 3 gene loci).  
Table 2.3.12 Giardia spp. genotypes in Labrador retrievers 
Genetic characterization WA VIC 
 2011,n=39 2012, n=27 2013, n=20 n=44 
PCR positive  15 4 11 29 
Successfully genotyped  8/15 3/4 8/11  
Assemblage A 2 0 1 11 
Mixed Assemblage 5 0 0 6 
Assemblage C 0 0 2 4 
Assemblage D 1 3 5 8   
2.3.5.3 Giardia spp. genotypes in adult male dogs in a breeding population of 
Labrador retrievers, Victoria  
Faecal samples tested for Giardia spp. infection from working dogs showing signs of ill 
thrift and failure to gain weight. Genotyping results are shown in Table 2.3.13, six dogs 
in the group were infected with host specific Giardia assemblage C/D (150 -250 days 
old) and the results were confirmed at all 3 gene loci. Two samples tested showed 
mixed infections with Giardia assemblage A whilst the other 4 dogs were infected with 
only host specific Giardia assemblage C and/or D. 




Table 2.3.13 Genotyping results for working dogs 
 
2.3.5.4 Molecular genetics – comparison of polymerase chain reaction (PCR) with 
the light microscopy gold standard for Victorian dogs 
The positive predictive value for PCR results relative to the gold standard indicates that 
up to 100% of all Giardia spp. infections, are likely to be detected, as shown in Table 
2.3.14 In the litter with the lowest prevalence rate (29.6%) the PPV was lowest at 75%.  
Table 2.3.14 Sensitivity and specificity of PCR against the standard for dogs tested in WA 




 Sensitivity Specificity PPV NPV 
   PCR Gold std     
2011 35-49 39 38.5% 73.7% 0.52 1.0 100% 42% 
2012 29-49 27 14.81% 29.6% 0.50 0.95 75% 87% 
2013 68-85 20 50% 75.0% 0.60 0.80 90% 40% 
2011-13 29-85 86 31% 60.0% 0.54 0.94 93% 60% 
Results are shown in Appendix 1. 
2.3.6 Giardia spp. genotypes in Labrador retriever breeding dams and 
litters of puppies  
Faecal samples from more than 15 breeding dams were examined during this study.  
Giardia spp. genotyping results for six dams are reported in Table 2.3.15 below where 
data was collected for both puppies and maternal dam.  
Samples positive for Giardia spp. infection by microscopy were confirmed positive by 
PCR at the 18s gene locus and beta giardin gene locus and both genotyped to 
Assemblage A. The other samples were PCR positive samples (18s gene locus) not 
previously confirmed using light microscopy gold standard. 
Gene loci Working dogs 
18s Beta Giardin GDH 
N=6 
A D D 1 
A/D D  1 
C C C 1 
C/D D D 1 
D D D 2 




Table 2.3.15 Genotyping results for Giardia spp. infections in breeding dams and litters of 
puppies 
Gene loci Positive results by group 
18s BG GDH Breeding Dams n=11 




A   9 2 1  A/C  1   
A/D    1 2 
 C    2 
C  C   1 
 D D   1 
D D  1  1 
D D D  2  
 
The samples from the litters of young puppies and breeding dams were much easier to 
genotype at all 3 loci than the other groups of samples. The results were consistent 
even when DNA re-extractions and PCR reactions were repeated on faecal samples 
that had been frozen for 12 months or more.  
Genotyping results for faecal samples from juvenile dogs (aged over 12 weeks) were 
mainly host specific assemblages C and or D, shown in Table 2.3.16.  
 
Table 2.3.16 Genotyping results for juveniles (over 3 months old) 
Number of dogs 18s BG GDH 
1 A - - 
2 - C - 
2 A/D - - 
2.3.7 Summary of the performance of four Giardia spp. faecal diagnostic 
tests relative to light microscopy in two breeding populations of 
dogs 
A comparative summary of the different diagnostic tests used to determine Giardia spp. 









Table 2.3.17 Summary of sensitivity and specificity tests for Giardia spp. diagnostic tests 
Diagnostic Tests 
Test performance Sample Source (State) 
 WA VICTORIA 
Reference Standard  Prevalence 60% 28.6% 
Light Microscopy  n=86 n=155 
Copro-antigen Tests 
Test 1 
Sensitivity 0.6 0.65 
Specificity 1.0 0.82 
PPV 100% 50% 
NPV 76% 82% 
  n=46 n=155 
Test 2 
Sensitivity 0.75 0.75 
Specificity 0.60 0.60 
PPV 82% 60% 
NPV 50% 60% 
  n=17 n=10 
ELISA 
Sensitivity 0.45 0.33 
Specificity 1.0 0.43 
PPV 100% 56% 
NPV 24% 23% 
  n=26 n=22 
DNA 
PCR 
Sensitivity 0.54  
Specificity 0.94  
PPV 93%  
NPV 60%  
  n=86  
n= number of samples tested    
2.4 Discussion 
2.4.1 Comparison of Giardia spp. diagnostic tests  
The diagnostic standard used throughout this study, centrifugal zinc sulphate 
flotation and light microscopy had low values for sensitivity (0.31) and specificity 
(0.74). The Positive Predictive Value (48%) suggests that using this method of 
diagnosis for this dog population (breeding facility with Giardia spp. prevalence rate 
of 28.6%) would detect less than half of Giardia spp. infected dogs, similar to 
(Geurden et al., 2008, Gates and Nolan, 2009a). However the accuracy of this 
method for confirming dogs without Giardia spp. infections was relatively poor, the 
Negative Predictive Value was only 58%, much lower than the value (81-95%) 
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reported by (Geurden et al., 2008).  
In summary, the performance of the four different Giardia spp. diagnostic tests shown 
in Table 2.3.16, shows that the positive predictive value PPV, was consistently higher 
for the WA population, for all tests used, and an overall higher Giardia spp. prevalence 
rate suggesting a high level of confidence in diagnostic accuracy. There were apparent 
differences in the types of Giardia spp. infections diagnosed in dogs from WA and 
Victoria. Results for copro-antigen test 2 and ELISA indicate that these tests were not 
able to accurately confirm uninfected samples. 
Data in the Table 2.3.5 shows test results for a small subgroup of ten samples (from a 
larger group) tested for Giardia spp. with copro-antigen tests 1 and 2. Results for these 
ten samples using copro-antigen test 2 indicated fewer positive test results than copro-
antigen test 1, relative to light microscopy. The sensitivity and specificity values 
calculated for test 2, as shown in Table 2.3.4 were calculated to be 0.5 and 0.5 
respectively, relative to the gold standard. Calculation of the positive predictive value 
indicates that 60% of Giardia spp. infections are likely to be detected using test 2 in 
canine faecal samples containing Giardia spp. cysts and 40% of test results can 
accurately confirm the absence of Giardia spp. infection.  
2.4.1.1 Individual and pooled faecal samples 
The levels of test sensitivity, indicating the effectiveness of the test to detect infections, 
was highest for samples collected from individual puppies (0.8), and lowest for the litter 
of puppies aged 29-49 aged days. The highest PPV for light microscopy gold standard 
diagnostic (76%) was for puppies aged 35-49 days where pooled faeces were collected 
from mixed litters of puppies, and lowest (27%) for the litter of puppies which were 
older and sampled individually. 
Nevertheless, despite the fact that samples came from the same breeding facility, the 
puppies were from different litters. The level of exposure reflected by the disease 
status of the dam together with genetic pre-disposition may exert higher levels of 
influence on infection rates in newborn puppies. 
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At lower prevalence rates, reduced specificity and positive predictive value for the 
copro-antigen tests suggests that genetic confirmation by PCR methods is important.  
2.4.1.2 Comparison of test standard (Light Microscopy) with immuno-antigen 
tests  
Previously published results have compared copro-antigen tests with molecular 
genotyping or microscopy methods (Rimhanen-Finne et al., 2007), but few studies 
have compared different immuno-antigen tests for Giardia spp. diagnostics in dogs 
(Geurden, et al., 2008).  
Three copro-antigen tests used in this study showed variability in sensitivity and 
specificity values, summarized in Table 2.3.17. Increased detection rate using 
microscopy and copro-antigen tests included both dogs that are excreting cysts and 
those dogs that were infected and not excreting intact cysts, but where the 
presence of a cyst wall antigen was detected. This is likely to indicate the 
excystation transition phase to trophozoites has occurred, or is occurring. 
For the longitudinal diagnostic testing of a breeding population of Labrador retriever 
puppies (WA) the prevalence rate over three years was 60%, a high rate of 
infection. Combined with light microscopy, a combined diagnostic test series 
produced consistently higher scores for sensitivity specificity and PPV and NPV 
than if immuno-antigen test was used alone. Similar results were also found for the 
Copro-antigen test 2 when used in series with light microscopy. It is worth noting 
that all the positive test results for Copro-antigen test 2 were from faecal samples 
with no signs of clinical infection (asymptomatic). More tests would need to be 
performed on dogs experiencing clinical signs of infection. 
The results in Table 2.3.5 indicate that the ELISA plate assay was most effective at 
detecting Giardia spp. positive samples when the prevalence rate was high (100% 
PPV) and less effective at low prevalence levels, in shelter dog group (12.5% PPV). 
The frequent occurrence of false negative results was reflected in low NPV values (23 
– 72%).  
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When results from all groups of dogs were considered as a combined group, the ELISA 
test failed to perform as well as any of the other immune-antigen tests giving a PPV of 
41-58%. Results from the ELISA test used to diagnose Giardia spp. infections in faecal 
samples from Western Australian puppies with high prevalence rate showed high 
sensitivity and in the absence of false negatives gave 100% NPV. However, the NPV 
for the Victorian group was only 25%, most likely due to the presence of low levels of 
antigen caused by asymptomatic or recurrent infection. This low efficacy in excluding 
non-infected individuals could be attributed to the presence of Giardia spp. antigen in 
most samples, regardless of clinical signs of infection, or to the diagnostic test 
preferential detection of one genotype over another. So, for the case of mixed 
infections, one genotype may be detected by immuno-antigen reaction but another 
genotype may remain undetected by other tests.  
2.4.2 Molecular diagnostics 
The confirmed detection of Giardia spp. DNA in 16% (64/398) of all samples and 28% 
(18) of these genetic positives were negative by light microscopy has confirmed the 
findings of other researchers that diagnosis by light microscopy alone is an 
underestimate (Palmer et al., 2008). Furthermore, only five samples that tested 
negative by light microscopy and returned positive results by DNA sequencing were 
confirmed positive using the copro-antigen test, which suggests that as many as 13% 
of all Giardia spp. infections remain undiagnosed using current diagnostic methods. 
2.4.2.1 Comparison of the test standard with polymerase chain reaction (PCR)  
In the litter with the lowest prevalence rate (29.6%) the PPV was lowest at 75%. The 
NPV was 40-87%. The failure to genotype all samples at multi-locus genes from canine 
faecal samples is common (Covacin et al., 2011, Gomes et al., 2011). No assemblage 
B isolates were confirmed by sequence analysis by any of the three gene loci used in 
this study. PCR is an important tool for genetic characterization and understanding 
epidemiology and transmission routes. However, is it actually possible to separate 
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epidemiological and clinical studies as suggested by Geurden et al. (2008), when the 
presence of clinical signs are unclear and the diagnosis unsubstantiated. 
2.4.2.2. Discordant diagnostic results 
The source of samples was blinded during this study to minimize biased interpretation 
of results. The data presented here supports an explanation from a comparative study 
to detect Giardia spp. infections in humans for discrepant results which occur when 
microscopy results are positive and immunoassay results are negative (Johnston et al., 
2003). The authors suggest this may occur due to low levels of Giardia spp. cyst 
intensity whilst also noting that positive controls in commercial kits were far more 
intensely coloured than results for positive test samples, even those with highest cyst 
intensity, as was the case here. One study, Gates and Nolan (2009a), focused 
attention on technical troubleshooting. Maybe such small quantities of faecal material, 
1g (less than 0.5 % of total stool from large dogs) are not sufficiently representative, as 
it is unlikely that parasitic cysts are evenly distributed throughout a stool sample. Whilst 
sporadic cyst shedding is a reality facing diagnostic technicians, it is unconfirmed if 
multiple sampling strategies actually generate a more accurate picture of Giardia spp. 
infections (Rimhanen-Finne et al., 2007). 
The results from this study confirm that detection of antigenic protein occurs less 
frequently than observation of parasitic Giardia spp. cysts by light microscopy There 
were differences in diagnostic test results using the different copro-antigen tests. As 
the details of the antigens included in the commercial diagnostic tests are unknown, it 
is possible that one test is preferentially detecting a particular genetic isolate.  
If the antigen is only expressed during trophozoite replication or attachment it is 
possible that any cysts which have been ingested and failed to become active would 
be excreted. This explanation could account for the false negative results reported, 
which were more frequent than false positive results, similar to (Dryden et al., 2006).  
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The number of cysts observed did not appear to influence copro-antigen test results, 
but increased numbers of cysts in faecal samples may be associated with the ability to 
elicit PCR results.  
2.4.3 Gold standard diagnostic validation  
Standards for reporting diagnostic tests in a medical context have been reviewed for 
methods lacking a gold standard Rutjes et al. (2007). The authors recommend 
validation of tests by statistical methods, clinical data or reference standard 
development. The comparative diagnostic analysis reported for Giardia spp. infections 
in the current study was performed in the absence of a gold standard. Attempts to 
determine the accuracy of the light microscopy gold standard using clinical signs of 
infection were inconclusive as other parasites were also detected by microscopy. A 
gold standard diagnostic requires a study which generates a two by two table to 
express test results as Disease Positive with clinical infection and Disease Negative in 
the absence of clinical infection (Greenhalgh, 1997). Accurate assessment of clinical 
(and subclinical) signs is an important factor for appropriate development of Giardia 
spp. diagnostic tools. Of critical importance is the impact of infection in the population 
under study. Many studies refer to asymptomatic infections, assuming no detrimental 
consequences caused by the infection. 
In addition to the diagnostic methods described in this study another interesting factor 
associated with canine faecal samples positive for Giardia spp. was a distinctive odour. 
Whilst frequently referred to as malodorous, (Carlin et al., 2006, Caccio and Ryan, 
2008) the Giardia spp. positive faecal samples could be identified when the pots were 
opened, due to a distinctive “sweet odour” not present in other samples. Whilst this 
observation is neither a proven or preferred diagnostic method, it is worthy of further 
investigation. Olfactory detection methods have reported for other infectious and 
intestinal diseases using Enose (Bijland et al., 2013). 
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2.4.4 Longitudinal data 
The collection of faecal samples from litters of puppies at the same breeding facility 
over a three-year period clearly demonstrated ongoing Giardia spp. infections at 
higher rates than published for the wider dog population. 
Longitudinal diagnostic testing of puppies showed a prevalence rate at one WA 
Labrador retriever breeding facility of 60%. This is a high rate of infection, the only 
other published prevalence rate that exceeds those reported here were for puppies 
in remote Canadian communities (74%) (Himsworth et al., 2010). These high 
infection rates are indicative of high levels of exposure to cysts and reinfections in 
dogs, either because they are housed together, or due to poor levels of hygiene. 
Another possible explanation is the genetic pre-disposition of the host breed, such 
as reported by Upjohn et al. (2010) for purebred Rottweilers. 
Reinfections are likely to be occurring within the facility and the lower rates of 
infection in the second year could be due to chance sampling from uninfected 
puppies, when using pooled sampling methods or an uninfected maternal dam. The 
timing of collection and age of the dogs sampled is also an important factor and is 
discussed more in the context of patent infection in Chapter 3. 
This study has shown the importance of longitudinal studies (Hamnes et al., 2007) 
and has shown to be valuable for monitoring infections in puppies, as 
recommended by Ballweber et al. (2010). Whilst this study was able to conduct 
repeated sampling of individual puppies, unfortunately it was unable to monitor 
presence of parasite infections in maternal dams over time pre- and post- 
consecutive whelping. Point prevalence studies are limited in their ability to capture 
dynamics of parasite infections and host-parasite interactions. 
2.4.4.1 Prevalence and infection rates 
The prevalence of Giardia spp. Infections in Labrador retriever puppies (60%) aged 
14-56 days was nearly three times higher than for miniature schnauzers (18.2%) 
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aged 14-72 days. Prevalence rates for different populations of dogs tested in this 
study varied according to characteristics of the populations being investigated. The 
differences were attributed to different geographical locations, breeds and ages of 
dogs, management practices and potential exposure to Giardia spp. and other 
enteric parasite infections. Prevalence rates for Giardia spp. Infections differed 
between dogs from two different purebred breeding facilities.  
2.4.4.2  Subpopulations 
Prevalence rates for different subpopulations of dogs showed that Giardia spp. 
Infections were highest in young Labrador retrievers 75% (14-85 days) and this 
supports the findings of others (Itoh et al., 2005, Batchelor et al., 2008, Epe et al., 
2010, Uehlinger et al., 2013). The overall higher rates of infection in litters of 
puppies was considerably higher with almost 100% infection rate in some litters at 
certain points in time.  
Many studies reporting overall prevalence rates may create a misleading picture of 
Giardia spp. epidemiology if the differences which exist within different discrete 
groups of dogs, one considers as suggested by (Carlin et al., 2006). 
2.4.5 Host pre-disposition 
There are already indications that in human infections two different European isolates 
of Giardia spp. exist, of Polish and Belgian origin, (Homan et al., 1992, Mayrhofer et al., 
1995, Van Keulen et al., 2002). Different distributions of the different genetic 
assemblages that occur in humans of dogs have been reported from studies in the 
USA (Nash and Keister, 1985) and a predominance of sub-genotype A in remote 
Australian communities (Hopkins et al., 1997).  
2.4.5.1 Breed differences 
Diagnosis of Giardia spp. Infections by the light microscopy gold standard was much 
lower in faecal samples from the miniature schnauzer breeding facility (18.2%) 
although this is located in the same catchment area (within 20 kilometres) as the 
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Labrador retriever breeding facility (60% infected) in Western Australia. Similar studies 
found conflicting results, Hamnes et al. (2007) examined Giardia spp. Infections in 
purebred dogs including Labrador retrievers, but obtained no results for differences 
between breeds whereas Fontanarrosa et al. (2006) suggested higher infection rates in 
purebred dogs. The differences may be due to different host genetics, or may be due 
to husbandry and management system for large groups of dogs. It was confirmed 
during this study that some dogs imported for breeding purposes might be a 
contributing factor for introducing Giardia spp. Infections. Facility management may be 
an influencing factor, however the propensity for host pre-disposition and possible 
parasite co-evolution should be considered. Further detailed studies would be required, 
including statistical validation, to determine if breed differences do exist, which affects 
host susceptibility to Giardia spp. Infections.  
2.4.5.2 Dogs from shelter facilities 
The Giardia spp. Infection rate in shelter dogs was lower than expected and could 
be due to the sampling method, as most were dogs older than 12 months and many 
were new to the shelter, similar to results found by Upjohn et al. (2010) and Swan 
and Thompson (1986) (14.4%). This suggests that they could be lost dogs from well 
cared for homes. Nevertheless it is more likely that those dogs resident at the 
shelter for longer periods, genuine ownerless strays or young or sick dogs at the 
shelter, would be more likely to have higher infection rates. Most infections 
successfully sequenced were shown to be host specific assemblages. 
2.4.6 Geographical and ecological variation 
Survival of Giardia spp. in the environment may pose a risk, recent reports have 
already identified the changes in distribution of some parasites as an impact of climate 
change (World Health Organization, 2003). Despite environmental factors and 
exposure to infection this study supports the view that some hosts may be more 
susceptible than others to particular Giardia spp. Genotypes.  
Chapter 2 Comparative Diagnostics 
 113 
Some researchers have recognized that geographic and climatic variations on a global 
scale have a consequence for localized weather patterns, habitat, and ecology, 
including for parasites such as Giardia spp. (Leonhard et al., 2007, Ballweber et al., 
2010, Covacin et al., 2011). Giardia spp. prevalence rates might be affected by 
seasons, or climate throughout the world as found for Cryptosporidium spp. (Kirkpatrick, 
1988, Hamnes et al., 2007, Britton et al., 2010, Lal et al., 2012). It is apparent that the 
occurrence is not as marked as for Cryptosporidium spp. or Plasmodium spp., 
infections although with appropriate tools for of spatial, temporal and weather related 
information is being compiled for Giardia app. Infections in dogs (Fontanarrosa et al., 
2006). Monitoring the patterns of infectious outbreak may be performed using a 
systematic parametric framework similar to the one described by Naumova et al., 
(2007). Research of this nature is important because of the variation in environmental 
and climatic conditions, human population density, and pet ownership in different 
countries. Inclusion of more than a single parasite species may improve the validity 
and application of data models (Viney and Graham, 2013). Parasitic organisms are 
major health concerns for communities where conditions are conducive to spread of 
infectious disease, including climate, large populations, recent industrialization and 
large-scale deforestation (Wilcox and Colwell, 2005, Bates et al., 2008, Wilkes et al., 
2011, Nuwagaba and Namateefu, 2013). Giardia spp. Infections can directly cause 
debilitating disease and death in children and contribute to the subsequent indirect 
effects of missed educational and employment opportunities – key contributors to 
poverty, are particularly evident in developing countries (Thompson, 2004, World 
Health Organization et al., 2006). 
2.4.7 Genotyping of Giardia spp. Infections in adult dogs  
In total, 65% of samples confirmed positive for Giardia spp. By microscopy also tested 
positive using PCR methods. This correlates well with PCR positive test results for 
canine faecal samples from USA (62%) (Covacin et al., 2011). The limited success for 
multi-locus sequence analysis, only 7 samples, indicates that genotyping at one locus 
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may produce unreliable results, although the reasons for this remain unexplained. Only 
one dog showed infection with potentially zoonotic specific genotype, assemblage A. 
Results from this study for asymptomatic dogs found that sequence alignments to 
assemblage A at 18SrDNA were unconfirmed using multi-locus genotyping. This 
indicates that mixed infections were frequent and that none of the adult male dogs 
were infected with only zoonotic Giardia spp. Isolates. 
2.4.8 Clinical signs of infections in adult male dogs 
This study has demonstrated that testing for Giardia spp. infections in individual adult 
male dogs displaying sub-clinical signs, such as loss of appetite, lacklustre body 
condition and weight loss, or failure to gain weight, generated positive results, similar to 
clinical cases reported for G. duodenalis infections in children (Ajjampur et al., 2009). 
Recognition of sub-clinical signs of infection is important and is discussed further in 
Chapter 3. These include signs such as anorexia, failure to thrive or general ill-thrift 
(Table 2.3.12) which present sporadically, not necessarily on consecutive days.  
The ‘asymptomatic‘ infections detected here were successfully genotyped and shown 
to be exclusively host specific Giardia spp. assemblages C and D, although the 
presence of mixed assemblage sequences was also confirmed in two samples. 
Detection of Giardia spp. infections in the absence of classical signs of infection, such 
as diarrhea, vomiting and flatulence, suggests an ongoing problem of asymptomatic 
Giardia spp. infections within this group of dogs. This is similar to the reports of 
abdominal pain rather than diarrhoea in humans infected with G. duodenalis (Hussein 
et al., 2009). Numerous studies report the incidence of asymptomatic infection, but few 
have pinpointed the significance and implications of circulating asymptomatic Giardia 
spp. infections within populations of dogs. Determining the cause of symptomatic 
cases of infection becomes more important in understanding the impact of 
asymptomatic infections. 
The faecal collection methods used and potential limitations to the design of this study 
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include (1) the maternal dam – her willingness for puppies to be handled and her 
persistence on removal of excreta whilst the puppies were young, and therefore 
unavailable for sample collection purposes. (2) Pooled samples from litters may 
randomly miss Giardia spp. infected puppies. (3) The aim of regular and multiple faecal 
sample collections was to overcome inaccuracies posed by sporadic cyst excretion (but 
difficult to check that this was actually improved). (4) The use of stool consistency as 
an indicator of clinical signs of infection. The results show that samples collected from 
individual puppies, rather than pooled samples gave higher Negative Predictive Values. 
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Chapter 3 
Enteric parasite infections in dogs – determination of  
the pre-patent period and clinical signs of infection 
3.1 Introduction 
Protozoan parasite infections affect young dogs (Canis familiaris), with higher 
prevalence rates reported in intensive housing situations, such as kennels or shelters, 
where rapid and high rates of transmission can occur among individuals (Bajer et al., 
2011). There is little published data documenting the earliest pre-patent for enteric 
protozoan infections in dogs, such as Giardia spp. especially in canines; published 
data focuses on infections in humans. Questions that remain to be answered concern 
the correlation of confirmed parasite infections, host exposure to Giardia cysts, and the 
presence of clinical signs of infection. What role do these sub-clinical infections have in 
the circulation of infectious organisms and potential zoonotic transmission cycles?  
3.1.1 Patency of Giardia infection  
Transmission studies using G. duodenalis trophozoites and cysts to artificially infect 
domestic and wildlife species (including dogs) have shown the pre-patent period to be 
of 5-22 days and that infections may last as long as six months and that apparent host 
re-infection and cyclic cyst excretion occurs (Davies and Hibler, 1979, Hewlett et al., 
1982). Artificial infection studies in humans established that variation in pathogenicity 
occurs between G. duodenalis species. Clinical signs may occur after patency is first 
observed, where the average pre-patent period was recorded as 7.5 days (Nash et al., 
1987). 
3.1.2 Clinical signs of infection in dogs 
Some studies have suggested that clinical signs of Giardia spp. infection in dogs are 
caused by infection of host specific Giardia spp., assemblages C and D (Barutzki et al., 
2007). It is important to know which genetic Giardia spp. strains can cause infection in 
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humans, which produce clinical signs and are the cause of subsequent re-infection or 
the transmission potential to other individuals or species. Cross-species studies are 
needed which can assess both development of patent infections and determine the 
genotype. It is important to understand the pre-patent period, patency duration, 
evidence of cyclic cyst excretion to establish the opportunity and frequency of Giardia 
spp. re-infection, which may vary according to Giardia spp. genotype or between host 
species. 
3.1.3 Prevalence of canine enteric parasites 
It is common for dogs to be infected by more than one parasite at one point in time, a 
number of recent studies report on multiple parasite infections, concurrent with Giardia 
spp. infection in dogs; Batchelor et al. (2008) and Hamnes et al. (2007) in Europe and 
Itoh et al. (2005) in Japan. The widespread occurrence of co-infections of Giardia spp. 
and Cystoisospora sp., infections in Japan, with half of all dogs having multiple parasite 
infections, raises questions concerning the source of infections as 88.3% of dogs were 
housed indoors. Reported results were based upon fresh faecal examination and 
copro-antigen tests, although genetic characterization was absent. The prevalence of 
Giardia spp. and Cystoisospora infections was significantly higher in symptomatic dogs 
(7.9%) than asymptomatic cases (1.6%).  
A study conducted in India indicated that dogs were infected with multiple parasite 
infections, with 28.7% infected with 3 concurrent parasite species and were suggested 
to serve as indirect reservoirs of parasite infection (Traub et al., 2002). This study in 
India confirmed patent infections in 99% of dogs tested with identification of 16 different 
parasite species. Giardia spp. infection rates were low, and 9% of dogs were infected 
with coccidian species. Significantly higher infection rates were observed in young 
dogs which is in agreement with results from the longitudinal study by Hamnes et al. 
(2007) investigating multiple parasite infections of Giardia spp., Cryptosporidium sp. 
and helminths in dogs, during the first year of life. Results from this study indicated that 
13.6% of dogs were suspected of being re-infected with Giardia spp. and 
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Cryptosporidium sp. between different sampling dates, although there was no 
indication if other protozoan species were present. Similar evidence for re-infection 
rates were published by Gates and Nolan (2009b).  
A national survey of 1400 asymptomatic Australian dogs by Palmer et al. (2008) 
reported that protozoan infections were common (16% of all dogs surveyed). Detection 
methods used in the study used light microscopy to confirm more than 10 parasite 
species in faecal samples. Multiple parasite infections were confirmed in 4.1% of all 
dogs tested, although the authors support the view that prevalence rates are likely to 
be underestimated (Gates and Nolan, 2009a). This study confirmed earlier work using 
per rectum random sampling of dogs in Buddhist communities of Thailand (Traub et al., 
2009) where sophisticated molecular diagnostic tools determined the prevalence of 
Giardia spp. infections to be high (56.8% in dogs and 20.3% in humans). In contrast, 
Inpankaew et al. (2007) reported 7.9%. Giardia spp prevalence rates in dogs using zinc 
sulphate flotation and light microscopy methods. 
3.1.4 Significance of concurrent infections 
The majority of parasitology research has focused on detection and control of parasite 
species in isolation. There have been minimal attempts to address parasite infections 
at a community or catchment level. Stoll (1947) alluded to the parasitization of 
communities, although mainly in the context of helminth infections, with the notable 
absence of protozoan parasites.  
This study uses the term mixed or concurrent infections in acknowledgement of 
synonymous expressions common in other epidemiological settings describing 
‘polyparasitism’ or multi-parasitism. Steinmann et al. (2008) argues from a systematic 
biology standpoint that multi-parasitism has not been fully accounted for as 
morphological differentiation between many known parasite species is not possible, 
suggesting that well recognized parasites might actually form a complex of several 
species, distinguishable only by the use of molecular tools.   
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Houk et al. (2013) are of a similar opinion when they refer to Cystoisopora “ohioenis-
like” parasitic organisms due to the inability to distinguish between different species by 
morphology, definitive confirmation of Cystoisospora species is not possible by 
microscopy alone. A wide range of factors influence the survival of parasite 
communities and the interrelationships between different parasites affect pathogenicity 
(Petney and Andrews, 1998). 
Keusch and Migasena (1982) presented polyparasitism as a ‘biological norm’ in the 
human context and reflect upon the ideas of Buck et al. (1978) who proposed that 
parasite infections are self-limiting by host, population size and ecological factors. This 
idea is also supported by research indicating that males of mammalian species are 
more frequently parasitised by multiple species than females, suggesting some type of 
protection mechanism for unborn and young offspring (Budischak et al., 2012). Murray 
et al. (1978) suggested that parasites compete for access to the host, and inevitably 
one species wins at the expense of the other species. 
3.1.5 Pathogenicity and concurrent infections  
The effect of multiple parasite infections may exert synergistic impact on the host. This 
may occur due to cooperative interactions between parasites to overcome the host 
immune defence system. There is strength in this concept, as it is known that Giardia 
spp. is not invasive, but has a specialised attachment mechanism and subsequent 
disruption of the membrane barrier inducing cell leakage (Cotton et al., 2011, Buret and 
Cotton, 2011). This attachment mechanism is still far from being fully understood, with 
cell biologists supporting either a physical mechanism, ligand binding to surface 
proteins; or immunologic secreted protein interactions (Ortega-Pierres et al., 2011). 
However, phenotypic alteration first became apparent in polyparasitized hosts when 
Blom et al. (1979) showed elevated levels of alpha-1-acid glycoprotein, alpha-1-anti-
trypsin and ceruloplasmin in serum from human patients with concurrent helminth 
infections. These acute-phase protein reactants present in serum suggested an 
associated inflammatory reaction although the functional significance and metabolic 
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consequences were unknown. Lefèvre et al. (2009) discuss the cascade effects of 
phenotypic alterations in parasitized hosts suggesting that parasite survival 
mechanisms extend beyond the physiology of individual hosts. Parasites are attributed 
with the potential to modify host population ecology, competition processes, food web 
structures and metabolic flows of energy and nutrients. 
3.1.6 Transmission routes and artificial infection studies 
Questions concerning the reliability of results from artificial transmission studies which, 
were unable to provide assurance for the absence of prior, or accidental, infections of 
Giardia spp. This directed an interest in using specific pathogen free (SPF) hosts. 
Consequently, Mongolian gerbil (Meriones unguiculatus) studies confirmed that patent 
infections could develop from human, dog, cat and, sheep isolates of Giardia spp. 
(Gasser et al., 1987, Visvesvara et al., 1988). 
Experimental infection studies in Mongolian Gerbils (M. unguiculatus) with Giardia spp. 
isolates of human origin successfully demonstrated 100% infection rates for one isolate, 
however not all gerbils in the experiment became infected leading researchers to 
conclude that only certain Giardia spp. isolates had infective capability (Visvesvara et 
al., 1988). Prepatent period variation occurs between hosts infected with Giardia spp., 
both interspecies and intraspecies infections, in a similar manner to that reported for 
Cryptosporidium sp. (Xiao et al., 2004). 
These artificial infection studies clearly demonstrate the infective capability of cysts and 
trophozoites and that inter species infections can occur. What is not clear from this 
data – is the specific Giardia genotype responsible for infection. The early work using 
artificial infection studies precede the start of genetic characterization methods, and the 
phylogenetic alignment work for establishing Giardia genotype assemblages (Andrews 
et al., 1989, Mayrhofer et al., 1995, Ey et al., 1996, Hopkins et al., 1997). 
Whilst artificial infection of dogs with Giardia cysts and trophozoites is achievable 
infection is not always successful, even in young dogs (Hewlett et al., 1982). The lack 
of success in artificial infection could be due to host immunity, but could equally be 
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attributed to the Giardia genotype of the infective cyst or trophozoite. That is, genetic 
variation of cysts or trophozoites isolated from different hosts. Giardia spp. cysts 
isolated from humans are most likely to be genotypic assemblages A or B, unlike the 
host specific canine assemblages C and D. 
3.1.7 Risk factors for canine parasite infection 
The first reports of Giardia spp. infections in dogs in Western Australia usefully 
demonstrated that higher prevalence rates occur in younger dogs, or those dogs 
considered to be stressed or on a diet of poor nutritional value, such as puppies from 
breeding facilities or from dog shelters (Swan and Thompson, 1986). Furthermore, 
Swan and Thompson suggest that Giardia spp. may not be the cause of clinical signs 
as the incidence of clinical signs did not correlate with Giardia spp. infections, although 
the study failed to detect or report on the presence of any other parasites.  
Thompson (2000) raised the issue of Giardia spp. re-emerging as an infectious disease 
with potential zoonotic origins. Whilst risk factors include host and parasite elements, 
environmental factors such as population density, environmental pollution and quality 
of pet care and animal welfare are also critical factors contributing to the incidence of 
infectious parasitic disease (Gates and Nolan, 2009). The patterns of cyclic excretion 
of Giardia spp. cysts may also be critical factors in transmission. In recognition of the 
increasing concern of potential zoonotic reservoirs and potential transfer of Giardia spp. 
infection either to or from dogs to humans this study examined two different high-risk 
groups. Risk factors for infection include; neonates and juveniles; poor nutritional 
status or eating patterns and resultant gut microflora populations and pH; poor 
sanitation and hygiene conditions; poorly managed animals with lack of prophylactic 
anti-parasite programs, intensive housing situations and dogs during periods of 
physiological stress (mating, pregnancy, whelping). The groups studied were puppies 
from breeding facilities and dogs kept at dog shelter facilities. 
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3.1.8 Environmental and economic factors 
Findings from different countries appear to support data from a retrospective study by 
(Gates and Nolan, 2009) identifying socio-cultural factors as an important factor 
influencing the likelihood of parasite infections in dogs. Dog ownership in high density 
population areas, synonymous with lower income households, were more frequently 
infected than those from low density housing areas. Contrasting parasite profiles occur 
in animals from different socio-economic groups. Experimental evidence has shown 
that there is predominantly less diversity in parasite species in wealthier communities 
(Traub et al.,2002). The literature reports that Giardia spp. infections are common in 
intensive, well cared for or semi-domestic dogs (Gates and Nolan, 2009) and this 
observation is supported by other research studies (Itoh et al., 2009, Itoh et al., 2011).  
An epidemiological study of parasite infections in stray and pet dogs in Spain, by 
coprology and necroscopy examination, (Martinez-Carrasco C. et al., 2007), noted 
25% of dogs carried patent infections and that variation occurred with seasonality and 
climate; Cystoisospora sp. infections were reported at ten times higher levels than 
Giardia spp.  
3.1.9 Host pre-disposition 
Host characteristics, such as breed and age; are also associated with higher 
prevalence rates of multiple parasite infections, where juvenile dogs under 6 months of 
age have been shown to be infected with 4 parasite species, where Giardia spp. and 
Cystoisospora co-infections were common (Hamnes et al., 2007, Batchelor et al., 
2008). 
There is a similarity in infection rates between the two protozoan pathogens Giardia 
spp. and Tritrichomonas species with similar distinctive morphological features, 
including three or more anterior flagella, and musco-flagellate features for invasion and 
disruption of the mucosal epithelial membranes of gastro-intestinal or reproductive tract. 
These two pathogens infect intensively housed or stressed domestic pets, in both cats 
and dogs (Payne and Artzer, 2009). Accordingly, as many questions concerning 
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excretion of Giardia spp. cysts and transmission mechanisms currently remain 
unanswered veterinarians and pet owners need to be aware of the potential risks from 
zoonotic disease, or implications of anthroponotic transmission (Zajac et al., 2000, 
Thompson et al., 2008). If, indeed the incidence of protozoan infections of more 
affluent communities in humans and domestic pets is increasing either in prevalence, 
or in priority for medical or veterinary intervention. It is important to better understand 
the conditions enabling parasite populations to flourish as well as any synergistic 
effects between microorganisms contributing to pathogenicity and clinical signs. 
Knowledge about the patency and duration of infection serves a useful purpose in 
identifying appropriate intervention and treatment points. Also, other influencing factors, 
such as concurrent infections, nutritional status or genetic pre-disposition of the canine 
host may be critical in the development of clinical signs.  
3.1.10 Hypothesis 
That pre-patent infection period can be determined in dogs and that longitudinal 
sampling and testing can provide evidence of Giardia cyst excretion patterns. 
That Giardia spp. infections cause clinical signs of infection in dogs. 
3.2 Methods  
Investigation of the earliest patent Giardia spp. infections, pre-patent period, duration of 
patency to determine cyclical cyst excretion and recrudescence infections was 
performed by collection and examination of canine faecal samples for the presence of 
parasites, as part of a longitudinal study. Microscopy was used as the reference 
standard in this study to confirm patent parasite infections. The results are presented 
as temporal dynamics of parasite patency and sequence of infection. Phenotypic 
analysis is reported in Chapters 4 and 5. 
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3.2.1 Sampling strategy  
High-risk groups were identified as dogs less than one year of age (puppies and 
juveniles), dogs kept in intensive rearing or production groups, or in situations with poor 
husbandry standards. Private breeding facilities and dog shelters were approached for 
their cooperation. One dog-breeding establishment was in Victoria, Australia and all 
other samples were collected from metropolitan locations in Perth, Western Australia, 
as described in Chapter 2. Samples were collected from brood bitches and litters of 
pups to assess potential transmission, both pre and post whelp. 
3.2.2 Sample collection 
Samples were kept refrigerated at 4oC and generally arrived at the lab for processing 
within 48 hours of collection. Samples were processed as soon as possible and an 
aliquot dispensed and stored in ethanol for future use. 
For the litters of puppies samples were collected on a weekly basis from the age of 2 
weeks. Samples were pooled from litters of puppies, rather than from individual 
animals. Following positive confirmation of Giardia, samples were collected on a daily 
basis to monitor patency and duration. 
3.2.3 Assessment of clinical signs 
Stool consistency was the method used to assess the presence or absence of clinical 
signs of infection as determined by record of faecal stool form, ‘normal’ or ‘mucus or 
diarrhoeic’.  
3.2.4 Diagnosis of Giardia infection 
The experimental methods used in this study rely on the standard diagnosis of Giardia 
spp. infections by detection of cysts in faecal samples using centrifugal flotation and 
light microscopy methods, as described in Chapter 2, section 2.2.2. 
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3.2.5 Grading of infection 
Giardia spp. infected faecal samples were graded using a relative scale to represent 
the quantity of cysts observed. Samples with low cyst intensity graded (1+), those 
graded moderate (2+) and (3+) and those with high cyst intensity were graded (4+). 
3.3 Results 
Results presented here describe the pre-patent infection periods for enteric parasites 
detected in faecal samples obtained from dogs (including puppies and juveniles). This 
section includes a comparative analysis of enteric protozoan parasites in two naturally 
infected populations from dog breeding facilities in different geographical areas. The 
following characteristics of parasite infections in canine hosts were determined:  
1. Giardia spp. earliest patent infections and pre-patent period  
2. Association between parasite patency and presence or absence of clinical signs 
of infection  
3. Temporal dynamics and sequence of enteric parasite infections 
4. Zoonotic and host specific genotypes of Giardia infections 
5. Giardia spp. cyst intensity 
3.3.1 Giardia spp. infections and pre-patent period in canine hosts 
The pre-patent period for Giardia spp. infections and the presence of concurrent 
parasite infections were determined by examination of fresh faecal samples. Data from 
shelters and breeding kennels, in Perth, Western Australia and Bulla, Victoria revealed 
that 20.1% of adult and juvenile dogs were infected with Giardia spp., as outlined in 
Chapter 2, section 2.3.2.  
3.3.2 Determination of the pre-patent period of Giardia spp. infections in 
puppies from breeding facilities 
The earliest detection of Giardia spp. infections was confirmed in Labrador retriever 
puppies at 17 days (2 weeks) of age from a Victorian breeding facility. Patent Giardia 
spp. infections were also detected in different litters of Labrador retriever puppies from 
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a breeding facility in Perth, Western Australia at 35 days (5 weeks) 42 days (6 weeks) 
and 62 days (9 weeks) of age. Miniature schnauzer puppies in Perth, Western 
Australia were confirmed with Giardia spp. infections at 58 days of age. 
3.3.2.1 Labrador retriever breed, Bulla, Victoria 
Giardia spp. cysts were recovered from pooled faecal samples collected from Labrador 
retriever puppies in Victoria on four occasions when puppies were aged 17, 28, 45 and 
67 days old, as shown in Table 3.3.1.  
3.3.2.2 Longitudinal sampling of Labrador retrievers, Perth, W.A. 
Over a three-year period, canine faecal samples were collected from the same 
Labrador retriever breeding facility In Western Australia. In 2011, Giardia spp. cysts 
were recovered from pooled faecal samples collected from puppies on two occasions 
when puppies were aged 35 days and 42 days. In 2012, Giardia spp. positive pooled 
faecal samples were confirmed by microscopy on one occasion when puppies were 30 
days of age, shown in Figure 3.3.6.  
In 2013, Giardia spp. cysts were recovered from faecal samples collected from 
individual puppies 72 days of age, shown in Figure 3.3.3 and Figure 3.3.8. 
3.3.2.3 Miniature schnauzer breed  
Giardia spp. cysts were recovered from pooled faecal samples collected from miniature 
schnauzer puppies in Western Australia on one occasion when puppies were aged 58 
days of age, shown in Figure 3.3.4.  
3.3.3 Concurrent parasite infections in Labrador retriever puppies  
Infections detected in faecal samples by gold standard microscopy occurred as single 
parasite species infections or as co-infections with Giardia spp. Notably, all concurrent 
infections were associated with Giardia spp. that is, no co-infections were recorded for 
Sarcocystis sp. and Cystoisospora sp. in the absence of Giardia spp. Faecal samples 
were collected from separate litters of Labrador retriever puppies and examined for 
enteric parasites infections by microscopy. 
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3.3.3.1 Concurrent parasite infections, Litter 1 
Results from the examination of twenty-seven pooled faecal samples from one litter of 
Labrador retriever puppies (29-50 days of age) are shown in Figure 3.2. More than half 
(65.2%) of all positive samples were infected with Cystoisospora sp. cysts, and 26.1% 
of samples were infected with Giardia spp. cysts, a small number (8.7%) were infected 
with Toxocara canis. No other types of parasitic organisms were detected for this litter 
of puppies. No parasite infections were detected in seven faecal samples and 23 
parasite infections were recorded in total.  
Table 3.2 Enteric parasites detected in litters of Labrador retriever puppies in Perth 
All Parasites detected Perth litter 1 27 Pooled faecal samples 
Perth litter 2 
20 Individual faecal samples 
  N % n % 
Sarcocystis sp. 0 0.0 7 28.0 
Cystoisospora sp. 15 65.2 2 8.0 
Toxocara canis 2 8.7 1 4.0 
Giardia spp.  6 26.1 15 60.0 
Total parasite infections 23 100 26 100 
 
The 23 infections shown in Table 3.2 included single and concurrent species of 
protozoan parasites. The proportion of four types of infections that are shown in Table 
3.2.1 include Giardia spp. (16.7%) and Cystoisospora sp. (66.7%) and co-infections 
(16.7%) of both Giardia spp. and Cystoisospora sp., a total of 18 protozoan infections. 
Table 3.2.1 Concurrent and single parasite infections detected in two litters of puppies 
Single species of enteric 
protozoan parasites and 
Giardia spp. co-infections 
Perth litter 1 
27 individual faecal samples 
Perth litter 2 
20 Individual faecal 
samples 
 
n % n % 
Sarcocystis sp. 0 0 2 11.8 
Cystoisospora sp. 12 66.7 0 0.0 
Giardia spp. 3 16.7 7 41.2 
Giardia spp. co-infections 3 16.7 8 47.1 
 Total 18 100 17  100 
 
3.3.3.2 Concurrent infections Litter 2 
Results from the examination of 20 individual faecal samples collected from one litter of 
Labrador retriever puppies (68-85 days of age) are shown in Table 3.2. More than half 
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(60%) of all the positive samples were infected with Giardia spp. cysts, 28% of samples 
were infected with Sarcocystis sp, and 8% infected with Cystoisospora sp. A small 
number (4%) of samples were infected with Toxocara canis eggs, no other types of 
parasitic organisms were detected for this litter of puppies and three samples were 
uninfected. 
The 26 parasite infections included both single species and concurrent enteric 
protozoan infections as shown in Figure 3.2.1 Giardia spp. (41.2%) and Sarcocystis sp. 
(11.8%) and Giardia spp co-infections (47.1%). The co-infections present with Giardia 
spp. were T. canis (28.5%) and Cystoisospora sp. (71.5%).  
3.3.3.3 Multiple litters of Labrador retriever puppies, Victoria  
Results from microscopic examination of 155 faecal samples from maternal dams and 
multiple litters of Labrador retriever puppies are shown in Table 3.3 with 74 negative 
test results. The samples positive for parasite infections indicated that 37% were 
infected with Giardia spp., 40.7% infected with Cystoisospora sp. and 22.2% were 
infected with Sarcocystis sp. No other types of parasitic organisms were detected and 
48% of samples were uninfected. In total, 81 of 155 samples (52%) from breeding 
dams and puppies tested positive for enteric protozoan parasites. 
Table 3.3 Enteric parasites detected in multiple litters of Labrador retriever puppies  
All Parasites detected Bulla, Victoria 
 
n % 
Sarcocystis sp. 18 22.2 
Cystoisospora sp. 33 40.7 
Toxocara canis 0 0 
Giardia spp.  30 37.0 
Total 81 100.0 
 
These samples infected with parasites were both single species enteric protozoan 
parasites as shown in Table 3.3.1 Giardia spp. (23.9 %) and Sarcocystis sp. (16.4%) 
and co-infections (20.9%) with Giardia spp. The co-infections present with Giardia spp. 
were Sarcocystis sp. (28.5%) and Cystoisospora sp. (71.5%). 
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Table 3.3.1 Concurrent and single parasite infections in multiple litters of puppies 
Single species of Protozoan Parasites 
and Giardia spp. co-infections detected Bulla, Victoria 
 
n % 
Sarcocystis sp. 11 16.4 
Cystoisospora sp. 26 38.8 
Giardia spp. 16 23.9 
Giardia spp. co-infections 14 20.9 
Total 67 100.0 
 
3.3.4 Temporal dynamics of Giardia spp. infections and concurrent 
enteric protozoan infections in dogs  
The dynamics of parasite detection in faecal samples was consistent across groups of 
puppies, regardless of breed and location. The first onset of parasitic infection occurred 
in puppies as young as 17 days after birth and the order of infection commenced with 
Cystoisospora sp., followed by Giardia spp. and Sarcocystis sp. Generally, when 
Sarcocystis sp. was detected, Giardia spp. was absent and Cystoisospora sp. was 
frequently found as a co-infection with Giardia spp. At the weaning stage (4-6 weeks) 
the number of Giardia spp. cysts (cyst intensity) in faecal samples increased 
considerably. The results are presented below as timelines of patent infection.  
3.3.4.1 Parasite infections in puppies in breeding facilities 
In all puppies diagnosed with patent Giardia infections, the initial diagnosis recorded 
faecal samples with low cyst intensity, rising to higher cyst intensities at later dates, 
described in more detail in Section 3.3.5. 
3.3.4.2 Labrador retriever (Victoria) 
Pooled faecal samples were collected from litters of puppies aged over 14 days, the 
first patent Giardia spp. infection was recorded at 17 days, Cystoisospora sp. was also 
detected in puppies of the same age, as shown in Figure 3.3.1. Both of these parasites 
continued to be detected until puppies were aged 40 days. In puppies of this age, and 
at 44 days of age Sarcocystis sp. was detected as a single species infection. Both 
Giardia spp. and Cystoisospora sp. were detected between 50 – 60 days of age. Single 
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species parasite infections of Sarcocystis sp. were detected in puppies at 60 days of 
age, and Sarcocystis sp. infections were not detected in puppies older that 62 days of 
age, unlike Giardia spp. and Cystoisospora sp. that continued to be detected until 
puppies were aged over 70 days of age. 
 
 
Figure 3.3.1 Sequence of patent parasite infections in Labrador retrievers Bulla, Victoria 
3.3.4.3 Labrador retriever (Perth) 
Pooled faecal samples were collected from one litter of eight puppies from the age of 2 
weeks during January - February 2013. The first parasite infection was recorded when 
the puppies were 29 days of age, shown in Figure 3.3.2. This was a concurrent 
infection of Cystoisospora sp. and Toxocara canis. Cystoisospora sp. was the parasite 
most frequently detected, as a single species infection at 35 and 36 days of age. 
Giardia spp. and Cystoisospora sp. were both present in faecal samples collected from 
puppies aged 37 days of age. Both Giardia spp. and Cystoisospora sp. were observed 
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Figure 3.3.2 Sequence of patent parasite infections in Litter 1 of Labrador retriever puppies 
 
Individual faecal samples were collected to determine levels of Giardia spp. infection 
and sequence of patency in one litter of four Labrador retriever puppies, in Perth 
Western Australia, from the age of 14 days. No parasite infections were detected by 
microscopy during the first 30 days after birth. At 30 days of age Toxocara canis eggs 
were observed, as shown in Figure 3.3.3. After 70 days of age Giardia spp. infections 
dominated, with high levels of cyst excretion and Cystoisospora sp. co-infections 
reduced. Only one type of concurrent infection, Giardia spp. with Sarcocystis sp 
occurred in puppies over 75 days of age. 
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3.3.4.4 Observation and sequence of patent parasite infections in miniature 
schnauzer puppies Perth, Western Australia 
Pooled faecal samples were examined from one litter of ten miniature schnauzer 
puppies aged 14 days until 72 days of age. No parasitic organisms were detected 
when puppies were aged 14-40 days of age. At 40 days of age Sarcocystis sp cysts 
were observed in faecal samples. The sequence of patent parasite infection and 
temporal dynamics of parasite patency are shown in Figure 3.3.4 No other parasites 
were detected until puppies were 57 days (aged 8 weeks) when Cystoisospora sp. was 
detected. The earliest observation of Giardia spp. patency was in puppies aged 58 
days. Giardia spp. cysts were not detected again until puppies were aged 69 days (10 
weeks). Sarcocystis sp. was not detected at the same time as Giardia spp. and the 
numbers of Giardia spp. cysts observed increased greatly over a two-week period from 
58 – 72 days. 
 
Figure 3.3.4 Sequence of patent parasite infections and temporal dynamics in one litter of    
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3.3.5 Enteric parasite infections and association with clinical signs of 
infection in Labrador retriever dogs from breeding facilities 
Comparisons were made between the presence or absence of clinical signs of infection 
in dogs, based upon stool consistency, to determine the likelihood of parasite infections 
being associated with clinical signs in Labrador retriever dogs, using chi squared 
analysis, as shown in Table 3.4.  
Table 3.4 Clinical signs and enteric parasite infections in Labrador retriever puppies from Victoria 
Victoria Breeding Facility  
Parasites detected (Total tested) N Clinical signs of infection χ2 value 
  Symptomatic Asymptomatic  
 155 68 87  
Sarcocystis spp. 11 6 5} 
14.47* (0.001) Cystoisospora spp. 26 19 7} 
Giardia spp. 30 13 17 NS 
Giardia co-infections  14 8 6 3.94 (0.05) 
No parasitic organisms  74 22 52 3.86 (0.05) 
3.3.5.1 Likelihood of Giardia spp. and enteric parasite infections being associated 
with clinical signs of infection 
The results shown in Table 3.4 suggest that in the Victorian breeding facility dogs and 
puppies were more likely to display clinical signs when they were infected with enteric 
protozoan parasites. Dogs infected with Giardia spp. (single and concurrent infections) 
were statistically significant χ2 = 3.86 p<0.05 and all co-infections were statistically 
more likely to show clinical signs of infection, χ2 = 3.94. A higher likelihood was 
calculated for coccidian infections (both single and concurrent infections) χ2 = 14.47 
p<0.05, p<0.01 and for all parasite infections, as single species (Giardia spp. and 
coccidians, excluding concurrent infections) χ2  = 10.48 p<0.05, p<0.01.  
3.3.5.2 Likelihood of Giardia spp. and enteric parasitic infections being 
associated with clinical signs of infection in Labrador retriever dogs from 
Perth, WA 
To compare parasite infections with clinical signs of infection three different litters of 
Labrador retriever puppies were tested over a three-year period in Perth, Western 
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Australia. Due to the low numbers of samples, it was not appropriate to use a chi-
squared test for statistical validation on a litter-by-litter basis therefore results for all 
litters were combined. Details of parasite infections detected for each litter are shown 
in the Appendices, puppies were aged between 14 and 85 days old.  
Table 3.5 Clinical signs and enteric parasite infections in 3 litters of Labrador retriever 
puppies from in Perth, Western Australia 
Parasites detected Number (N) Symptomatic Asymptomatic 
Sample size  85 54 31 
Sarcocystis spp. 2 0 2 
Cystoisospora spp. 12 10 2 
Giardia spp. 37 25 12 
Giardia co-infections  14 5 9 
No parasitic organisms  20 14 6 
The likelihood of concurrent (co-infections) parasitic infections being associated with 
clinical signs of infection in dogs was tested using chi-squared analysis and no 
significant results were obtained.  
3.3.5.3 Likelihood of Giardia infections being associated with clinical signs of 
infection in dogs from two Labrador retriever breeding facilities 
Results from all canine faecal samples tested from two breeding facilities (in WA and 
Victoria) were combined to analysis of the likelihood of parasite infections being 
associated with clinical signs in dogs from a two Labrador retriever breeding facilities 
was performed using chi-squared analysis, shown in Table 3.5. Details of all samples 
tested for parasite infection and clinical signs of infection are included in Appendix 2. 
Table 3.6 Association between faecal parasite detection and clinical signs of infection in Labrador 
retriever breeding facilities 
 χ2 value (p value) 





Detection of parasites 10.48 (0.01) NS 9.72 (0.01) 
Any coccidian parasite 14.47 (0.001) NS 8.67 (0.01) 
All single species infection  NS 11.63 (0.001) 
Single coccidian species 14.25 (0.001) NS 12.17 (0.001) 
Giardia spp. infection 3.86 (0.05)* NS 4.5 (0.05)* 
Concurrent parasite infections 3.94 (0.05) NS NS 
* single and concurrent infections 
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Determination of any association between detection of Giardia spp. infection - single or 
concurrent infections with clinical signs of infection was performed using chi-squared 
analysis. There was no association with clinical signs of infection for the combined 
group. 
These results indicate that clinical signs of gastro-intestinal upset in dogs, such as 
loose stool form or mucus in the stool, are significantly associated with enteric 
protozoan parasite infection χ2 = 9.72, p<0.05, p<0.01; and also for infections of single 
parasite species (excluding co-infections) χ2 = 11.63, p<0.05, p<0.01. Dogs were 
significantly more likely to display clinical signs if infected with a single species 
coccidian parasite than those dogs with no parasitic infections χ2 = 12.17 p<0.05, 
p<0.01 (0.0005). 
3.3.6 Genotyping results for Giardia spp. 
From the Giardia spp. positive faecal samples, 46 out of 64 (72%) were successfully 
genotyped as host specific Giardia spp. assemblages C and or D. Eighteen of these 
(28%) were successfully genotyped as Giardia spp. assemblage A and eight (3.5%) 
were considered to be of mixed assemblage both A and (host specific) C and D. 
There were eighteen faecal samples, negative by microscopy that did produce positive 
results by PCR and results are shown in Table 3.7. The results are differentiated by 
faecal stool form (clinical sign of gastro-intestinal infection). Only one of the eighteen 
Giardia spp. negative faecal samples was confirmed positive for Cystoisospora sp. 
infection. 
Table 3.7 Genotyping results for dogs with and without clinical signs of infection 
Clinical signs Genotype A Mixed genotype A / C / D 
Host specific genotype 
C and/or D 
Symptomatic 2 1  
Asymptomatic   15 
Genotyping results by performing PCR at 3 different loci, were successfully amplified at 
all 3 loci and sequences obtained from 2 of 18 (11%), 4 samples (22%) successful at 2 
loci and 12 samples (61%) successfully sequenced from a single, 18s, gene loci. 
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3.3.6.1 Litters of puppies – maternal infections and puppies infected with enteric 
protozoa and the presence of clinical signs of infection 
Five of the six mothers were confirmed with patent parasite infections by light 
microscopy from 4 – 44 days post-whelp and results for each litter are presented here.  
Litter #1 The maternal dam did not show clinical signs of infection and faecal samples 
collected at 2 and 15 days post-whelp were free from parasite infections. Puppies 
appeared to have clinical signs, such as loose stools, at 16 days of age but no 
parasites were detected by microscopy. 
Litter #2 The maternal dam displayed clinical signs of infection and she was confirmed 
positive for parasite infections on 4 out of 5 sampling occasions. Infection with 
Sarcocystis sp. was confirmed at 8 days post-whelp, no infections detected during 
subsequent 2 -3 weeks. Sarcocystis sp. was detected again at 38 days post whelp and 
Cystoisospora sp. infection after 42 days. Puppies were confirmed with Cystoisospora 
sp. infections at 108 days old accompanied by clinical signs of diarrhoea.  
Litter #3 The maternal dam was confirmed with concurrent infections of Giardia spp. 
and Sarcocystis sp. and showed clinical signs at 37 and 44 days post whelp. At 45 
days old puppies were confirmed with parasite infections; either Cystoisospora sp. 
alone or as concurrent infections with Giardia spp.  
Litter #4 The maternal dam was negative for parasitic organisms pre-whelp but positive 
for Cystoisospora sp. at 23 and 27 days post whelp. Puppies were positive for Giardia 
spp. at 17 days of age and for Cystoisospora sp. at 36 days old.  
Litter #5 The maternal dam had a history of clinical signs and she was confirmed 
positive for Giardia spp. infection 4 and 15 days post whelp. Puppies were confirmed 
with Cystoisospora spp. infection at 15 days old.  
Litter #6 The maternal dam was positive for Cystoisospora spp. infection 28 days post 
whelp although clinical signs were absent. Puppies were also positive for 
Cystoisospora sp. infection at 28 days old although none showed clinical signs.  
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3.3.6.2  Puppies infected with enteric protozoa and clinical signs of infection 
All the puppies with loose stool consistency (symptomatic cases) were infected with 
host specific Giardia spp. confirmed by multi-locus genotyping. The majority of those 
puppies considered as asymptomatic cases were infected with host specific Giardia 
spp., although one faecal sample contained assemblage A genotype, as shown in 
Table 3.8. 
Table 3.8 Combined genotyping data for seven litters of Labrador retriever puppies infected with 
Giardia spp. 
Litter Gene loci Clinical Signs 
 18s BG GDH  
1 D D D Symptomatic 
2 D D D Asymptomatic  
3 C C C Symptomatic 
4 D D D Symptomatic 
5 A D D Asymptomatic  
6 D D D Symptomatic 
7 C/D D D Asymptomatic 
 
3.3.7 Grading of infection 
Results are presented in charts showing the frequency of samples that were confirmed 
with Giardia spp. based on similar numbers of cysts (cyst intensity). The data displayed 
as a timeline, according to the age of the puppy when faecal samples were collected. 
3.3.7.1 Intensity of Giardia spp. infections in Labrador retriever puppies 
The majority of samples were considered to have low cyst intensity (75%), 14% were 
graded moderate (2+, 5%) and (3+, 9%) and samples with high cyst intensity occurred 
in puppies over four weeks of age (11%) as shown in Figure 3.3.5. 
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Figure 3.3.5. Giardia spp. cyst intensity and frequency of detection from multiple litters of 
puppies in one Victorian breeding facility at different time intervals 
 
The intensity of cysts excreted was lower in younger puppies (20 – 40 days) infected 
with Giardia spp. and peak intensity occurred once puppies reached 45 days of age, as 
shown in Figures 3.3.5, 3.3.6, 3.3.7 and 3.3.8.  
 
Figure 3.3.6 Giardia spp. cyst intensity and frequency of detection for two litters of Labrador 
retriever puppies at 35 and 42 days old at a Perth breeding facility 
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Figure 3.3.8 Giardia spp. cyst intensity and frequency of detection for Litter 2, Perth 
3.4 Discussion 
3.4.1 Pre-patent period for Giardia spp. infection  
Results from this study have established that patent Giardia spp. infections occurred at 
17 days (2 weeks) of age in Labrador retrievers from the Victorian breeding facility and 
at 35 days (5 weeks) 42 days (6 weeks) and 62 days (9 weeks) in Labrador retrievers 
in Perth, and at 57 days (8 weeks) in miniature schnauzer puppies in Perth. These 
results confirm that the pre-patent period is 17 days or less, as the precise day of 
ingestion of Giardia spp. cysts could not be determined. At this young age the 
transmission to neonatal host is expected to be of maternal origin or from an 
environmental source. Despite the fact that this study was relatively small, the data 
suggests that differences in the pre-patent period may exist between breeds of dogs. 
Differences in infection rates between the dog breeds may be due to husbandry or 
management factors, but more likely to arise from unique phenotypic diversity of the 
host species, an outcome of the selective breeding of Canis lupus familiaris, into the 
dog breeds of the 21st century. 
Similar studies have also shown that endoparasite infections in dogs can occur at an 
early age and that more than one parasite species causes infection, (Barlough, 1979, 
Bugg et al., 1999, Traub et al., 2002, Inpankaew et al., 2007, Martinez-Carrasco C. et 
al., 2007, Batchelor et al., 2008, Rinaldi et al., 2008, Thompson and Smith, 2011, Itoh 
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confirmed high levels of enteric protozoan infection in puppies under 12 months of age, 
where infections commenced in puppies aged 3 weeks (Barutzki and Schaper, 2013). 
In addition, other studies have demonstrated different physiology between different 
breeds of dogs (German et al., 2000) and their responses to infection. 
3.4.2 Concurrent parasite infections  
In this study detection of Cystoisospora sp. was common, and was the most frequently 
detected enteric protozoan, often present as concurrent infections with Giardia spp. 
This is in contrast to Sarcocystis sp. which was seldom concurrent with Giardia spp. 
infections, although a small number of samples were concurrently infected with all 
three parasite species. 
Maternal transmission of parasites, via the placental route, for T canis, appears within 
first three weeks (Glickman and Schantz, 1981). Other parasites do not appear as 
quickly, and the results reported here demonstrate a pattern in which Cystoisospora sp. 
infection precedes Giardia spp. infections, and that concurrent infections commonly 
occur. This sequence maybe linked to development of the innate immune system. 
When the host responds to infectious challenge often through antigen recognition by M 
cells (Gebert, 1997, Jung et al., 2010) this initiates production of cellular immune 
responses (Maynard et al., 2012). Development of M cells in the follicle associated 
epithelium of Peyer’s patches commences in utero with a rapid increase in numbers 
after birth, and there is a species variation in the frequency of M cells (Brandtzaeg and 
Pabst, 2004). 
Characteristics of Giardia spp. infected maternal immune system may directly influence 
embryonic development of foetal immune system affecting vertical and horizontal 
transmission as described in other parasite life cycles (Dunn and Smith, 2001). 
Distinctly different physiologies have been suggested to be associated with variable 
cyst excretion levels and the suggestion of action by a specific anti-Giardia 
immunoglobulin (Danciger and Lopez, 1975). In addition to potential in utero events 
there is also the role of colostrum and other nutritional factors in maternal milk, which 
Chapter 3 Clinical signs and temporal dynamics 
 141 
provide protection during the early stages of life (Hennart et al., 2002, Hellweg et al., 
2008, Liao et al., 2012, Rodriguez et al., 2015,). 
The salient points concerning sequence of parasite infection concerns physiological 
and immune responses of the neonatal dog when exposed to different enteric parasites 
and other microbial organisms and the consequent development of the innate immune 
system. Does early exposure confer a level of immunity, and capacity for host 
clearance of subsequent infection? 
These results suggest that different types of enteric protozoan infections, including co-
infections, are associated with clinical signs. Patent infections with Cystoisospora sp. 
either as single species infection or concurrently with Giardia sp. are more likely to be 
associated with clinical signs, than patent infections of single species Giardia spp. 
infections. This in turn, emphasizes the importance of understanding more clearly the 
synergies and conflicts of multiple infections (Lymbery and Thompson, 2012). 
3.4.3 Clinical signs of infection 
Collection of faecal stool consistency data as an indicator of clinical signs of infection 
did reveal some associations between parasite infections and differences were noted 
between groups of dogs in different geographical locations. Statistical analysis 
indicated that the likelihood of dogs in the Victorian breeding facility displaying clinical 
signs of infection was associated with coccidian parasite infection  (χ2 value = 14.7). 
These results suggest that coccidian infections are the most likely cause of clinical 
signs of infection in the Victorian group, both singly and as concurrent infections. The 
results also indicate that infections with a single species of parasite are likely to be a 
factor contributing to clinical signs in infected dogs (χ2 value = 10.4). The results also 
suggest that concurrent parasite infections could also be associated with clinical signs 
of infection (χ2 value = 3.94). The association of clinical signs with Giardia spp. 
infections was not evident and the potentially zoonotic genotypes of Giardia spp. did 
not appear to have a clinical impact on the canine host.  
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In the Western Australia group single parasite infections, including coccidian species 
were not associated with clinical signs of infection, and no association with concurrent 
infections was apparent. Nevertheless, an association between the presence of Giardia 
spp. infections and clinical signs of infection was determined (χ2 value = 4.25). The 
most likely conclusion for this group is that Giardia spp. infections are contributing to 
clinical signs of infection and these infections are predominantly assemblage D 
genotype. Consequently, if parasite infection is the cause of clinical signs, as unformed 
stools, the cause is due to host specific Giardia spp. infections. 
By combining the data as a larger sample size for a group of 240 Labrador retrievers 
the statistical analysis indicated that concurrent parasite infections were not associated 
with clinical signs of infection. The results show that parasite infections that include 
detection of Giardia spp. are more likely to be associated with clinical signs of gastro-
intestinal upset in dogs, such as loose stool form or mucus in the stool (χ2  value = 4.5). 
3.4.4 Zoonotic and host specific genotypes - Are clinical signs of 
infection associated with particular Giardia spp. genotypes? 
Results from this study are inconclusive. Whilst data shown in Table 3.7 suggests that 
asymptomatic Giardia spp. infections in dogs are associated host specific genotypes, 
these samples were not confirmed to contain Giardia spp. cysts by microscopy. In 
addition, the results for more robust genotyping across multiple gene loci, shown in 
Table 3.8 suggests that host specific infections occur in dogs with clinical signs of 
infection as assessed by stool consistency. The presence of mixed infections 
demonstrated that dogs are host to multiple genetic assemblages of Giardia spp. 
Increasing reports of zoonotic assemblages in domestic animals, such as cats and 
cattle, and in wildlife species suggests that further work is required to fully understand 
transmission routes and consequences of pathogenic infections. 
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3.4.4.1 Age and development of the neonatal canine host 
Since this study has shown that zoonotic isolates can infect puppies from a young age 
there is a strong indication that mechanical transmission may occur from maternal dam 
to neonatal puppies, causing infection within the first few days of life. 
During weaning transitions from maternal milk to solid food in young mammals it is 
reported that the intestine undergoes a profound transition induced by blood circulating 
insulin levels or suckling reflexes. These mediate signaling of fucose biosynthesis and 
subsequent fucosylation of glycoconjugates of intestinal mucins and down regulation of 
sialylation processes (Becker and Lowe, 2003). Furthermore, these authors refer to 
impaired fucose glycosylation as the cause of phenotypic variation in mice and its 
association with inflammatory bowel disease and episodes of diarrhoea.  
The importance of these findings in puppies has relevance for Giardia spp. infections in 
children. There are reports of cognitive impairment in very young children (Berkman et 
al., 2002, Simsek et al., 2004) and whilst the incidence of acute diarrhea is higher in 
countries with lower levels of development it has proven difficult to attribute the cause 
as Giardia spp. infections (Hollm-Delgado et al., 2008).  
3.4.4.2 Host specific Giardia spp. infections  
These may be explained by the carbohydrate moiety of the cell wall glycoproteins, 
where the host is able to recognize the particular polysaccharide polymers. 
Determining the relative composition of the cyst cell wall may be beneficial for 
establishing any variation between zoonotic and host specific Giardia spp. isolates. It is 
already established that the galactose content of CWP is higher in G. duodenalis than 
G. muris isolates (Jarroll and Paget, 1995). Evidence of how host genotype and 
phenotype expression may be of relevance to the establishment of infectious disease 
of the mucosal tract, such as Giardia spp. infections, and associated clinical signs can 
be reflected in results from a study of mannose binding lectins in neonates in Poland 
(St. Swierzko et al., 2009). This study demonstrated the existence of a rare gene 
haplotype pre-disposing infants to respiratory infections, the rare gene expression is 
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considered to be of Slavonic origin occurring in individuals with Polish, Czech and 
Brazilian ethnic heritage. This information concerning potential pre-disposition of hosts 
to infection may contribute to the explanation of geographical or breed variations 
reported in Giardia spp. infections described in Chapter 1 and 2.  
3.4.5 Transmission of Giardia spp. infections in breeding dams and litters 
of puppies  
Giardia spp. genotyping results for the group of Labrador retriever breeding dams 
indicated that they were positive with assemblage A infections. Individual dams 
sampled on different dates returned the same genotyping results. Genotyping results 
from the dams and litters indicated that if the dam was host to assemblage A Giardia 
spp. infections the pups would also be confirmed with assemblage A infections. 
Results from one litter of puppies detected Giardia spp. and Cystoisospora sp. 
Infections during the period 38 – 56 days after birth. Faecal samples collected from the 
maternal dam during this time were positive for Toxocara canis at 27 days post-whelp. 
Cystoisospora sp. was not detected, but 3 copro-antigen tests were positive for Giardia 
spp. infection 54 days post-whelp, although Giardia spp. cysts were not observed by 
microscopy.  
These results demonstrate the potential for young puppies, that when exposed, are 
susceptible to infection from an early age with host specific Giardia spp. The immune 
responses may contribute to clearance of infections, even when re-exposed to host 
specific infections. However, in litters of puppies where the maternal dam was 
confirmed with Giardia spp. assemblage A infections pre- or post-whelping the puppies 
were also confirmed with assemblage A infections, although this study was unable to 
determine if immune responses contributed to clearance of these infections or if 
immunity was conferred to individuals for preventing re-infections.  
The faecal samples from this group of puppies were much easier to genotype at all 3 
loci than the other groups of samples. The results were consistent even when DNA re-
extractions and PCR experiments were repeated on faecal samples that had been 
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frozen for 12 months or more. This could be explained by faecal DNA sequences 
closely matching the primer sequences and the possibility of nucleotide substitutions in 
other infections causing difficulties with sequencing. 
Parasite infections carried by the maternal dam are likely to affect the incidence of 
infections in puppies and the genetic type of Giardia spp. Infections. Factors at 
weaning, such as age, type of food and prophylactic treatments could also account for 
intra-breed variations. These factors are also related both to geography, physical 
location and husbandry practices. 
The juvenile dogs in co-housing situation with litter mates or other kennel mates were 
infected mainly with host specific assemblages C and or D, as shown in Table 2.3.16, 
some of which failed to amplify at 18S gene locus but were successfully amplified and 
sequenced at beta giardin and GDH loci. The reasons for poor results using the 18S 
gene locus are unclear. 
3.4.5.1 Asymptomatic infections  
Data collected in this study showed that asymptomatic infections were common in 
older dogs, raising questions over the significance of these infections: 1) the impact on 
the general health and well being of the dog 2) possible transmission routes and 
reservoirs of infection.  
3.4.5.2 Disruption of transmission routes 
Detection of Giardia spp. infections in puppies less than three weeks of age in this 
study has confirmed earlier reports of multiple concurrent parasitic infections. This 
raises questions concerning the influence of patent parasite infections upon 
development of neonatal host immune system. What factors determine when infections 
become acute or when the host develops chronic infections in the absence of immune 
protection? How are the interactions and association with other parasitic species 
important during concurrent infections? Knowledge of where and when susceptible 
hosts become vulnerable to disease through exposure to infectious parasitic forms is 
critical for disruption of transmission routes. Applying networking principles for 
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examining factors influencing the transmission of parasites require detailed and 
ongoing recording of the activity of susceptible hosts and frequency and methods of 
exposure to infection sources. 
Whilst researchers advocate the use of networks in ecological studies for 
understanding transmission of wildlife parasites, the same principles and methods 
could be applied to studying ecological consequences of protozoan infections in 
naturally infected domestic animals, such as domestic dogs (Godfrey, 2013). In fact 
Giardia spp. is highly suited to this type of approach, which is most appropriate in 
parasites with a simple life cycle. Inclusion of elements that consider spatial proximity 
may be applicable. Research questions and approaches may include 1) social 
interactions and behavioural studies. Do Giardia spp. infected dogs affect host 
behaviour? Both the infected individual and others closely associated, such as 
littermates. 2) Use of shared space. What are the implications of housing and 
management situations, where animals are separated in time but not in access (or 
contact) to a physical space. 3) The value of point prevalence studies. Parasite 
transmission as a dynamic (rather than static) process signals the usefulness of 
longitudinal evidence, particularly in the context of multiple genetic strains of Giardia 
spp. so called host specific and zoonotic, and the consequences of co-infection by 
other protozoan parasites (Beldomenico and Begon, 2010). Networks imply 
relationships and construction of both direct and indirect networks may prove useful to 
determine if directional influences exist.  
Three levels of investigation using networking models might provide greater 
understanding of transmission processes useful for managing the spread of parasitic 
disease as described by (Godfrey, 2013). Firstly, longitudinal studies in individual dogs 
from birth, and asymptomatic mature dogs with confirmed Giardia spp. infection. 
Secondly, examination of dyadic relationships could be performed which could be 
either bitch to pup or interactions between littermates. Thirdly, closer analysis of the 
population as a whole, could include both behavourial and environmental factors to 
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determine possibility of vertical or horizontal transmission routes and where reservoirs 
of infection may be critical in symptomatic outbreaks, such as introduction of 
individuals from external communities or ecosystems. 
Could classical Giardia spp. transmission routes require further examination? Whilst 
infection routes have been considered to be solely by faecal-oral transmission, earlier 
studies have suggested the possibility of vector based routes (insects) and also the 
possibility of physical transfer (Barlough, 1979). Puppies have direct contact with 
mammary gland, fur and bedding, any one of which has the potential to serve as a 
conduit for transfer of Giardia spp. cysts.  
3.4.6 Grades of infection 
The levels of cyst intensity in faecal samples recorded in this study demonstrate the 
critical time point of Giardia spp. cyst shedding that occurred in puppies aged 45-85 
days of age. This reflects the period in which there is maximum opportunity of 
infectious exposure, which is generally at the weaning and immediately post-weaning 
stage. In all puppies diagnosed with patent Giardia spp. infections, the initial diagnosis 
was confirmed in faecal samples graded as 1+, rising to higher numbers of cysts at 
later dates. Giardia infections in the groups of dogs studies indicates that the majority 
were graded as low (1+) cyst excretors (75%), with one or more cysts present 14% 
graded as moderate excretors and 11% were considered to have high faecal content of 
Giardia spp. cysts. 
Parasitologists are still unclear if the numbers of Giardia cysts excreted in faeces is 
indicative of symptomatic or asymptomatic infection, or if higher cyst excretion is 
related to increased infection rates. For diagnostic purposes, it has been calculated 
that 50 cysts/g faeces for bovine samples is the minimum level of sensitivity (Uehlinger 
et al., 2006). Routine diagnostics at Murdoch University using zinc sulphate flotation 
and light microscopy confirm positive samples to be any sample with one or more 
Giardia spp. cysts are observed. Active infections can be produced by ingestion of low 
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numbers of cysts in humans and gerbils (Rendtorff, 1954, Amorim et al., 2010) hence 
the reason for accepting low cyst observations. 
Different research studies have reported results of Giardia infection in different units, 
some as cysts/microliter (Kohli et al., 2008) or number of Giardia cysts/g faeces 
(Hamnes et al., 2007, Rosa et al., 2007, Duffy et al., 2013). Accordingly, quantification 
of faecal cyst excretion does provide some indication of the extent that the new hosts 
may become exposed to infection. Future studies examining the quantification of faecal 
cyst excretion should also take into account the infectious potential of cysts, or their 
viability. Are those cysts excreted in small numbers at the onset of patent infection 
equally infectious to those excreted in higher numbers at the weaning period? In 
addition, one study in gerbils has shown that detection of the earliest patent infection 
(low numbers of cysts) is associated with elevated faecal immunoglobulin levels. No 
change in serum immunoglobulin levels was observed at this early point of infection 
however during the period of high cyst excretion both faecal immunoglobulins and 
serum immunoglobulins levels were raised (Amorim et al., 2010). 
Importantly, results from these experiments demonstrate that on numerous occasions 
Giardia spp. was not shown to be the cause of clinical signs of infection, which is a 
cause for concern. If this is case, then much of the earlier published literature reporting 
clinical impacts of Giardia spp. infections in dogs are of limited value if the presence of 
other parasites was not determined using microscopy methods. This is the only method 
that can exclude other parasites as a cause of clinical signs. These findings also 
reduce the value of the IFAT as a gold standard Giardia spp. diagnostic test as 
proposed by Mekaru et al. (2007), Rimhanen-Finne et al. (2007), Rishniw et al. (2010) 
and Uehlinger et al. (2013). 
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Chapter 4 
Canine faecal protein extraction – detection of Giardia spp. 
proteins using proteomic tools 
This chapter describes and analyses approaches and outcomes from the different 
methods used for the proteomic analysis of Giardia spp. infected canine faecal material. 
The different methods developed in the current study are described according to the 
sequential experimental steps that were required prior to analysis of mass spectral 
data. Each stage formed an element in an iterative process for establishing appropriate 
methods of sample preparation. 
Two work flow diagrams are included, one to introduce the various stages in each 
experiment and another to provide an overview of the analytical framework. 
Summaries of the experimental data are provided in figures and tables. Results and 
interpretation of the biological significance of the data are detailed in Chapter 5 with 
supplementary data contained in Appendix 3.  
4.1 Introduction 
Enteric protozoan infections are common in young dogs. Diagnostic tools remain 
ineffective for differentiating between host specific and potentially zoonotic Giardia spp. 
infections. Information is lacking for transmission cycles and for the implications of 
symptomatic and asymptomatic infections. A glycoprotein, 65kDa in size, was first 
identified and characterized from human faeces using counter-immunoelectrophoresis 
(CIE) and latex agglutination tests, and named Giardia Specific Antigen (GSA) by 
(Rosoff and Stibbs, 1986). Subsequent production of the commercially available 
ProSpecT Giardia microplate assay for diagnosis of G. duodenalis infections was 
based upon detection of GSA 65 (Anderson et al., 2004). Detection of GSA 65 antigen 
in faecal samples has been considered a reliable and sensitive diagnostic technique for 
confirming active G. duodenalis infections in humans (Vidal and Catapani, 2005). Since 
this glycoprotein was easily detected and stable under variable conditions it is likely 
that the same, or similar, protein might be present in faeces from dogs infected with 
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Giardia spp. The importance of confirming protein expression will inform metabolic 
processes because in the case of Giardia species a detailed understanding of cellular 
metabolism is not yet fully described. A deeper understanding of host-parasite 
interactions is a critical area of work for the prevention, management of infections and 
therapeutic intervention of infected hosts. Using a proteomics approach may enhance 
current genomic characterization studies and drive capacity building for the 
differentiation between G. duodenalis genotypic assemblages (Humphrey-Smith et al., 
1997, Steuart, 2010). 
Proteomics enables integration of biochemical and biological data to complement that 
of genomic and transcriptomic data. It produces insights into developmental regulation 
aspects of Giardia spp. metabolism and the interaction processes within the host 
gastro-intestinal tract. Specialized genetic techniques such as expressed sequence 
tags have greatly improved the quality of genetic data, whilst proteomic techniques 
have become available for describing protein expression. Proteomic techniques include 
standardization of sample preparation methods (D'imperio et al., 2010) and high 
resolution methods for detection of low abundance proteins when comparing two 
organisms with highly similar gene sequence (Jungblut et al., 1999). 
Detailed protocols are available for separation of proteins based upon physical and 
chemical characteristics as well as cellular or organelle location (Pedersen et al., 2003, 
Mastro and Hall, 1999). Here the work sought to provide a preliminary investigation into 
the ability to detect Giardia spp. proteins and peptides using methods described for 
similar experiments, such as 2D LC MS/MS (Blonder et al., 2006, Hustoft et al., 2014). 
The investigation was carried out on Giardia spp. infected canine faecal samples, using 
a proteomic approach, whilst also seeking biomarkers to differentiate between G. 
duodenalis genotypes. 
Canine faecal samples were collected from dogs naturally infected with Giardia spp. 
Only those samples containing high numbers of Giardia spp. cysts were used in the 
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proteomic experiments. Faecal samples were first homogenized and the total faecal 
protein was extracted, details are provided in Section 4.2.  
Resolubilized protein fractions were digested into peptide fragments and separated 
using a strong cation exchange column. Proteome enrichment methods using 
commercially available kits were unsuccessful in improving the proteome coverage, 
and methods were revised to overcome initial low protein yields. Fractions were 
collected and spotted in preparation for MALDI-TOF/TOF mass spectrometry analysis. 
The spectral data generated was analysed using database-matching algorithms to 
identify known G. duodenalis proteins, in addition to identification of unique or 
hypothetical proteins. Further critical examination of acquired spectral data identified 
proteins of host origin providing evidence of responses to G. duodenalis infection in 
dogs.  
4.1.1 Sample preparation for proteomic analysis - Introduction 
Proteome research in non-medical fields has reported a wide range of protein 
extraction protocols, which rely on the chemical characteristics of the target proteins, 
such as those in soil (Benndorf et al, 2006) that require alkaline conditions. Wilmes and 
Bond (2006) describe the metaproteome and Wilmes et al. (2008) outline proteomic 
methods for analysis of wastewater sludge. 
Medical research reporting the use of proteomic tools has mainly used blood and blood 
products, such as serum or plasma, as the biological samples of choice. Whilst other 
biological samples, tissues and excreted body fluids such as urine, and faecal material 
are not commonly used due to the complexity and variability between and within 
individuals (Jiang et al., 2008).  
Metaproteomics is a specific type of proteomic approach that examines whole 
microbiota communities and measures and identifies changes to protein profiles as 
they occur, (Wilmes and Bond, 2006). A study by Klaassens et al. (2007) demonstrated 
the use of 2D PAGE and mass spectrometry methods in identifying faecal proteins 
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from the gastrointestinal tract of infants using a metaproteomics approach. A similar 
investigation of the metaproteomics of microbiota present in the human distal gut used 
a non-targeted shotgun mass spectrometry method to successfully illustrate potential 
interactions between the human microbiome and host organism (Verberkmoes et al., 
2009). The potential of a novel proteomic approach to identify host proteins from faecal 
samples has been demonstrated in a murine model by Oleksiewicz (2004). 
Proteomic analysis of proteins from biological samples commonly uses changes in 
protein conformational structure. These structural changes can be revealed by 
reduction and alkylation reactions (Gilar et al., 2004), and enzymic proteolysis for 
peptide cleavage assisting with protein characterization (Phillips and Fletterick, 1992). 
These principles formed the basis of the methodology used in this study. 
The workflow diagram below in Figure 4.1 provides an overview of the main steps 
included for sample preparation to extract and identify Giardia spp. proteins in Giardia 




Figure 4.1 Workflow Diagram 
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4.2 Methods  
4.2.1 Samples  
Fresh canine faecal samples, previously confirmed as positive for Giardia spp. by light 
microscopy, were processed within 1-7 days of arrival at the laboratory and stored at 4o 
C or at -20 o C if longer than 7 days. Details of the diagnosis and grading of Giardia spp. 
cyst numbers are described in Chapters 2 and 3. 
Some clinical data was recorded concerning the source of samples - dog breed, sex, 
age and stool form. No other parasitic organisms were observed by microscopy and all 
samples tested contained high numbers of Giardia spp. cysts.  
4.2.2 Faecal protein extraction 
In total, four different canine faecal samples were tested, and processing of each 
sample used different surfactants and buffers with the aim of maximizing the amount of 
Giardia spp. proteins recovered. This is summarized in Table 4.1 and detailed below. 
Table 4.1 Summary of sample preparation methods 







1 Fresh homogenate 



















50mM Tris HCl, 












0.5M TEAB 2.0% 
SDS solution 
4 Fresh homogenate 
At 4oC PBS 
solution, Protease 




50mM Tris HCl/ 
0.5%Triton X 
solution  pH5.6 
Performed at room temperature  
 
Experiment 3 was performed on two different canine faecal samples although the same 
methods were followed, as described in 4.2.4. 
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4.2.2.1 Aqueous phase extraction 1  
In Experiment 1 the whole fresh faecal sample (1g) was emulsified with 4ml distilled 
water (and filtered through gauze or filter paper if large particulate matter was present) 
and then centrifuged at 2000g for 2 minutes. The supernatant was discarded and the 
faecal material was resuspended in phosphate buffered saline (PBS) (136mm NaCl, 
13.4mM KCl, 10.1mM Na2HPO4, 1.76mM KH2PO4 in deionized water containing 10mM 
EDTA) as described by Oleksiewicz (2004). After thorough stirring the mixture was left 
to settle on the bench at 23oC for 5 minutes, and then centrifuged at 5000g for 20 
minutes (4oC).  
4.2.2.2 Freeze thaw extraction  
• In Experiment 2, 0.2g of whole frozen faecal sample was extracted in 1ml of 
extraction buffer containing phosphate buffered saline in deionized water with 
0.5% (v/v) TritonX-100 and protease inhibitor (Roche Complete Mini). This 
faecal suspension was then subjected to three, 5 minute freeze-thaw cycles by 
alternate immersion in liquid nitrogen and boiling water. 
• In Experiment 3, whole frozen canine faecal extract was extracted in 5ml of 50mM 
Tris HCl containing 0.5% (w/v) SDS solution and mixed by vortex, then 
subjected to eight cycles of freeze thawing prior to acetone precipitation.  
4.2.2.3 Aqueous phase extraction 2 
In Experiment 4 proteins were extracted from 1g of whole fresh canine faecal sample 
using 5ml of extraction buffer containing PBS (without EDTA) solution and protease 
inhibitor (Roche Complete Mini). 
4.2.3 Protein precipitation 
Protein was precipitated from all samples using the same method by decanting each 
sample supernatant into a 50ml centrifuge tube. Five to six volumes of ice-cold acetone 
were added to the contents of the tube to precipitate the proteins, and then inverted 
several times before cooling the contents to -20oC for 4-12 hrs. Then, working on ice, 
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the faecal precipitate was centrifuged at 2000g for 5 minutes (4oC). The acetone 
fraction was decanted and discarded. Complete removal of residual acetone was 
achieved by a second centrifugation step at 1000g for 20 seconds (4oC) and the 
residual pellet was transferred to 1.7ml micro centrifuge tube.  
4.2.4 Protein resolubilization 
Different methods were tested to resolubilize each of the precipitates to maximize 
protein yield. 
• Experiment 1  
The protein fraction was resuspended in 200µl of resolubilization buffer, 0.5M 
triethylammonium bicarbonate (TEAB) solution. To maximize resolubilization the 
protein was mixed using a bath sonicator for 15 mins and also mixed by vortex. An 
additional 200µl TEAB solution was added until all solid had resolubilized and further 
mixed by vortex. The protein fraction was separated by gel electrophoresis. Excised 
gel bands were reduced, alkylated and digested as described in 4.2.6.2 prior to further 
analysis. 
• Experiment 2  
Following acetone precipitation the residual protein pellet was resolubilized in 200µl 
0.5M TEAB solution containing 2% (w/v) SDS solution. The protein sample was 
reduced, alkylated and digested as described in 4.2.7.1 prior to further analysis. 
• Experiment 3 
The protein fraction was resolubilized at room temperature in 0.5M TEAB solution 
containing 2.0% (w/v) SDS solution. The protein sample was reduced, alkylated and 
digested as described in 4.2.7.1 prior to further analysis. 
• Experiment 4  
The protein fraction was resolubilized in 300µl of resolubilization buffer containing 
50mM Tris HCl and 0.5% Triton X-100, pH5.6, by gradual increases in the volume of 
buffer, in combination with prolonged vortex and pulse spins, to ensure complete 
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protein solubilization. The protein sample was reduced, alkylated and digested as 
described in 4.2.7.1 prior to further analysis. 
4.2.5 Protein quantification  
This was determined using the Bradford protein assay by colorimetric detection at 
595nm. 
4.2.6 Protein separation by gel electrophoresis - Introduction 
Sodium Dodecyl Sulphate (SDS) Polyacrylamide Gel Electrophoreis (PAGE)  
Two dimensional sodium dodecyl sulphate polyacrylamide gel electrophoreis (2D SDS-
PAGE) separates proteins based upon size and charge. The first stage separation 
isoelectric focusing (IEF) occurs across a pH gradient and protein separation is based 
upon the isoelectric point (pI), whereas the second dimension further separates 
proteins based upon their molecular mass.  
Application of these principles for protein separation using SDS PAGE techniques has 
been successful for identifying the protein profile of Giardia spp. trophozoites  (Smith et 
al., 1982, Capon et al., 1989). Protein differences observed in Giardia spp. isolated 
from different species using alloenzyme electrophoresis were observed in earlier 
studies (Meloni and Thompson, 1987). Further work using 2D SDS PAGE coupled with 
western blot successfully identified immunoreactive proteomics of G. duodenalis from 
serum samples of Giardia spp. infected human patients (Palm et al., 2003). 
An investigation into proteomic expression of the Giardia spp. genome carried out 
using cultured trophozoites identified an isolate specific protein, alpha 2 giardin as an 
assemblage A protein (Steuart et al., 2008). A comparative 2D SDS PAGE study that 
examined in vitro induction of Giardia spp. cyst formation from cultured trophozoites 
reported dramatic changes in protein expression during encystation (Kim et al., 2009). 
In addition to Giardia spp. proteins identified from trophozoites and cysts, PAGE is a 
frequently performed technique for identification and characterization of wide range of 
biological materials and has been used in parasitology to document the proteome of 
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Leishmania viannia and Cryptosporidium spp. (Truong and Ferrari, 2006, Gongora et 
al., 2003). Two dimensional PAGE methodology enabled researchers to effectively 
analyse and identify 10 discrete parasitic proteins of Entamoeba histolytica (Leitsch et 
al., 2005). Use of PAGE for the identification and characterization of excretory-
secretory products of Giardia spp. has provided a clearer understanding of the parasite 
biology in addition to host immunologic responses (Nash and Keister, 1985). The early 
work on phenotypic characterisation using SDS PAGE techniques has served to 
improve understanding of Giardia spp. metabolism and immunoreactive proteins (Palm 
et al., 2003).  
The early electrophoretic studies on Giardia spp. infections in humans furthered the 
understanding of biological and biochemical functions of Giardia spp. proteins although 
limited information is available specifically concerning Giardia spp. infections in dogs. 
Depending upon the gel size and pH gradient used, approaches using two dimensional 
SDS PAGE can resolve more than 5000 proteins simultaneously and detect and 
quantify proteins at picogram level (Gorg, 2004). Detection of low abundance proteins 
is dependent upon pre-fractionation methods and high sensitivity mass spectrometry. 
In this study polyacrylamide gel electrophoresis was used as an initial step to visualize 
proteins from canine faecal extract that contained Giardia spp. cysts, following the 
methods described by Steuart et al. (2008) for electrophoretic separation of Giardia 
spp. trophozoite sonicated material. Tris tricine gels were used to visualize smaller 
proteins and peptides. In experiment 1 proteins extracted from whole faecal extract 
were separated by one dimensional gel electrophoresis using Tris Tricine 10%-20% 
Peptide Criterion gel (Bio-Rad) and stained with Coomassie Brilliant Blue G-250 
(Sigma) as described by (Candiano et al., 2004).  
4.2.6.1 Gel band excision and destain 
Each faecal protein extract separated within the gel was excised. Gel bands were cut 
into small pieces and destained by adding 25 µl of 25 mM ammonium bicarbonate in 
50% (v/v) acetonitrile to each gel band and incubating at 37°C for 45 minutes. The 
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liquid was removed and discarded and the process repeated until the gel bands 
became transparent.  
4.2.6.2 Reduction and Alkylation of gel band samples 
Each separate gel band, containing faecal protein extract, was reduced with 50 µl of 
10mM dithiothreitol (DTT) in 50 mM ammonium bicarbonate and incubated for 15 min 
at 56°C.  
Alkylation was performed by addition of 50 µl of 50 mM iodoacetamide (IAM) in 50mM 
ammonium bicarbonate and incubated for 20 min in the dark at room temperature 
before washing with water and drying by centrifugation under vacuum. 
4.2.6.3 Enzymic Digestion of gel bands 
Enzymic digestion was performed by adding 10 µl of 0.1µg/µl bovine trypsin (Roche 
Diagnostics) to each gel band and incubated overnight at 37oC. Peptides were 
extracted using 50 µl of 99% (v/v) acetonitrile and 1% (v/v) trifluoracetic acid solution 
into clean tubes. The extracted peptide samples were then dried under vacuum before 
mass spectrometry analysis. 
4.2.7 Protein separation by High Performance Liquid Chromatography 
(HPLC)  
4.2.7.1 Reduction and Alkylation of protein samples in solution 
Protein supernatant from Experiments 2, 3, 4, 5 were reduced and alkylated as follows: 
The volume of sample solution used was dependent upon the protein concentration, 
and adjusted accordingly to perform reduction and alkylation based upon 100µg of 
protein. An aliquot of supernatant (100 µg of protein) was reduced by adding 10µl of 
50mM Tris (2carboxethyl)phosphine (TCEP). The contents were mixed thoroughly by 
vortex and centrifuged briefly for 5 seconds before incubation at 60ºC for 1 hour. 
Alkylation was performed immediately by addition of 5µl of 200mM 
methylmethanethiosulphate (MMTS) to the sample solution and thoroughly mixed by 
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vortex. The sample was centrifuged briefly for 5 seconds and incubated at room 
temperature for 10 minutes.  
4.2.7.2 Enzymic digestion of protein samples in solution 
Enzymic digestion of the sample was peformed by adding 5µl of 0.2mg/ml solution of 
trypsin sequencing grade (Roche) (1:100 ratio) followed by addition 10µl of acetonitrile 
to each sample and incubated overnight at 37oC. The final samples containing 100µg 
of digested protein was dried by centrifugation under vacuum and stored at -80oC prior 
to cation exchange using High Performance Liquid Chromatography (HPLC). Samples 
and controls were resuspended in 100 µl of Buffer A 10 mM potassium dihydrogen 
orthophosphate (KH2PO4), 10% (v/v) acetonitrile (pH 3.0).  
4.2.7.3 Two Dimensional Liquid Chromatography (2D LC) 
4.2.7.3.1 High Performance Liquid Chromatography system. 
Peptides were separated by strong cation exchange chromatography on an Agilent 
1100 HPLC spectrum analyzer system (Agilent Technologies, Germany). Each sample 
was processed separately. Sample volumes of 99 µl, were injected onto a HPLC 
column 5 micron 30 nm 4.6x100 mm (PolyLC Inc.) at 25ºC. The samples were run 
under linear gradient, using eluents: Buffer A: 10 mM potassium dihydrogen 
orthophosphate (KH2PO4), 10% (v/v) acetonitrile (pH 3.0) and Buffer B: 10 mM 
potassium dihydrogen orthophosphate  (KH2PO4), 1 M potassium chloride (KCl), 10% 
(v/v) acetonitrile (pH 3.0). A column wash was run pre- and post- sample application 
and blank runs were run prior to running each sample on each occasion and 
subsequently subtracted from the sample run. Spectral traces were recorded on an 
Agilent 1100 UV detector at 214 nm wavelength controlled by Chromelon software, 
over 50 min run time. For each run, 40 eluted fractions were collected into glass vials 
using an autosampler at 4ºC with a flow rate of 0.5 mL/min.  
After viewing the chromatograph trace peak heights were recorded, shown in Table 4.3, 
and the area under the curve (AUC) was calculated. The AUC value represents the 
total peptide content this was then divided into 8 areas of equal peptide content for the 
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next stage of separation. Each of the eight, newly combined, fractions was desalted on 
a solid phase extraction column, Strata-X 33 µM polymeric reversed phase, 
(Phenomenex) following the manufacturers’ instructions to remove salts and impurities. 
The eluted samples were dried under vacuum and refrigerated prior to 
chromatographic separation. 
Second Dimension Reverse Phase nanoLC: Peptide solutions were loaded onto a C18 
pre-column and then separated on a C18 PepMap100, 3 µm column (Dionex, USA) 
using the nano HPLC system Ultimate 3000 (Dionex, USA). A gradient of 10-40% 
acetonitrile in 0.1% formic acid at a flow rate of 300 nl/min was used. The eluent was 
mixed with matrix solution 5mg/ml CHCA (α-cyano-4-hydroxycinnamic acid) for 
spotting. Each fraction was spotted over 180 wells on a 384 well Opti-TOF plate (AB 
SCIEX, USA) using a Probot Micro Fraction Collector (LC Packings, USA). Quality 
control protein standards (BSA solution) were spotted on wells for calibration.  
4.2.7.3.2 Total protein content 
The protein content of the canine faecal samples was quantified and is shown in Table 
4.3 in µg/µl, together with the amount of protein (µg) loaded onto the HPLC column.   
Total protein content was calculated as follows: 
Digested protein extract was resolubilised in100µl of Buffer A x protein content (µg/µl) 
determined by Bradford assay.  
For example, in sample 1 the amount used in the first dimension separation was 100 x 
7.7µg/µl. That is 770µg of protein loaded onto column.  
The second dimension using reverse phase chromatography required a target load of 
100µg protein on the column. The appropriate volume to load, based upon 9µl 
resuspension in 2% (v/v) acetonitrile and 0.05%(v/v) trifluoracetic acid, was calculated 
by referring to the AUC from the first dimension chromatograph trace. The protein 
yields for all samples are shown in Table 4.3. 
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4.2.7.3.3 Chromatographic peptide separation 
The chromatographic separations for the five experiments conducted with peptide 
mixtures from different protein extracts of canine faecal samples are shown in the 
results.  
4.2.8 Mass spectrometry - Introduction 
Different types of mass spectrometer have different capabilities. Simple instruments 
will measure a set of molecular masses for the intact peptides in a mixture. This study 
used an instrument with MS/MS capability that provides additional amino acid 
sequence information by recording the fragment ion spectrum of a peptide. For 
complex mixtures, such as canine faecal protein extracts, enzymic digestion and 
separation by chromatography are necessary steps prior to MS/MS analysis. Trypsin 
cleaves polypeptides at the basic amino acid residues of arginine and lysine, resulting 
in positively charged peptides which are retained on the strong cation exchange HPLC 
column, performed under acidic conditions (pH 3.0). Further separation using reverse 
phase chromatography enables greater separation of peptides increasing sensitivity for 
mass spectrometry and reducing background contaminants that hamper detection of 
lower abundant peptides (Gilar et al., 2004). 
MS/MS spectra from individual peptides were measured and the experimental mass 
values were then compared with theoretical peptide mass or fragment ion mass values, 
obtained by applying peptide cleavage rules to the entries in a comprehensive primary 
sequence database. When the closest match or matches were identified from database 
sequences as a "hypothetical" protein the aim was to determine the precise amino acid 
sequence. This was achieved by extracting those database sequences entries that 
exhibited the closest homology, possibly occurring as equivalent proteins from similar 
species. 
The separated protein fragments are further analysed using mass spectrometry 
methods which in these experiments used laser ionization (Matrix Assisted Laser 
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Desorption Ionization MALDI) with Time of Flight (TOF) mass analysis based upon 
mass-charge ratio (m/z) and TOF /TOF fragment analysis mass spectrometry. 
Researchers have successfully used MALDI-TOF/TOF mass spectrometry in a wide 
range of medical applications and this technique has been used in the development of 
a rapid simple method to differentiate between morphologically similar species of 
plants (Perera et al., 2005).  
Current diagnostics for Giardia spp. based upon microscopy are unable to distinguish 
between different genotypes of Giardia spp. and the proteomic approach used here 
aimed to identify proteins associated with Giardia spp. infections in dogs. Faecal 
proteins were extracted and precipitated, and further separated using two dimensional 
liquid chromatography (2D LC) and applied mass spectrometry analysis using MALDI-
TOF/TOF techniques. The resultant mass spectra were analysed and compared to 
existing protein database entries. An overview of the workflow for mass spectrometry 
data analysis is provided in Figure 4.2. 
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Figure 4.2 Workflow for mass spectrometry spectral data analysis. 
 
4.2.8.1 Mass spectrometry separation and analysis of peptides – plate spotting 
Samples were resuspended in 10 µl of 2.0% ACN and 0.5% TFA solution, and spotted 
in duplicate onto a 384 well Opti-TOF plate (AB SCIEX, USA), 0.6 µl sample and 0.6 µl 












Assemblage B Universal  
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Assemblage A 
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4.2.8.2 Mass spectrometry analysis 
Peptides were analysed on a MALDI-TOF/TOF mass spectrometer (Model 4800 or 
5800 AB SCIEX, USA) operated in reflector positive mode. MS data were acquired 
over a mass range of 800-4000 m/z and for each spectrum a total of 400 laser shots 
were accumulated.   
Precursors for MS/MS analysis was automatically generated by the instrument 
software (4000 Series Explorer Software, AB SCIEX) according to the following 
selection criteria: minimum signal-to-noise ratio, 10; precursor mass tolerance between 
spots, maximum outlier error ±50 ppm; maximum 20 peaks per spot; maximum 
precursors 40 per spot. MS/MS spectra were generated by 1 kV collisions with ambient 
air and accumulation of maximally 10,000 laser shots. Stop conditions for MS/MS were 
defined as a minimal number of five fragment peaks with S/N ratio of 100 with at least 
20 subspectra accumulated. 
4.2.8.3 Spectral evidence 
The manufacturer’s data analysis software (ProteinPilot) was used for matching mass 
spectra against the following databases using the Paragon algorithm (AB SCIEX). 
Spectral data were matched to theoretical fragment ion patterns to determine peptide 
presence. Spectral data were also matched to a specialized database with parasite 
protein information for G. duodenalis assemblages A and B (GiardiaDB) and to a 
universal protein database, details are given in section 4.2.10.1. Confidence scores for 
peptides determined by pattern matching were only accepted if there was 95% or 
higher certainty of accurate identification. One or more peptides were used to confirm 
protein identification. Protein matches were accepted at 95% or above confidence 
levels.  
4.2.9 Bioinformatics 
Over many years information has accumulated concerning Giardia spp. biology, and 
the significance of this protozoan as a model organism has been recognized by 
parasitologists in a recent publication containing a summary of the current knowledge 
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(Luján and Svärd, 2011). Genomic data has been published for G. duodenalis 
genomes WB and GS, and P15 (Morrison et al., 2007). This data forms one of the 
fundamental sources of reference data for researchers, and is also integral to this 
study.  
Bioinformatics for systems biology is approached from two perspectives; 1) describing 
the biological system and applying a model to relate the different processes; 2) 
collection of data, recording observations and then explaining the processes which are 
occurring to construct a model. 
The term model implies representation or display of structure or process, and use of 
model organisms (e.g. Aradopsis sp., C. elegans, Drosophila sp.) as simpler organisms 
may serve to depict events occurring in more complex organisms. As a model 
organism, G. duodenalis represents eukaryotes, unicellular protists and parasitic 
pathogens. Biological experiments that rely on existing knowledge are exposed to 
erroneous interpretation of data, depending upon the stringency of baseline data 
accuracy and validation.  
4.2.9.1 Genomic and proteomic reference databases 
Prior to commencing this project searches were conducted using the keywords ‘G. 
duodenalis’ ‘Proteomics’ and ‘Canine faecal protein’. The most frequently accessed 
web-based material was from www.ncbi.nlm.nih.gov and www.Giardiadb.org 
(EuPathDB). 
The Universal Protein Resource (UniProt) www.UNIPROT.org is a comprehensive 
resource for protein sequence and annotation data. A universal database selected for 
this study available online provides an alternative source of reference protein 
sequences, and has been developed jointly by the Ludwig Institute for Cancer 
Research, www.ludwigcancerresearch.org/. The LudwigNR database contains high 
quality annotated and non-redundant protein sequences, derived from experimental 
results, computed features and scientific conclusions. This database is updated 
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regularly and the most recent version used in this study, contained 12,595,433 entries 
(5.31GB), 2013. 
Pattern matching software developed and commonly used in publications includes 
Mascot (Matrix Science, London UK) and Sequest, (Thermo Finningan, USA). 
Sequence alignment or pattern matching software depends upon algorithms that 
combine data from peptide detection to construct protein identifications. 
4.2.9.2 Spectral data from two dimensional LC MALDI experiments  
This pattern matching software used in this study for analysis of the raw spectral data, 
matched ion fragmentation patterns to amino acid sequence data from specific 
databases. Spectral data from two dimensional LC MALDI-TOF/TOF experiments were 
submitted to Protein pilot protein matching software, using the parameter set Sample 
Type:ID; Cys alkylation: MMTS; Digestion: Trypsin; Instrument 4800 or 5800; Special 
factors: None; Species: None; ID Focus: Biological Modifications; Database G. 
duodenalisAandB_130801; Search Effort: Thorough; Results Quality: Detected Protein 
Threshold (0.05); Run False Discovery Analysis. 
False discovery detection settings were applied to all analyses performed and any 
matches to reverse sequences discarded (Shilov et al 2007, Lu et al 2008). Sample 
spectra were matched to 3 different databases Database 1) and 2) were genomic 
databases for G. duodenalis assemblages A and B (G. 
duodenalisAandBcombined.fasta) G. duodenalis DBv 3.1  (7/05/13); Database 3) 
served as a decoy database – a universal genomic databases 
LudwigNR_Q113_genericforward.fasta (10/01/13).  
4.2.9.3 Data analysis  
The proteins were non-redundant (nr) which refers to database entries that have been 
manually curated to provide only one entry per protein product; variants are annotated 
in entry and cross-referenced to other databases. The majority of the protein 
sequences in the database are derived from the translation of genetic coding 
sequences from public nucleic acid databases. 
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Whilst Giardia spp. isolates originated from canine (domestic dog) faecal samples, 
there is currently no genomic data available for host specific Giardia spp. strains 
infecting canines. G. duodenalis genome information was published by Morrison et al. 
(2007) and genetic sequence and annotations are now available for assemblages A, B 
and E. It has been established that 91% homology exists between these three G. 
duodenalis genomes (Jerlstrom-Hultqvist et al., 2010). In the absence of genomic data 
for host specific Giardia spp. assemblages C and D existing genomic reference 
databases were used for proteomic analysis.  The G. duodenalis genomic databases 
used for protein matching against the mass spectral data were obtained from 
http://giardiadb.org/ (Aurrecoechea et al., 2009). Assemblages A and B were used as 
the reference sequences DB v 2.0 (16/11/2009) v 2.1 (15/7/2010) and v3 (11/3/2013) 
and contain 9663 entries for protein-coding genes.  
4.3 Results 
4.3.1 Sample preparation 
Sample preparation methods to map the canine faecal proteome are summarized in 
Table 4.2, showing the numbers of parasite and host proteins detected by LCMS 
analysis.  
Four faecal samples from different dogs (i) – (iv), were used in the proteomic 
experiments. Experiment 3 was performed by the same method, on two different 
canine faecal samples (ii) and (iii) 
Table 4.2 Summary of sample preparation and proteins detected 






1 Fresh sample (i) homogenate 3 81 
2 Fresh sample(ii) Freeze thaw (x3) 2 120 
3.1  Frozen sample (ii) Freeze thaw (x8) 2 22 
3.2  Frozen sample (iii) Freeze thaw (x8) 4 30 
4 Fresh sample (iv) homogenate 6 3 
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4.3.2 Gel separation  
Results from the separation of faecal protein extract showed distinct bands, in Figure 
4.3, that were visible between 25-100kDa for Giardia spp. infected canine faecal 
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 Lane 1 10-250 kDa Protein Marker   
Figure 4.3  








 Lane 2  BSA Protein Std   
 Lane 3 20µg canine faecal sample – no Giardia spp. cysts  
 Lane 4 40µg canine faecal sample – no Giardia spp. cysts  
 Lane 5 100µg canine faecal sample – no Giardia spp. cysts  
 Lane 7 100µg canine faecal sample – moderate numbers of Giardia spp. cysts  
 Lane 8 50µg canine faecal sample – moderate numbers of Giardia spp. cysts  
 Lane 9 20µg canine faecal sample – moderate numbers of Giardia spp. cysts  
 
 
Lane 11 100µg canine faecal sample – high numbers of Giardia spp. cysts  
Lane 12 50µg canine faecal sample – high numbers of Giardia spp. cysts  
Lane 13 20µg canine faecal sample – high numbers of Giardia spp. cysts  
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4.3.3 HPLC separation 

















sample(i) 70 2520 350 7.7 
2 
sample (ii) 129 1369 615 0.43 
3.1 
sample(ii) 95 2020 270 1.28 
3.2 
sample (iii) 61 3567 505 0.97 
4 
sample (iv) 100 1528 150 3.69 
Calculation of protein content is shown in section 4.2.7.3.2 
Figure 4.4 displays an example of an analytical HPLC trace obtained from 1st 
dimension separation and an example of the second dimension chromatography traces 
are shown in Figure 4.5. The results of peptide separation using UV detection at 
214nm are presented as area under the curve (mAU/min) and maximum peak height 
(mAU).  
The area under the curve and maximum peak heights are shown in Table 4.3 for all 
samples. Some traces showed separation into smaller peaks at later elution times, 
however in general all samples were visible as one large peak, with limited resolution 
into discrete peptide peaks. 
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Figure  4.4 An example of the analytical HPLC trace of 1st dimension separation of peptides in canine faecal protein  
extract (ii) in Experiment 2. 
  









Figure 4.5 An example of second dimension reverse phase chromatography trace of peptide mixture from 8 fractions eluted by cation 
exchange chromatography of canine faecal extract (i) digested proteins and peptides. 
The maximum absorbance values ranged from 10-38mAU. 
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4.3.4 Mass spectral data 
For each dataset the number of peptides identified are reported in tables below, and 
protein(s) identified containing the peptide sequences where confidence levels are 
determined by specific algorithms of the software. 
4.3.4.1 Spectra matched to peptide sequences within G. duodenalis database for 
assemblages A and B  
When the same mass spectral data was submitted to a universal protein database, in 
this instance Ludwig database, a different set of potential peptide and protein matches 
are generated. In column four the percentage of total spectra that were assigned to 
peptide sequences is given. The percentage of total spectra is the same for both 
databases because the spectral evidence does not change, only the confidence 
matching based upon mass and ion score. 
4.3.4.2. Spectra matching to universal protein database (LudwigNR) using 
ProteinPilot. 
The mass spectral data analysed using a universal protein database detected peptides 
at a high level of confidence. Many of these were of host origin. A summary of the 
parasite and host proteins and peptides detected is presented in Table 4.4. Details for 
individual samples are shown in subsequent tables. 
Table 4.4 Total spectral matches 
Confidence 
Threshold Proteins Detected Distinct Peptides % Total Spectra 
 GiardiaDB Universal DB GiardiaDB Universal DB GiardiaDB Universal DB 
>99% 1 1 13 14 0.4 0.4 
>95% 6 3 32 28 1 0.9 
>66% 10 8 45 45 1.4 1.5 
 
The tables below represent data summaries from analysis of mass spectra data as 
determined using Protein pilot pattern matching software.  
Results generated by the protein matching software were assigned a rank value for 
each protein detected, where N=1 is the most confident protein match relative to other 
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proteins identified. The results were examined for true G. duodenalis protein matches 
and any proteins matching to other organisms were excluded. For example, in Table 
4.5 matched proteins ranked N=1 to N=3 were of host origin. 
All proteins matched were based upon detection of peptides at 95% confidence or 
higher.  
Tables 4.5 - 4.9 display the mass spectra matched to G. duodenalis proteins contained 
within GiardiaDB database. The tables include the total number of proteins and 
peptides identified, with footnotes accompanied by ranked scores for each confident G. 
duodenalis protein match. Higher ranked proteins that are not displayed were excluded 
during the validation stage described above.  
 
4.3.4.3 Whole faecal sample (i) 
Table 4.5 spectral matches for fresh faecal homogenate sample 
 G. duodenalis database Ludwig database Total Spectra 
   9958 
Spectra identified 259 1178  
Proteins detected 14 105  
Distinct peptides 231 930  
Best matching G. duodenalis protein  
N=4 Confidence score 66% match to hypothetical protein  
 
 
4.3.4.4 Whole faecal, freeze thaw (x3) sample  (ii) 
Table 4.6 Spectral matches for freeze thaw sample 
 G. duodenalis database Ludwig database Total Spectra 
   2152 
Spectra identified 215 887  
Proteins detected 45 64  
Distinct peptides 202 727  
Best matching G. duodenalis protein  
N=2 Confidence score >99% match to histone methyl transferase  
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4.3.4.5 Freeze-thaw faecal extract (ii) 
Table 4.7 Spectral matches for freeze thaw sample  
 G. duodenalis database Ludwig database Total Spectra 
   5196 
Spectra identified 188 642  
Proteins detected 20 76  
Distinct peptides 145 387  
Best matching G. duodenalis proteins  
N=1 confidence score 99% hypothetical protein 
N=2 confidence score 66% Nek kinase (matched two G. duodenalis isolates, A and B) 
 
Protein identifications were accepted with 66% confidence score because of a peptide 
assignment at 99% confidence level and because no other homologous peptide was 
found in the universal protein database. 
4.3.4.6 Freeze-thaw disrupted cysts faecal extract (iii) 
Table 4.8 Spectral matches for freeze-thaw disrupted cysts 
 G. duodenalis database Ludwig database Total Spectra 
   5219 
Spectra identified 113 436  
Proteins detected 16 59  
Distinct peptides 92 289  
Best matching G. duodenalis proteins  
N=2 confidence score 99% signal recognition particle receptor protein 
N=4 confidence score 95% hypothetical protein  
N=5 confidence score 66% hypothetical protein  
4.3.4.7 Faecal homogenate protein extract (iv) 
Table 4.9 Spectral matches for faecal homogenate protein 
 G. duodenalis database Ludwig database Total Spectra 
   3576 
Spectra identified 171 278  
Proteins detected 55 139  
Distinct peptides 134 212  
Best matching G. duodenalis proteins  
N=1 confidence score 99% hypothetical protein  
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(continued)  
N=2 confidence score 99% mismatch repair protein (matched two G. duodenalis 
isolates, A and B) 
N=3 confidence score 99% axoneme central apparatus protein (matched two G. 
duodenalis isolates, A and B) 
N=4 confidence score 99% hypothetical protein  
N=5 confidence score 95% pyruvate flavodoxin oxidoreductase (matched two G. 
duodenalis isolates, A and B) 
N=6 confidence score 95% coiled coil protein  
 
Table 4.10 Comparative summary of the spectral data for each of the 2D LC 
experiments. 




























































































1 9958 259 2.6 1178 11.8 1:  4.5 
2 2152 215 9.9 887 41.2 1:  4.2 
3 5196 188 3.6 642 12.4 1:  3.4 
4 5219 113 2.1 436 8.4 1:  4.0 
5 3576 171 4.8 278 7.8 1:  1.6 
Confidence scores with threshold set at 95% confidence. 
4.3.5 Examination of raw spectral traces 
The mass spectra were analysed to determine an amino acid sequence and therefore 
protein identity and fraction. This was achieved by; 1) pattern matching to G. 
duodenalis proteins, 2) pattern matching to all known proteins as described above and 
3) de novo sequencing. Proteins identified by G. duodenalis database matching were 
investigated further by examination of individual spectral peaks. Each spectral peak 
was analysed by comparison with proteins matched using the Ludwig database to 
determine if there was an equal or better match than the G. duodenalis protein 
identified. An example of fragmentation patterns and peptide assignment are shown in 
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Figures 4.6 and 4.7 for GiardiaDB and universal DB respectively. The peptides 
generated and matching to peptide sequences in Ludwig database were then 
examined by BLAST search against Uniprot and NCBI databases to identify if any 
protein matches occurred with a higher degree of confidence.  
The same spectra were submitted to two different databases for peptide matching, 
different peptide sequences were assigned to the spectra according to the database 
used. Figure 4.6 shows that the peptide sequence determined by mass spectra 
matching to GiardiaDB entries is KNSILNTLK.  
 Figure 4.7 shows the peptide sequence assigned by pattern matching to the universal 
protein database. The peptide sequence determined by mass spectra matching to 
universal protein database entries is QLDFTLSPK. 
Only one confident b ion was detected for this peptide and is not matched to a protein 
in the universal protein database. The total ion score of 4 is less than the total ion 
score of 6 for spectra matching to Giardia database. A higher ion score increases the 
confidence of accurate protein identification. The conclusion from spectral analysis 
accepts that there is no evidence for any other (non-Giardia) protein. 
Fragmentation evidence for  (Giardia DB) assignment of spectra 
At the lower end of the 
spectrum ( in the table) Y ion 
with mass of 147 indicates 
lysine as the terminal  amino 
acid (128 plus the mass of 
water and hydrogen ion) 
Diamino mass of 
lysine and 
asparagine is 242. 
In the mass spectrometer laser ionization causes ion collision and 
breakage  of peptide bond resulting in 2 types of daughter ions  - b ion 
fragments and y ion fragments. Each of the fragments consists of an amino 
acid sequence    
Knowing the mass of a b ion allows calculation of the 
y ion and vice versa. The different fragment sizes are 
shown as spectral traces below and in exact mass 
value in the table. This spectra shows the mass for 
amino acids as they fragmented from 1 – 9 different 
mass scores indicating peptide of 9 amino acid 
residues 
At the lower end of the spectrum (in the table) b ion with a 
mass of 129 indicates lysine as the terminal amino acid 
(mass of glutamine is 128, with positive charge) 
Difference in mass between y7 and y6 is 
87 (mass of serine is 87) 
Difference in mass between b4 and b3 is 
113 (mass of leucine is 113). 
Figure 4.6 Annotated ms spectra for mismatch repair protein  









Figure 4.7 Fragmentation evidence for universalDB assignment of spectra 
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Results for the parasite and host faecal proteomes are described in Chapter 5. 
Summary tables for the parasite faecal proteome present protein identifications in 
Table 5.2 and peptide identifications in Table 5.3. 
Summary tables for the host faecal proteome protein identifications are shown in 
Tables 5.4 – 5.7. 
4.3.6 Conclusion 
Faecal protein analysis using a proteomic approach has for the first time been 
successful in the identification of parasite proteins associated with Giardia spp. 
infections in canines. The approach of focusing on aqueous phase proteins was 
appropriate although variation in the types and numbers of Giardia spp. proteins was 
noted. Further work is required to determine if sample preparation methods influence 
the types of proteins identified for example different buffers and surfactants may be 
affecting the integrity of proteins.  
The iterative process used here to inform subsequent steps in protein extraction, 
separation and identification worked well over time. This is a preliminary study and 
these methods form a firm base for continued work on protein extraction methods and 
optimisation for parasite protein profile.  
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Chapter 5 
Host-parasite faecal proteome mapping for the canine host 
infected with Giardia spp. parasite 
5.1 Introduction 
This chapter examines the results from mass spectral data reported in Chapter 4 in the 
context of the faecal proteome, protein function and host-parasite biology. 
5.1.1 Host species investigated  
Early studies investigating transmission of Giardia spp. were conducted in humans and 
animal models such as mice or Mongolian gerbils, not specifically for Giardia species 
infecting dogs. These studies provided important fundamental data necessary for 
further understanding of the biological and biochemical functions of Giardia proteins 
(Holberton and Ward, 1981, Jarroll et al., 1989) and disease processes in humans 
(Nash and Keister, 1985, Nash et al., 1987).  
The research described in this thesis aimed to improve the wider understanding of 
host-parasite interactions, particularly how Giardia spp. infections affect dogs.  
5.1.2 Proteomic approach to phenotypic characterization of G. 
duodenalis 
Protein analysis using proteomic tools may hold the key for differentiating between the 
various G. duodenalis sub-types and provide the opportunity to extend descriptors 
beyond the genome sequencing and genotyping of G. duodenalis to the phenotypic 
expression of protein at the cellular level. 
Whilst molecular investigations into Giardia spp. have focused on genetic analysis, 
work has already advanced at the proteomic level to elucidate Giardia spp. protein 
expression. To date there is increasing data concerning basal bodies  (Lauwaet et al., 
2011), protein kinases Manning et al. (2011), mitosomes Jedelsky et al. (2011) and 
mitosomal transport proteins of Giardia spp. Dagley et al. (2009). Kim et al. (2009) 
reported the dramatic change in protein profiles of Giardia cysts and trophozoites 
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sourced from in vitro culture during encystation or excystation periods in Giardia spp. 
using a proteomic approach.  
5.1.3 Biomarkers of infection 
Medical research criteria, together with convenience and patient preference have 
influenced the type of biological samples required for scientific testing, with blood 
products and urine being the most frequently used (Xu and Veenstra, 2008, Steiner, 
2014). However, advances in scientific understanding combined with changes in 
human disease patterns have prompted researchers to investigate wider use and 
application and use of biological samples. Examples of this type of research are the 
use of faeces for isolation of biomarkers, such as haemoglobin in human colorectal 
cancer, calprotectin and lactoferrin in inflammatory bowel disease (IBD), or elastase in 
canine exocrine pancreatic insufficiency (Battersby et al., 2005, Ang et al., 2011, Lamb 
and Mansfield, 2011). Although faecal samples are proving useful in biomarker 
investigations and proteomic profiling, there remain some limitations due to the 
complexity and diverse composition arising from dietary and host proteins, in addition 
to dynamic and variable microbial content (Zoetendal et al., 2011). 
5.1.4 Ecosystem of the digestive tract 
Conditions of the mammalian gastro-intestinal tract are affected by host species, 
genotype and physiology, host diet and immunological status (disease, vaccination 
etc.) (Round and Mazmanian, 2009). In fact, unique and specialized ecosystems of the 
gastro-intestinal tract exist, which contains anaerobic or microaerophilic microbial 
populations of bacteria, fungi, and parasites, within fluids of the intestinal lumen and 
have been estimated to contribute up to ten times the number of cells in a human body 
(Hattori and Taylor, 2009, Qin et al., 2010, Shen et al., 2010). The functional efficacy of 
a particular organism in the complex microbial environment of the GIT is dependent on 
its numerical abundance, survival, competitiveness, and metabolic activity (Fitzsimons 
et al., 2003). Completion of the digestive process, which provides nutritional benefits 
both to host and microbial members of the ecosystem, generates waste products, urine 
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and faeces. Faecal material contains waste products from digestive tract processes 
and faecal protein composition includes dietary proteins, host epithelial cells and 
secretory proteins, and other microbial proteins (bacterial, fungal, parasite, or viral) 
(Eckburg et al., 2005). The dark coloration of faecal matter is due to the end products 
from breakdown of bilirubin (Liu et al 2008) and this and other components can be 
responsible for inhibition of PCR reactions in genetic studies.  
5.1.5 Faecal proteomics 
Proteomic analysis of faecal material is a recent method and one approach has been 
used to examine microbial populations of the gastro-intestinal tract. A metaproteomics 
study by Klaassens et al. (2007) has demonstrated the use of 2D PAGE and mass 
spectrometry methods for identifying faecal proteins from the gastrointestinal tract of 
infants. A similar metaproteomic investigation of the microbiota present in the human 
distal gut used a non-targeted shotgun mass spectrometry method to successfully 
study functional gene expression in illustrating potential interactions of the gut microbial 
ecosystem with the human host (Verberkmoes et al., 2009). 
5.1.6 Hypothesis  
That novel proteins or peptides detected in canine faeces be used to differentiate 
between different genotypes of Giardia spp. That faecal proteome data can 
detect host-parasite interactions 
5.2 Results for faecal proteome mapping  
Presented here are the proteins identified by matching peptide assignments introduced 
in Chapter 4.  
5.2.1 Mapping the faecal proteome 
Experimental work investigating parasite proteins in infected faecal material has not 
been performed before, and it presented significant challenges because Giardia cysts 
form only a small portion of total faecal proteins. Validation of all proteins identified was 
essential and only proteins identified from peptides at the highest confidence level 
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(including screening for false positives) were included in the final proteome map. Some 
proteins identified did not meet validation criteria and were excluded from the final 
proteome map. 
 
As each sample was unique in origin, from different locations, different individual dogs 
(diet, host genetics, physiology and symptomology), together with variation in the 
processing methods, analysis of the results could not be meaningfully combined. The 
objective of this study was for mapping and single sample analysis was considered 
appropriate. Detailed results are presented as follows: 1) a summary of the individual 
samples analysed in this exploratory study; 2) the parasite faecal proteome map; 3) 
species composition of proteins detected in the faecal sample; 4) the host faecal 
proteome map.  
5.2.1.1 Summary of canine faecal samples investigated  
A summary of all faecal samples used for proteomic analysis are show in Table 5.1. 
Sample processing methods are detailed in Chapter 4. All protein samples were 
obtained from G. duodenalis infected fresh canine faeces, and processed immediately 
following diagnostic techniques. Canine faecal samples, numbered 1-5 originated from 
G. duodenalis infected dogs, including 2 symptomatic dogs and 2 asymptomatic dogs. 
Chapter 2 describes in more detail the methods used for collection of diagnostic and 
clinical information.  











1 (Spring) 283 Melbourne Victoria breeder Symptomatic 4 D 
2 (Spring) 730 Perth, WA shelter Asymptomatic 4 D 
3 (Autumn) 42 Perth, WA shelter Symptomatic 3+ D 
4 (Autumn) 42 Perth, WA breeder Symptomatic 3+ D 
5 (Summer) 2190 Perth, WA shelter Asymptomatic 3+ C/D and A 
• no other parasites were observed by light microscopy gold standard 
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5.2.2 Giardia spp. (parasite) faecal proteome  
Results presented in Table 5.2 include only those proteins identified with at least one 
matching peptide at 99% confidence. Most protein identifications also included 
matches to other peptides at lower confidence levels, which supported acceptance of 
the database matched protein, and in the absence of contrary evidence from de novo 
sequencing methods. 
Homologous proteins, with different accession numbers were confirmed when peptides 
were matched to those of G. duodenalis assemblage A and assemblage B, such as 
axoneme central apparatus protein, as shown in Table 5.2.  
Several proteins identified were based upon detection of unique peptides, where 
peptides were assigned to only one protein and not to any other protein, host, parasite 
or other organism contained in the database described in Chapter 4.  
Two unique peptides were identified in one protein (hypothetical protein) and one 
unique peptide in one each of four proteins (mismatch repair protein, axoneme central 
apparatus protein, hypothetical protein and coiled-coil protein). 
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1 Hypothetical protein 2.0 A8BBE2 GL50803_117192 A 
2 Histone methyltransferase MYST1 2.0 C6LVL9 GL50581_2825 B 
3 Nek Kinase 0.62 C6LMX7 GL50581_75 B 
(3) Nek Kinase 0.62 A8BVL0 GL50803_92498 A 
4 Signal recognition particle receptor 2.0 C6LN45 GL50581_145 B 
5 Hypothetical protein 1.64 C6LN73 GL50581_174 B 
6 Hypothetical protein 3.18 C6LS33 GL50581_1569 B 
7 Hypothetical protein 2.02 C6LSL4 GL50581_1753 B 
8 
 Mismatch repair protein 2.0 C6LTM7 GL50581_2123 B 
(8) Mismatch repair protein 2.0 A8B6C1 GL50803_34058 A 
9 Axoneme central apparatus protein 2.0 C6LYT9 GL50581_3967 B 
(9) Axoneme central apparatus protein 2.0 A8BQ10 GL50803_16202 A 
10 Hypothetical protein 2.0 A8B8B6 GL50803_6625 A 
11 Pyruvate-flavodoxin oxidoreductase 1.68 E2RTZ1 GL50803_114609 A 
(11) Pyruvate-flavodoxin oxidoreductase 1.6 C6LZB6 GL50581_4147 B 
12 Coiled-coil protein 1.54 C6LY87 GL50581_3758 B 
13 Hypothetical protein 2.64 C6LUY7 GL 50581_2589 B 
14 tRNA/rRNA cytosine C5 methylase 1.30 A8BA69 GL 50803_3985 A 
15 Coiled coil protein 4.5 C6LZ39 GL 50581_4068 B 
16 Hypothetical protein 2.0 A8B278 GL 50803_37864 A 
The results presented in Table 5.2 include proteins detected over a threshold score, 
where the cut off value is 1.3; all scores equal and above represent highly confident 
protein matches (95% and above). 
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5.2.2.1 Peptides contributing to Giardia spp. protein identification  
Sequences and confidence scores for each peptide identified are shown in Table 5.3. 
Table 5.3 Peptides identified from spectra matching to G. duodenalis database 




















3 LSYDEIVR 1 @99% 4@<1% 8 
Nek Kinase 
C6LMX7 GL50581_75 
(3) LSYDEIVR 1 @99% 8@<1% 8 
Nek Kinase 
A8BVL0 GL50803_92498 





5 ILNDDLLELK 1 @99% 5@<1% 7 
Hypothetical 








7 Hypothetical protein C6LS33 GL50581_1569 




6 Hypothetical protein C6LSL4 GL50581_1753 




protein C6LTM7 GL50581_2123 
(8) KNSILNTLK 1 @99% 7@<1% 6 
Mismatch repair 
protein A8B6C1 GL50803_34058 




























































Coiled coil protein 
C6LZ39 GL50581_4068 
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Twenty-two unique amino acid sequences provided positive Giardia spp. peptide 
identifications. Those protein matches in Table 5.2 that were underpinned by multiple 
peptide matches (sequences shown in Table 5.3) at high quality provide greater 
confidence of the protein identification. Some peptide sequences appear in more than 
one entry, which indicates either a conserved sequence, or redundant entries in the 
database. The most accurate peptide assignments determined by Protein Pilot 
software report the likelihood of an individual spectra matching to that protein 
sequence. The ion score is determined at the peptide level only as described in 
Figures 4.6 and 4.7. The top ion score reflects the most accurate spectral match to a 
peptide sequence. 
5.2.2.2 Peptide alignment by comparison of amino acid sequences  
This section contains comparison of the amino acid sequence alignment for proteins 
matching to different G. duodenalis genotypic assemblages obtained from database 
searching.  
An * (asterisk) indicates positions which have a single, fully conserved residue.  
Point accepted mutations are illustrated as follows: 
A : (colon) indicates conservation between groups of strongly similar properties  
A . (period) indicates conservation between groups of weakly similar properties  
A   (space) indicates residue differences due to discrepant sequence 
The red circles mark consecutive amino acid insertions or deletions. The yellow 
circles mark amino acid point mutations. Peptide sequences detected by mass 
spectrometry are highlighted. 
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A comparison using uniprot protein database BLAST search with clustal omega of Nek 
kinase proteins detected in sample 3 showed 92% identity between sequences from G. 
duodenalis Assemblage A and B shown in Figure 5.1. The peptide detected consists of 
an amino sequence (LSYDEIVR) indicating an area of homology between the two G. 
duodenalis strains. 
C6LMX7 Nek Kinase, G. intestinalis (strain ATCC 50581 / GS clone H7) (G. lamblia) 
GL50581_75 
A8BVL0 Nek Kinase, G. intestinalis (strain ATCC 50803 / WB clone C6) (G. 
duodenalis lamblia) GL50803_92498 
 
Figure 5.1 Amino acid sequence of Nek kinase for two G. duodenalis isolates 
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A comparison using clustal omega from uniprot protein database of axoneme central 
apparatus proteins detected in sample 5, shown in Figure 5.2, gave 99.8% identity 
between the two G. duodenalis sequences for Assemblage A and B with 501 identical 
positions and 1 similar position, with a point mutation occurring at position 9. The 
peptide identified using proteomic analysis in this study is highlighted in yellow for 
amino acid positions 145 – 156. This is an area of homology between the two G. 
duodenalis strains. 
 
C6LYT9 Axoneme central apparatus protein G. intestinalis (ATCC 50581 / GS clone 
H7) (G. lamblia) GL50581_3967 
A8BQI0 Axoneme central apparatus protein G. intestinalis (ATCC 50803 / WB clone 
C6) (G. lamblia) GL50803_16202 
 










C6LTM7 Mismatch repair protein G. intestinalis (strain ATCC 50581 / GS clone H7) 
(G. lamblia) GL50581_2123 
A8B6C1 Mismatch repair protein G. intestinalis (strain ATCC 50803 / WB clone C6) 
(G. lamblia) GL50803_34058 
 
 
Figure 5.3 Amino acid sequence of Mismatch repair protein for two G. duodenalis 
isolates 
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A comparison of pyruvate flavodoxin oxidoreductase protein amino acid sequence 
detected in experiment 5, showed 96.3% identity between the sequences from G. 
duodenalis Assemblage A and B with 1207 identical positions and 40 similar positions, 
shown in Figure 5.4. 
 
Figure 5.4 Amino acid sequence of pyruvate flavodoxin oxidoreductase protein for two 
G. duodenalis isolates 
 
1
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Figure 5.4 Amino acid sequence of pyruvate flavodoxin oxidoreductase protein for two 
G. duodenalis isolates 
 
E2RTZ1 Pyruvate-flavodoxin oxidoreductase G. intestinalis (strain ATCC 50803 / 
WB clone C6) (G. lamblia) GL50803_114609 
C6LZB6  Pyruvate-flavodoxin oxidoreductase G. intestinalis (strain ATCC 50581 / 
GS clone H7) (G. lamblia) GL50581_4147 
Two different peptides identified by proteomic analysis in this study are highlighted, 
one in yellow (NSVRLVAGGR) and one in pink (LGAGKNSVR). Two point mutations 
occur in these peptides identified at positions 365 and 367 for the two overlapping 
peptides (LGAGKNSVR) and (NSVRLVAGGR). The two G. duodenalis strains WB and 
GS have homologous sequence for NSVRLVAGGR peptide. There are different amino 
acid sequences with evidence for two point mutations, suggesting that these may 
constitute phenotypic differences between the G. duodenalis strains WB and GS or 
specific sequences for canine Giardia spp. isolates detected in this study. Giardia spp. 
protein identifications were detected in this exploratory study and a wider discussion on 
the function of proteins that were detected is presented here. These include metabolic, 
cytoskeletal and genetic replication proteins and provide a deeper insight into Giardia 
interactions in the canine gastro-intestinal tract. 
 
A comparison using clustal omega from uniprot protein database of mismatch repair 
proteins detected in sample 5, showed 78.3% identity between sequences from G. 
duodenalis Assemblage A and B. Areas of homology occurred between the amino 
sequences for G. duodenalis Assemblages A and B in the peptide identified 
(KNSILNTLK).  
 
5.2.3 Canis familiaris (Host) Faecal Proteome 
5.2.3.1 Universal protein database matching 
Spectra were analysed and matched to peptide entries in the Ludwig protein database. 
G. duodenalis proteins were not detected, but a number of peptides matched to 
proteins (at high level of confidence) of other organisms. Results were sorted 
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according to the most confident matching protein, host species and confidence score. 
The results presented here include proteins detected over a threshold score, where the 
cut off value is 1.3; all scores equal and above represent highly confident protein 
matches (95% and above). 
Host proteins detected from 5 different faecal protein extracts are described in Tables 
5.3 – 5.7, originating from Giardia spp. infected dogs. In total 256 host proteins at 95% 
confidence level were detected and identified by matching spectral traces to 
sequences in a universal protein database (Ludwig nr version) and those specific to 
Canis familiaris.  
5.2.3.2 Canine database matching 
Protein matching against Canis familiaris specific database did not detect matches with 
any degree of confidence. This may reflect the type of information contained in the 
database, much of which was derived from pathogens isolated from dogs. 
5.2.3.3 Common host proteins 
Digestive enzymes were easily detected in all samples, excluding sample 5.  Peptidase 
and trypsin forms were present in samples 1 - 4 the majority of which were 
homologous to previously recorded digestive proteins from C.familiaris. Two samples 
contained trypsin proteins which were homologous to C.familiaris and Bos taurus, 
which may indicate that residual digestion enzyme used in sample preparation process 
remained in the sample, or that the peptide sequences from both species have 
identical homology. 
Peptidase proteins detected included carboxypeptidase, aminopeptidase and 
endopeptidase. Amylase and sucrase-isomaltase proteins homologous to C.familiaris 
were present in samples 1 - 4, and galactose was detected in sample 1. Lipase was 
only detected in sample 2 and sample, 1, 2 and 3 all contained kinase enzymes. Mucin, 
detected in samples 1 - 4, was homologous to C.familiaris and Homo sapiens. 
Phosphatase was present in all samples, except for sample 2, occurring mainly as 
alkaline phosphatase with homology to C.familiaris.  
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Immunoglobulins were present in samples 1 - 4, and apart from one which was 
homologous to rumen bacteria (Prevotella sp.), all matched peptides for C.familiaris. 
Overall, all samples analysed provided strong evidence of host immunoglobulins. Table 
5.9 provides a description of different immunoglobulin types detected. 
Hemoglobin detected in samples 2 and 4 was of avian homology not canine. 
5.2.3.4 Proteins of interest 
A specialized peptidase, kallikrein, was present in sample 3 and is known to be present 
in epithelial tissues and has a vasoactive role associated with inflammatory processes 
(Goettig et al., 2010). It has been identified as a biomarker and linked to cancer 
(Borgono et al., 2004) and allergic and skin lesions such as dermatitis. 
Sample 1 contained 2 isoforms of a ‘Carcinoembryonic antigen related cell adhesion 
molecule’, which is a transmembrane cell adhesion protein first described in bile ducts 
of liver as a biliary glycoprotein, and subsequently confirmed as a cell-cell adhesion 
molecule located on leukocytes, epithelia, and endothelia (Oikawa et al., 1992, 
Kuespert et al., 2006, Ang and Nice, 2010).  
Sample 1 contained lactotransferrin and also blood protein complement C3. Both were 
homologous to lactotransferrin for C.familiaris with 11 and 9 matching peptides, 
respectively. 
Uncharacterized proteins were detected in all 5 samples, most of which showed 
homology with C.familiaris. In the case of sample 2, many of them showed matching 
homology to uncharacterized proteins of other species, including prokaryotes and other 
non-mammalian organisms. 
5.2.3.5 Species composition of detected faecal proteins 
The proteins matched to mass spectral data for each sample are displayed in piecharts 
below, which represent the species of origin.  
The species composition of detected proteins are shown in Figures 5.5 - 5.8 and 
Tables 5.4 - 5.7.  




Figure 5.5 Species composition of detected proteins (95% confidence) in Sample 1  
 
The ten highest scoring (most confident matches) out of 81 total protein matches are 
displayed in Table 5.4. 







Protein Name Species 




1 E2RH46 Uncharacterized protein Canis familiaris 60 
2 XP_856212.1 Amylase, alpha 2B; pancreatic precursor isoform 12 Canis familiaris 42 
3 XP_849413.1 
Immunoglobulin lambda-like 
polypeptide 1 precursor 
(Immunoglobulin-related 14.1 
protein) (omega p) 
Canis familiaris 34 
4 XP_547299.2 Calcium activated chloride channel 1 precursor Canis familiaris 29 
5 XP_536228.2 Leucine aminopeptidase Canis familiaris 19 
6 XP_538947.2 
Meprin A alpha-subunit 
precursor (Endopeptidase-2) 
(N-benzoyl-L-tyrosyl-P-amino-
benzoic acid hydrolase alpha 
sub 
Canis familiaris 22 
7 XP_534605.2 Intestinal alkaline phosphatase precursor (IAP) Canis familiaris 13 
8 E2RT38 Uncharacterized protein Canis familiaris 15 
9 XP_541903.2 Lactotransferrin isoform 1 Canis familiaris 11 



















Figure 5.6 Species composition of detected proteins (95% confidence) in Sample 2 
Data was sorted for protein matches specific to the host species, C. familiaris. The ten 
highest scoring (most confident matches) out of 120 total protein matches are 
displayed in Table 5.5.  












Bile-salt-activated lipase precursor 
(BAL) (Bile-salt-stimulated lipase) 
(BSSL) (Carboxyl ester lipase) sterol   Canis familiaris 6 
2 P19090 Colipase Canis familiaris 9 
3 E2QWR0 Uncharacterized protein  Canis familiaris 7 
4 P49822 Serum albumin  Canis familiaris 4 
5 
XP_856212.1 
amylase, alpha 2B; pancreatic 
precursor isoform 12   Canis familiaris 4 
6 
ENSCAFP00000018537 
ENSCAFG00000012561 transcript:ENSCAFT00000019984  Canis familiaris 7 
7 XP_856525.1 Ig lambda chain C regions isoform 19   Canis familiaris 4 
8 XP_536228.2 leucine aminopeptidase   Canis familiaris 4 
9 E2R3N3 Uncharacterized protein  Canis familiaris 4 


























Figure 5.7 Species composition of detected proteins (95% confidence) in Sample 3  
Data was sorted for protein matches specific to the host species, C. familaris. The ten 
highest scoring (most confident matches) out of 22 total protein matches are displayed 
in Table 5.6. 





















Number or  
DNA identifier 








Amylase, alpha 2B; pancreatic 
precursor isoform 12   Canis familiaris 27 
2 
XP_534605.2 
Intestinal alkaline phosphatase 
precursor (IAP)   Canis familiaris 7 




3 transcript:ENSCAFT00000021631  Canis familiaris 6 






4  Canis familiaris 2 
7 Q8WNN6 Superoxide dismutase (Cu-Zn)  Canis familiaris 2 
8 XP_545265.2 Sucrase-isomaltase, intestinal   Canis familiaris 2 
9 
XP_859826.1 
Aminopeptidase N (hAPN) (Alanyl 
aminopeptidase) (Microsomal 
aminopeptidase) (Aminopeptidase 
M) (gp150) (Myeloid   Canis familiaris 2 
10 E2RH46 Uncharacterized protein  Canis familiaris 2 




Figure 5.8 Species composition of detected proteins (95% confidence) in Sample 4  
The ten highest scoring (most confident matches) out of 30 total protein matches are 
displayed in Table 5.7 
Table 5.7 Sample 4 Host faecal proteome 
N 
Protein Accession 
Number or  
DNA identifier 
















precursor (PA)  
(1,4-alpha-D-glucan 
glucanohydrolase) isoform 1   Canis familiaris 12 
4 E2RH46 Uncharacterized protein  Canis familiaris 11 
5 XP_534605.2 
Intestinal alkaline 




(Elastase IIIB) (Protease E) 
isoform 1 Canis familiaris 9 
7 XP_545265.2 
Sucrase-isomaltase, 
intestinal   Canis familiaris 5 
8 XP_855328.1 
calcium activated chloride 
channel 4   Canis familiaris 4 
9 P55261 CarboxypeptidaseB  Canis familiaris 3 
10 A0FGS8 
Anionic trypsinogen 






REPTILES & FISH 
Other MAMMAL & 
BIRDS 
BACTERIA 
PLANTS & FUNGI 
DOG 
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Species composition of detected proteins (95% confidence) in Sample 5 were all Canis 
familiaris and the three proteins detected are shown in Table 5.8. 
Table 5.8 Sample 5 Host faecal proteome 
N Protein Score 
Protein 
Accession 








1 4.75 F1PYR1 
Uncharacterized 

















Table 5.9 Immunoglobulins detected 
Gene Access 
number Protein Name 
Matching 
Peptides 
XP_862349.1 Immunoglobulin J chain isoform 3  [Canis familiaris] 2 
XP_849413.1 Immunoglobulin lambda-like polypeptide 1 precursor (Immunoglobulin-related 14.1 protein) (Immunoglobulin omega p  [Canis familiaris] 34 
XP_543600.2 Immunoglobulin lambda-like polypeptide 1 precursor (Immunoglobulin-related 14.1 protein) (Immunoglobulin omega p  [Canis familiaris] 26 
XP_543515.2 Ig lambda chain V-I region BL2 precursor   [Canis familiaris] 8 
 
XP_855004.1 Ig lambda chain V-I region BL2 precursor   [Canis familiaris] 6 
 
XP_855010.1 Ig lambda chain V-I region BL2 precursor   [Canis familiaris] 5 
 
XP_848837.1 Ig heavy chain V-III region VH26 precursor   [Canis familiaris] 3 
XP_849174.1 Ig heavy chain V-III region VH26 precursor   [Canis familiaris] 3 
 
XP_848599.1 Ig heavy chain V-III region VH26 precursor   [Canis familiaris] 3 
XP_543520.2 Ig lambda chain V-III region LOI   [Canis familiaris] 1 
XP_848500.1 Ig heavy chain V-III region VH26 precursor   [Canis familiaris] 13 
D1PEJ7 Putative immunoreactive antigen PG33 [Prevotella copri] 5 
XP_856525.1 Ig lambda chain C regions isoform 19   [Canis familiaris] 4 
XP_855821.1 
Immunoglobulin lambda-like polypeptide 1 precursor (Immunoglobulin-
related 14.1 protein) 
(Immunoglobulin omega p  [Canis familiaris] 
6 
XP_848877.1 Ig heavy chain V-III region VH26 precursor   [Canis familiaris] 2 
XP_543600.2 
Immunoglobulin lambda-like polypeptide 1 precursor (Immunoglobulin-
related 14.1 protein) 
(Immunoglobulin omega p  [Canis familiaris] 
14 
XP_849413.1 
Immunoglobulin lambda-like polypeptide 1 precursor (Immunoglobulin-
related 14.1 protein) 
(Immunoglobulin omega p  [Canis familiaris] 
13 
P01785 Ig heavy chain V region MOO  [Canis familiaris] 4 
XP_848749.1 Ig heavy chain V-III region VH26 precursor   [Canis familiaris] 2 
Different immunoglobulin proteins were detected across all samples and the 
confidence of identification is shown in Table 5.9 by number of matching peptides. All 
three structural types of immunoglobulin were detected, Joining, Variable and Constant, 
Chapter 5 Host-parasite faecal proteome  
 202 
and the number of matching peptides ranged from 1-34 indicating some 
immunoglobulin forms are in sufficient quantity to be detected in faecal matter. 
5.4 Discussion 
Spectra were analysed and matched to proteins (at high level of confidence) entries in 
the GiardiaDB database. The proteomic data discussed in this section examines these 
G. duodenalis proteins identified by mass spectrometry that are reported in Table 5.2.  
The results presented here include the proteins matched with the highest confidence 
and supported by multiple matching peptides.  
5.4.1 Parasite proteome 
The most important proteins are discussed with regard to the technical success of 
highly confident protein matching and significance of the potential applications for 
understanding the biology, biochemistry and disease pathogenesis of Giardia spp. 
infections. This section also includes details of the individual peptides and their 
significance in contributing to protein identification (as shown in Table 5.3) and also 
includes comments from comparative sequence alignment for individual proteins. 
Section 5.4.2 illustrates an overview of how the proteome map fits with the genomic 
data, and is discussed in relation to the genetic characterization results from Chapter 2. 
5.4.1.1 Coiled coil proteins 
Two coiled coil proteins were detected as G. duodenalis Assemblage B proteins, 
(C6LY87, C6LZ39). The highest protein score for all the proteins detected in this study 
was 4.5 for the coiled coil protein C6LZ39 GL50581_4068 matching an assemblage B 
gene sequence. Four matching peptides were each detected at 99% confidence level 
and no homologous sequence matches could be identified to any other organism by 
alignment to existing database entries. The four peptides were also detected with a 
high degree of confidence with a top ion score of 13, shown in Table 5.3.  
This signifies identification of some unique G. duodenalis peptides, 
HDMHLSLEQQSSK, LSHSAQSVALLQEQVSQR, TEPSCQRKEGEQTILLDR, 
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IDKLNSVTASFTKATR. Importantly, these peptides of coiled coil proteins were not 
matched to sequences in the G. duodenalis Assemblage A database, making them 
priority candidates for further phenotypic characterisation. 
5.4.1.2 Hypothetical proteins 
In total, seven different hypothetical Giardia spp. proteins were detected with unique 
sequences at more than 95% confidence, shown in Table 5.10. These are an important 
discovery because until now gene sequences have been predicted but evidence for 
protein expression has been absent. More work is required to fully describe and 
characterize these proteins.  
The most confidently matched hypothetical protein (C6LS33) matched to sequences in 
the G. duodenalis Assemblage B database, with four matching peptides, although 
there was little other data available to inform the type of protein this might be. A second, 
high scoring hypothetical protein (C6LUY7) with three matching peptides has amino 
acid sequence similar to Lymphocryptovirus protein clusters and conserved viral 
glycoprotein domains. Related sequences matching to reproductive and respiratory 
type proteins were confirmed from existing database entries. 
There was one hypothetical protein (A8BBE2, GL50803_117192) that was detected in 
two different samples. This may indicate this protein as a potential biomarker of active 
Giardia infection with a protein score of 2.0 and a highly confident matching peptide, 
KCGIQHSSRR. As the samples originated from symptomatic and asymptomatic dogs, 
with different genotypic of Giardia spp. infections, this peptide may be potentially useful 
as a biomarker for Giardia spp. infections in dogs. This hypothetical protein (A8BBE2) 
contains similar peptide sequences to proteins known to be associated with spindle 
pole ATP binding (GLP15_4271) in G. duodenalis isolate P15 (Assemblage E) 
Jerlstrom-Hultqvist et al. (2010) and ATP binding reverse transcriptase in Monosiga 
brevicollis (Iyer et al., 2008). 
Two hypothetical proteins matched to Assemblage A and four matched proteins 
predicted for Assemblage B. .  
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Table 5.10 Hypothetical proteins detected 
Hypothetical 
protein 




Protein Clusters Conserved 
domains 
Related sequences 
1 GL50803_117192 A A8BBE2 None None 2 Giardia protein sequences (535 
related sequences) matching to 




A A8B8B6 None None 2 Giardia protein sequences (230 
related sequences) matching to 
RNA binding proteins and pre-
RNA splicing factors (isolated 
from fungi and Plasmodium spp.) 





Phage like glycoproteins 
4 GL50581_174 B C6LN73 None None UNIQUE 
5 GL50581_1569 B C6LS33 None None UNIQUE 
6 GL50581_1753 B C6LSL4 None None UNIQUE 





Arterivirus G1, GS, M, N 
Reproductive and respiratory 
protein (equine and porcine) 
Epstein-Barr virus protein 
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5.4.1.3 Pyruvate flavodoxin oxidoreductase 
The mass spectral data detected two different and overlapping peptides LGAGKNSVR 
(in pink) and NSVRLVAGGR (in yellow), shown in Figure 5.9. Both peptides detected 
in this study were matched to G. intestinalis (strain ATCC 50803 / WB clone C6 
GL50803_114609) Protein E2RTZ1 and to G. intestinalis (strain ATCC 50581 / GS 
clone H7 GL50581_4147) Protein C6LZB6, for pyruvate flavodoxin oxidoreductase 
protein. The overall protein score of 1.6 is a confident protein match supported by 
several peptide identifications as shown in Tables 5.2 and 5.3. A comparison of amino 
acid sequences of the two proteins, using clustal omega from uniprot protein database, 
showed 96.3% identity for sequences from G. duodenalis Assemblage A and B, with 
1207 identical positions and 40 similar positions. G. duodenalis strains WB and GS 
have homologous sequence for NSVRLVAGGR peptide. Proteomic data supports 
detection of this peptide as a biomarker of Giardia spp. infections. The amino acid 
sequence LGAGKNSVR for was observed for G. duodenalis Protein E2RTZ1 (WB 
clone C6 GL50803_114609) an Assemblage A genotype. The genomic data for 
Assemblage B genotype (strain ATCC 50581 / GS clone H7 GL50581_4147) Protein 
C6LZB6, suggests that two point mutations (in green) may occur at amino acid residue 
positions 365 and 367 for the overlapping peptide, although the proteomic data in the 
work presented here supports only the peptide sequence shown in pink for 
LGAGKNSVR. These possible differences in amino acid sequences may constitute 
phenotypic differences between the G. duodenalis strains WB and GS or, that specific 
sequences for canine Giardia spp. isolates were detected in this study. 
   
Figure 5.9 Amino acid point mutations in PFOR genotypes of G. duodenalis (full 
sequence shown in Figure 5.4). 
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5.4.1.4 Nek Kinase  
Comparison of two peptide and amino acid sequences for different G. duodenalis 
genotypes show 92% homology between Assemblages A and B sequence data for 
Nek kinase detected in this study are C6LMX7 (GL50581_75) and A8BVL0 
(GL50803_92498). Whilst the protein score assigned to Nek kinase was below the 
95% confidence level, the detection of a highly confident peptide (99%), LSYDEIVR, 
was important in this protein identification in addition to the biological significance of 
high numbers of Nek kinases known to involved with Giardia spp. metabolism 
(Manning et al., 2011, Moniz et al., 2011, Smith et al., 2012). The peptide identified by 
proteomic analysis in this study, shown in Figure 5.1, is highlighted in yellow for amino 
acid positions 424 – 431. The red circles mark consecutive amino acid insertions or 
deletions, four or six amino acids in length. The yellow circles mark amino acid point 
mutations. The majority of the 30 indel (insertion or deletion) positions were amino acid 
residues of glutamine, the significance of this is not yet known. Further work examining 
protein-protein interactions may provide more insight, and in similar studies these types 
of interactions have identified protein kinases in parasite control mechanisms (Taylor et 
al., 2011).  
5.4.1.5 Mismatch repair protein 
The peptide KNSILNTLK was detected and matched with 99% confidence to database 
sequences for the identification of Mismatch repair protein. The peptide sequence 
matched through proteomic analysis in this study to both G. duodenalis Assemblages 
were A8B6C1 (GL50803_34058) Assemblage A and C6LTM7 (GL50581_2123) 
Assemblage B. The location of the peptide in the protein amino acid sequence is 
highlighted in yellow for amino acid positions 788 – 797 in Figure 5.3.  
This peptide covers a region of homologous sequence between the two G. duodenalis 
strains examined. Mismatch repair protein sequences showed more variation between 
genotypes than other proteins with 78.3% homology between two sequences, and a 
large number of point mutations are apparent. The large number of point mutations and 
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two indels occurring in other areas of this protein amino acid sequence warrant further 
investigation to confirm the nucleotide sequences predicted from genomic studies. One 
approach may be to use a proteogenomic approach to further validate protein identity 
by confirming that intragenic amino acid sequences of peptides match to the nucleotide 
coding sequences of genomic DNA (Nesvizhskii, 2014). Examination of exons and 
other non-coding regions of RNA transcripts have been successfully used to identify 
novel peptides and to quantify and confirm protein expression. 
5.4.1.6 Axoneme Central Apparatus protein  
The results of novel peptides detected for G.duodenalis axoneme central apparatus 
protein (A8BQ10) in this study confirms the presence of the protein predicted by gene 
sequence for G.duodenalis deposited to NCBI collection by (Morrison et al., 2007). 
Detection of this protein matched to both Assemblages A8BQI0 GL50803_16202 and 
C6LYT9 GL50581_3967. The protein score of 2.0 was considered an accurate 
identification supported by a highly confident match to the peptide EAAAWALGYIAR. 
Genomic data suggest that axoneme apparatus protein has a relatively conserved 
(99.8% homology), with only one amino acid difference between the 2 Assemblages 
examined. There were no differences in amino acid sequence in the peptide region 
identified using mass spectrometry in this study. 
5.4.1.7 Histone Methyl transferase 
This study detected histone methyltransferase MYST1 (GL50581_2825), an 
Assemblage B predicted protein (Manning et al., 2011). The protein score, shown in 
Table 5.2 was 2.0, whilst the peptide assigned to this protein was highly confident at 
99% and with an ion score of 10, shown in Table 5.3. This unique identification of the 
peptide sequence SQLFNIR was not matched to assemblage A DNA sequence 
database.  This proteomic data suggests that this is an interesting protein to study in 
more detail as a potential strain specific biomarker of Giardia spp. infection in dogs. 
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5.4.2 Giardia spp. assemblage specific proteins 
Four proteins matched only to genomic G. duodenalis Assemblage A proteins. Three 
were hypothetical proteins (A8BBE2, A8B8B6, A8B278) and one was a translation 
protein tRNA/rRNA cytosine methylase (A8BA69). 
Eight proteins matched only to genomic G. duodenalis Assemblage B proteins. Four 
were hypothetical proteins (C6LN73, C6LS33, C6LSL4, C6LUY7). 
Two were cytoskeletal Coiled Coil proteins (C6LY87, C6LZ39) Two were proteins 
associated with DNA replication Histone Methyltransferase (C6LVL9) and Signal 
Recognition Receptor protein (C6LN45). 
 
Figure 5.10 Summary of Giardia spp. proteins detected in the canine faecal proteome  
 
Giardia spp. proteins detected in the canine faecal proteome are summarized in Figure 
5.10 according to genotype (Assemblage A or B). Four of the proteins detected were 
matched to entries in the Giardia database for both Assemblages A and B. These were 
Mismatch Repair protein (C6LTM7, A8B6C1), Pyruvate Flavodoxin Oxidoreductase 
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(E2RTZ1, C6LZB6), Axoneme Central Apparatus protein (A8BQ10, C6LYT9) and Nek 
Kinase (C6LMX7, A8BVL0). 
The ability to differentiate between genotypes for canine Giardia spp. infections is 
limited in the absence of Assemblage C and D genomic data. Many peptides matched 
proteins on both Assemblage A and Assemblage B databases. This does not indicate 
the presence of genotype specific proteins, but examination of the peptides showed 
differences in amino acid sequences for PFOR contributing to our understanding of 
Giardia spp. phenotypic expression.  
The value of this preliminary proteomic study suggests that some proteins are 
commonly expressed, regardless of Giardia spp. genotype. Of particular interest are 
the Giardia spp. proteins, which appear to be genotype specific. These proteins are 
important to pursue further, and different aspects that could be explored. One would be 
to obtain genomic data for canine host specific Giardia spp. isolates and analyse the 
existing mass spectral data against new DNA sequences or RNA transcripts to search 
for confident protein matches and compare to the existing proteome map data. This 
may prove successful in validating phenotypic differences between different isolates. 
Additionally, from a clinical perspective, it would be useful to confirm protein expression 
levels according to infection status that is, in acute, chronic and post-infection stages. 
5.4.3 Biology – introduction  
Sixteen proteins of G. duodenalis origin were successfully extracted and identified from 
canine faecal material. They were diverse in structure and appeared to possess 
functions integral to cycling transitions between two morphological forms of Giardia, 
cysts and trophozoites, likely to have regulatory control functions.  
5.4.3.1 Cytoskeletal Protein Function  
5.4.3.1.1 Coiled coil proteins 
Several unique peptide sequences were matched to G. duodenalis Assemblage B 
coiled coil protein gene sequences, (C6LY87, C6LZ39). The significance of the 
identification of these peptides and proteins by proteomic analysis is important.  
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Specific roles for coiled coil proteins include serving as domains for binding tubulin 
subunits in the microtubule surface lattice (Holberton et al., 1988). Coiled coil proteins 
are not unique to Giardia spp. having been identified in more than 65 eukaryotic 
organisms (Gerke and Moss, 2002).  
5.4.3.1.2 Flagella 
The roles of flagella are for trophozoite motility, fluid movement, signal mediation and 
protein trafficking by intraflagellar transport proteins. Flagella may play a key role in 
establishing infections and signaling responses, either immune or pathophysiological 
Pazour et al. (2005) and are indirectly associated with trophozoite attachment to 
epithelial cells (House et al., 2011). 
5.4.3.1.3 Involvement of median and basal bodies in Giardia trophozoite axoneme 
construction  
Axonemes, are the microtubule structures, arranged circularly as nine doublets forming 
the core structure of flagella (Luck, 1984; Zhang et al., 2005). Comparative genomic 
research has also predicted a role for axoneme central apparatus proteins in flagella of 
other protozoan parasites such as Leishmania sp.(Ivens et al, 2005) and T. Cruzi (El-
Sayed et al 2005).  In a biological context the detection of highly confident peptides 
matching to axoneme central apparatus protein is not a commonly observed, in 
contrast to other proteins, such as enzymes detected in most eukaryotic organisms. 
The peptide sequence for axoneme central apparatus protein detected in this study 
occurs in single protein cluster NCBI database (ID 2432253).  
Fifteen entries displayed in the publicly available entry for axoneme central apparatus 
protein cluster originate from only those species with protozoan or protist taxonomy, as 
shown in the phylogenetic alignment tree in Figure 5.11. 
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Figure 5.11 Phylogenetic alignment of axoneme central apparatus protein (protein 
cluster) 
 
Key features that place the axoneme central apparatus protein within the large 
Thioredoxin-like protein Superfamily include a distinctive thioredoxin fold structure, with 
a redox active CXXC motif (Haque et al., 2012). They function as protein disulfide 
oxidoreductases, altering the redox state of target proteins via the reversible oxidation 
of their active dithiol site (Gilbert, 1997). Whilst axoneme structure is conserved across 
a number of different species (Zhang, 2005) research has demonstrated that central 
apparatus proteins are associated with the dynamic regulation of flagella movement 
(Dawson et al., 2007). Axoneme central apparatus protein participates in regulation of 
microtubule movement and interaction with dynein arms for energy generation in 
creation of flagella waveforms (Dawson, 2011a). 
5.4.3.2 Regulatory protein function 
Protein kinase enzymes play a critical role in cell metabolism of most living organisms, 
and all eukaryotic organisms, and kinases have been described and characterized into 
superfamilies based upon cellular location and function. There are many types of 
protein kinase, and Nek kinase is one of the serine/ threonine protein kinases (Manning 
et al., 2002, Smith et al., 2012). 
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5.4.3.2.1  Nek kinase 
Nek kinase GL50803_92498 detected in this study has been associated with Giardia 
caudal flagella signaling and association with adhesive disk and protein phosphatase 
2A Manning et al. (2011) although the exact pathway is still to be determined, but 
functions as an ATP protein transphosphorylase. In the same study, this Nek 1 
(GL50803_92498) kinase was also immunolocalised to anterior and posterio-lateral 
flagella, basal and median bodies.  
The actions of Nek kinase in G. duodenalis trophozoites are multiple and repetitive, 
and integral to both ciliar and centrosomal processing (Parker et al., 2007, Davids et al., 
2008, Lauwaet et al., 2011). 
5.4.3.3 Genetic replication protein functions 
5.4.3.3.1 Histone Methyl transferase 
This study detected histone methyltransferase MYST1 (GL50581_2825), an 
assemblage B protein (Manning et al., 2011). This protein has also been reported as a 
protein of interest in the TDR database, www.tdrtargets.org. a chemogenomics 
resource for neglected tropical disease, (Magarinos et al., 2012).  
Histone methyltransferase, a regulatory protein located in the nucleosome of 
eukaryotic organisms appears to operate both in isolation and in combination with 
other proteins. Cell cycling events involving transcription, replication, DNA repair, and 
apoptosis are all mediated by the action of histone methyltransferase.  
5.4.3.3.2 Mismatch Repair Protein. 
Mismatch repair proteins are an integral component of DNA replication and 
recombination to correct transcription errors through nucleotide insertions, deletions 
and repair of damaged or mis-incorporated DNA. Four key steps involve mismatch 
recognition, identification of newly synthesized strand, removal of mismatch segment, 
and gap repair by DNA polymerase. The specific DNA repair pathways which have 
been identified in G. duodenalis include base excision repair, nucleotide excision repair 
and genetic evidence for mismatch repair proteins identified in genomic data by 
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(Morrison et al., 2007). Repair of double-strand DNA breaks in G. duodenalis are 
predominantly performed by homologous recombination and some genes detected in 
other eukaryotes are also present to perform non-homologous end joining repair. 
5.4.3.3.3 Signal recognition receptor particle protein  
Signal recognition receptor particle protein contains ribonucleic acids (RNA) and is 
responsible for transport of membrane and secreted nascent proteins to the 
endoplasmic reticulum (Shan and Walter, 2005) by a mechanism known as co-
translational protein targeting. 
Results from this research identified a signal recognition receptor particle matching the 
core protein GL50581_145, also identified by Manning et al. (2011), although not 
discussed. The dependency on a signal-mediated pathway for molecular transport of 
proteins from the endoplasmic reticulum has been confirmed for soluble cyst cell wall 
proteins (Hehl et al., 2000). The ability to detect a signal recognition receptor particle 
from a water soluble fraction of Giardia spp. infected canine faecal material appears to 
support the concept that an external Golgi complex pathway exists for secretory protein 
sorting.  
5.4.3 Disease and future considerations 
The results shown in Tables 5.3 -5.7 confirm that proteins of G. duodenalis origin can 
be detected in canine faecal material and that highly confident matches to host Canis 
familiaris proteins were also achieved. 
This study has illustrated two interesting aspects of Giardia spp. metabolism, firstly that 
the location of axoneme central apparatus protein within the thioredoxin superfamily 
may suggest that this protein could be involved with metabolic processes during 
replication. Secondly, the mutational changes to the amino acid residues are also 
apparent for the PFOR protein. 
Greater understanding of synthesis and conformational structure of coiled coil proteins 
assists with identifying mechanisms of pathogenesis, such as in viral invasion 
mechanisms (Moutevelis and Woolfson, 2009, Reed et al., 2009). Potential therapeutic 
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intervention (Chan et al., 1998, Mason and Arndt, 2004) for G. duodenalis treatments 
may focus on coiled coil proteins. Additional information about Nek kinase is needed to 
overcome the poorly understood role of this protein family in G. duodenalis metabolism, 
and to document any unique profiles or structures in G. duodenalis isolates infecting 
canines. Understanding evolution and phylogenetic links to other parasites is important 
and applying this information should contribute to a better understanding of protein 
kinase functions and potential as drug targets. 
Canine faecal protein analysis identified potential biomarker proteins for G. duodenalis 
infections, suggesting that proteomics may provide a useful tool for detection of canine 
host responses to Giardia spp. infections. The data will also be useful for directing the 
next steps of future research, seeking to answer questions concerning differentiation 
between G. duodenalis genotypes and inter-species transmission. In particular, the 
information can contribute to pinpointing therapeutic candidates or development of G. 
duodenalis diagnostics. In addition, this may improve our understanding of the 
infectious challenges to the host immune system and changes to gastro-intestinal tract 
environment and function.  
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Chapter 6 
Lactoferrin levels in canine faecal samples 
6.1 Introduction 
Lactoferrin is a bioactive molecule secreted in milk involved with regulation of small 
intestinal development in neonates (Liao et al., 2012). Giardia spp. infections in dogs 
are considered to cause inflammation and one marker of intestinal inflammation is 
lactoferrin (Kane et al., 2003, Halliez and Buret, 2013). 
6.1.1 Protein structure 
Lactoferrin is a single chain glycoprotein, in a folded structure containing two loops, 
each capable of binding ferric iron (III) with a molecular mass of 80kDa. This 
glycoprotein belongs to the transferrin family of iron-transport proteins, and the features 
that distinguish lactoferrin from transferrin are based on the cellular location of each 
protein and the pH of enzyme activity. Lactoferrin operates within a wider pH range, 
capable of retaining iron molecules until the pH reduces to 3.0 or lower (Brock, 2002).  
6.1.2 Cellular location 
Lactoferrin is present in neutrophilic granules of secondary polymorphonuclear cells, 
which release the contents of the granules into body fluids including lacrimal fluid, 
saliva, mucus, bile and breast milk (Eckmann, 2003). Lactoferrin has been associated 
with anti-inflammatory, anti-bacterial, anti-parasitic and innate immune responses. 
Neutrophils are the most abundant white cell type in blood (65%-75% of all leukocytes). 
They form the first response of the innate immune system to challenges by pathogenic 
microbes. Neutrophils originate from pluripotent haemopoietic progenitor cells of the 
bone marrow, where granules are synthesized. Three types of granules, azurophiic, 
specific and gelatinase are found inside neutrophils, and are responsible for phagocytic 
and host defence peptide mechanisms for destruction of pathogens. The contents of 
the granules, including lactoferrin are released to effect damage to the invading 
organism, by the enzymatic action of hydrolase, phosphatase or elastase or in primary 
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granules by anti-microbial peptides such as defensins or cathepsins in humans, 
although there is no evidence for defensins in canines (Shanahan et al., 2011). 
6.1.3 Secretion in milk 
Lactoferrin secretion in lacrimal fluid, saliva, mucus, bile and breast milk has been 
demonstrated in humans and bovines (Adlerova et al., 2008) although some reports 
suggest that canine milk and colostrum does not contain lactoferrin (Vorland, 1999, 
Masson and Heremans, 1971). Although work has now shown that relatively low levels 
of lactoferrin are secreted in canine milk (Berlov et al., 2007, Sinkora et al., 2007) Work 
has also shown the protective effects of cross species lactoferrin in humans (Ochoa et 
al., 2012). Pope et al. (2006) studied the effect of bovine lactoferrin supplements in 
dogs, and found no impact on the health indices recorded during the study. In contrast, 
Hellweg et al. (2008) reported that bovine lactoferrin included in the diet of Beagle dogs 
positively altered cellular immune responses and faecal microbial populations of 
healthy adult dogs. This included increased numbers of monocytes, T cells and 
cytotoxic T cells in the blood and the proliferative response of peripheral blood 
mononuclear cells. 
6.1.4 Biological functions. 
Unlike transferrin where a clear role in iron transport and homeostasis is established, 
no such role has been demonstrated for lactoferrin, although a wide range of functions 
have been proposed (Farnaud and Evans, 2003). It may play a role in iron absorption 
in the newborn infant, although whether it promotes or inhibits this process is 
controversial (Suzuki et al., 2005).  
The principal roles known for transferrin involve homeostasis and iron transportation, 
whereas the entire repertoire of lactoferrin functions are still to be fully determined. 
Lactoferricin, which has a highly basic N-terminal peptide, is the active peptide 
component of lactoferrin. This anti-microbial peptide acts by direct protein or peptide 
interaction with target molecules causing membrane disruption (Farnaud and Evans, 
2003), and is suggested to have potential use as a therapeutic agent  (Brock, 2012).   
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In addition to iron adsorption, other roles acknowledged for lactoferrin are associated 
with innate immune responses and differentiation of mucosal epithelia (Lönnerdal and 
Iyer, 1995). A range of lactoferrin biological functions have been reviewed including 
protein binding to cell membrane DNA and binding to nuclear DNA to activate 
transcription (Kanyshkova et al., 2001). 
The role of lactoferrin as a feedback mechanism and control point for inflammatory 
cytokines is a key feature of it’s role as an anti-inflammatory, and the 
immunomodulation mechanism of increased neutrophil production and degranulation to 
reduce circulating interleukin-1 and tumour necrosis factor released from monocytes 
and macrophages (Vorland, 1999).  
Numerous other functions including anti-inflammatory and immunomodulatory effects 
have been proposed for lactoferrin, including inhibition of tumour cell growth, and 
regulation of gene transcription (Legrand et al., 2005).  
6.1.5 Lactoferrin receptors 
The mammalian small intestine contains lactoferrin receptor sites. It has been 
suggested that serosal iron transport occurs by transferrin binding and that lactoferrin 
mediates iron transport across epithelial membranes in pigs (Liao et al., 2007, Kane et 
al., 2003). Lactoferrin receptors, in infants, specify conditions for proteolytic cleavage, 
when pH levels are slightly higher and iron binding capacity is optimal (Suzuki et al., 
2005). 
General receptors for lactoferrin and transferrin are non-species specific and binding is 
iron dependent (hololactoferrin), whereas specific lactoferrin binding at N terminal sites 
to receptors can occur in the absence of iron (apolactoferrin) (Kanyshkova et al., 2001).  
6.1.6 Faecal lactoferrin detection 
Gastro-intestinal tract physiology and function varies between species (Ajinomoto et al., 
1999) suggesting that specialized adaptations may have evolved due to diet, gut 
microflora, host genetics or, physiological differences. Faecal material is known to 
contain lactoferrin, and is associated with inflammatory processes and has been used 
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as a biomarker for Inflammatory Bowel Disease (IBD) in humans (Walker et al., 2007). 
Lactoferrin has also been reported as an important biomarker distinguishing between 
IBD and IBS in humans (Sidhu et al., 2010) where elevated lactoferrin levels are 
indicative of clinically active IBD, although normative values have not been agreed by 
researchers. Walker et al. (2007) reported that elevated lactoferrin levels were 
observed in clinically well patients who later developed a flare up of symptoms. Faecal 
calprotectin, another inflammatory marker has been used as a biomarker for colon 
cancer (Roseth et al., 1997, Bunn et al., 2001). The stability of lactoferrin in faecal 
samples and the correlation with calprotectin has been recommended for non-invasive 
assessment of gastro-intestinal inflammation in humans (Lamb and Mansfield, 2011).  
6.1.7 Antimicrobial peptides (AMP) 
Recognition of antimicrobial peptides by prokaryotic organisms occurs by a two 
component system within bacterial cell membranes (Ho et al., 2012). These usually 
comprise highly conserved signalling pathways involving histidine kinase and an 
intracellular response regulator, such as BasR in E.coli (Nagasawa et al., 1993). 
Lactoferrin, whilst resistant to proteolytic degradation by trypsin, has been shown to 
contain a different bioactive terminal peptide in humans and bovines (Vorland, 1999, 
Bellamy et al., 1992). These antimicrobial peptides (lactoferricin) from humans (H) and 
bovines (B), products of pepsin hydrolysis, are extremely small (6 – 11 amino acids) 
containing tryptophan and basic residues within a disulphide loop, with arginine 
residues binding to lipopolysaccharide (LPS) sites of the cell membrane (Farnaud and 
Evans, 2003). Recognition and signalling pathways in amitochondriate protists such as 
Giardia spp. are unpublished and the importance of lactoferrin and other antimicrobial 
peptides in canines are undetermined. 
6.1.8 Lactoferrin and Giardia spp. infections 
G. duodenalis, similar to many other parasitic protozoa has an obligate requirement for 
iron to fulfil metabolic processes (Townson et al., 1994, Adam, 2001).  
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Metalloproteins have been demonstrated, in vitro, to be non-immune host defence 
factors, such as the N-terminal peptide of lactoferrin directed against G. duodenalis 
trophozoites (Turchany et al., 1995). Lactoferrin is also known to be associated with 
protein binding in six pathogenic parasitic protozoan infections, providing the organism 
with a potential iron (Fe3+) source (Ortiz-Estrada et al., 2012). Three other 
mechanisms for iron acquisition include proteolytic enzymes to cleave lactoferrin; 
interaction of reductase enzymes to convert lactoferric iron to ferrous form; and 
specialized compounds such as siderophore action in Trichomonas foetus or rhoptry 
proteins in Toxoplasma gondii (Ortiz-Estrada et al., 2012). Lactoferrin as an iron source 
for T foetus is internalised via a receptor mediated endocytosis across a pH gradient to 
release the iron for metabolic processes (Tachezy et al., 1996). Results from proteomic 
analysis of canine faecal samples in Chapter 5 identified lactoferrin in at least one 
sample, as a highly confident protein match.  
6.1.9 Hypothesis 
That faecal lactoferrin is associated with parasite infection when clinical signs of 
infection are observed. 
A commercial antigen kit was used to determine if canine lactoferrin could be detected 
in faecal samples from Giardia spp. infected dogs. Determination of an association 
between lactoferrin levels, clinical signs of infection and presence of other parasites, or 
antigens was performed.  
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6.2 Methods 
Canine faecal samples previously screened for protozoan parasite infections formed 
the basis of this experiment. Samples selected included those positive for Giardia spp. 
infections, with differing levels of cyst intensity from both symptomatic and 
asymptomatic dogs. The samples included those with discordant diagnostic results for 
microscopy and copro-antigen test and some samples that tested negative for Giardia 
spp. but positive for other parasites.  
Canine faecal samples were tested for lactoferrin content using a commercially 
available lateral flow colorimetric immunochromatographic assay (Certest, Zaragoza, 
Spain) designed to detect lactoferrin in human faeces. The test did not detect 
lactoferrin in any of the samples tested and results are not reported here.  
Twenty-three fresh or frozen canine faecal samples were brought to room temperature. 
The Lactoferrin Enzyme Linked Immunosorbent Assay (ELISA) was performed as 
instructed by the manufacturer of Lactoferrin ELISA (BluegeneTM, Shanghai, China). 
Sterile water (300µl) was added to each solid faecal sample, mixed thoroughly and 
then centrifuged for 2 minutes at 1500g to sediment particulates. Aliquots of 100 µl 
were used to perform the assay. Each sample, standard and control was prepared in 
duplicate, adding 100µl of solution to well strips. Phosphate Buffered Saline was used 
as the blank control. Balance solution (10µl) was added to each well containing faecal 
sample supernatant. 50µl of enzyme conjugate was added to each well, except blank 
controls. The plate was placed on a vortex machine for 30 seconds to mix the contents 
thoroughly. The plate was sealed and incubated at 37oC for 1 hour and then wells were 
washed. The wells were refilled with wash solution and washed a total of five times. 
The plates were inverted and the wells emptied of contents by firmly tapping onto 
blotting paper to dry. To all the empty wells, including blank control well, 50 µl 
Substrate A and 50 µl Substrate B was added. The plate was sealed and incubated in 
the dark at 37oC. 
Chapter 6 Faecal lactoferrin 
  221 
After incubating for 15 minutes, 50 µl of stop solution was added to each well, including 
blank control wells to stop the reaction and the contents were mixed thoroughly. The 
optical density was immediately determined at 450nm using a microplate 
spectrophotometer reader. The results were interpreted by plotting standard 
concentrations x axis against the optical density (y axis) to produce a standard curve.  
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6.3 Results  
Sample standards provided in the Canine Lactoferrin ELISA kit (BluegeneTM, Shanghai, 
China) were included with the faecal samples as described in the methods, above. Results were 
used to construct the standard curve shown in Figure 6.1. 
 
Figure 6.1 Faecal lactoferrin standard curve (0-5000pg/ul) 
 
To calculate the concentration of lactoferrin in the faecal samples a linear log plot was produced, 
and the results for individual faecal samples were determined. 
 
 
Figure 6.2 Log plot of faecal lactoferrin concentration against optical density 
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Table 6.1 Calculated concentration of lactoferrin content in canine faecal samples presented with Giardia spp. diagnostic test results 
 Genotype Lactoferrin Microscopy Results Copro-antigen test 1 Clinical signs 
Sample 18S BG GDH pg/ml Giardia spp. Other parasites   
353 - - - >5000 P (1+)  N Symptomatic 
382 C - - >5000 P (3+)  N Symptomatic 
443 - D D >5000 N Cystoisospora sp. N Symptomatic 
445 - - - >5000 N  N Asymptomatic 
317 - - - >5000 P (1+)  P Symptomatic 
466 - C - >5000 P (3+)  P Asymptomatic 
435 D - - 4400 P (3+) Cystoisospora sp. N Symptomatic 
436 - - - 2300 P (1+) Cystoisospora sp. N Symptomatic 
465 - - - 2200 P  N Asymptomatic 
470 A - - 2200 P (3+)  N Asymptomatic 
408 - D D 2000 P (3+)  P Asymptomatic 
478 C - - 1450 P (3+)  P Asymptomatic 
467 D D D 1200 P (4+) Toxocara canis P Asymptomatic 
446 - - - 1100 N  N NA 
455 - - - 1100 N  P Asymptomatic 
469 - - - 1000 P (3+)  N Symptomatic 
462 D - D 900 P (4+) Sarcocystis sp. P Asymptomatic 
325 - - - 800 P (1+)  N Asymptomatic 
316 - C - 600 P (2+)  N Asymptomatic 
329 - - - 600 P (1+)  N Asymptomatic 
441 D D D 400 P (4+)  P Asymptomatic 
471 D D D 370 P (4+) Sarcocystis sp. P Symptomatic 
410 D - - 340 P (4+)  P Asymptomatic 
Table Key: N (Negative), P (Positive) bracketed numbers (Cyst intensity) 
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Some of the samples tested using the canine faecal lactoferrin ELISA were excluded 
and are not shown here as the duplicate results were inconsistent, probably due to the 
length of time the samples had been kept frozen, resulting in loss of bioactivity. 
6.3.1 Comparison of faecal lactoferrin content  
Results are shown in Table 6.1 
6.3.1.1 Highest levels (>5000pg/ml) of faecal lactoferrin 
From 23 samples tested (Table 1), Six samples (6/23, 26%) showed lactoferrin 
concentrations, which exceeded the limits of the test, greater than 5000pg/ml. Of these 
6 samples, 4 (75%) were from dogs with clinical signs of gastro-intestinal dysfunction 
(loose stool form) and 2 (25%) were considered as asymptomatic infections. For the six 
faecal samples that had lactoferrin concentration >5000pg/ml four samples (75%) were 
positive for Giardia spp. cysts, and 2 (25%) were negative for Giardia spp. and one 
(8%) was positive for Cystoisospora sp. infection. 
6.3.1.2 High level (≥2000pg/ml) of faecal lactoferrin 
Five samples (5/23) gave a faecal Lactoferrin content greater than 2000pg/ml, all were 
confirmed positive for Giardia spp. cysts and two were also positive for Cystoisospora 
sp. infection.  
6.3.1.3 Mid range level (>500 < 2000pg/ml) of faecal lactoferrin content  
Nine canine faecal samples (39%) gave a result for faecal lactoferrin content greater 
than 500 but less than 2000pg/ml. Two of these samples (22%) contained no parasitic 
organisms detected by light microscopy, and only one was considered to be from 
symptomatic dogs. 
6.3.1.4 Low levels (≤500pg/ml) of faecal Lactoferrin  
In total, 13% of samples had a faecal Lactoferrin content less than 500pg/ml, and 1 
from symptomatic and 2 from asymptomatic dogs. One Giardia spp. positive sample 
was also concurrently infected with Sarcocystis sp. with faecal lactoferrin content less 
than 500pg/ml.  
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6.3.2 Comparison of faecal lactoferrin content with detection of Giardia 
spp. antigen 
All samples were also tested with Giardia spp. copro-antigen test 1. Ten samples gave 
a positive test result, and 13 were negative results. Of the 10 positive for the presence 
of Giardia spp. antigen 2 were symptomatic and 8 asymptomatic and all contained 
Giardia spp. cysts, confirmed by light microscopy.  
Three samples (3/10, 33%) that tested positive with Giardia spp. copro-antigen test 1 
also had faecal lactoferrin levels in excess of 2000pg/ml and 1/3 (33%) was 
symptomatic. In addition, two of these samples with high levels of faecal lactoferrin and 
considered to be symptomatic, were concurrently infected with Cystoisospora sp. 
6.3.3 Comparison of faecal lactoferrin content with Giardia spp. 
genotype 
The results indicate that all but one of the samples tested and genetically characterized 
were host specific Giardia spp. Assemblage C or D infections and that lactoferrin 
content ranged from 340 - >5000 pg/ml. The single faecal sample genotyped as 
Assemblage A tested for lactoferrin gave a result of 2000pg/ml. 
6.4 Discussion 
The results presented here demonstrate that faecal lactoferrin levels were detected in 
dogs infected with protozoan parasites, and the highest levels detected occurred in 
faecal samples containing Giardia cysts. Faecal lactoferrin level is not currently a 
parameter used by veterinarians to indicate clinical signs of parasite infections. The 
results from this study suggest that canine Giardia spp. infections may be associated 
with the presence of lactoferrin in faecal samples. Further validation is required, 
especially with uninfected dogs, and a possible indicative value of 300pg/ml threshold 
level. Confirming a threshold value holds merit as it is likely that lactoferrin is present in 
uninfected faecal samples. The ability to measure differences and elevated levels of 
faecal lactoferrin is important in the diagnosis of inflammation and to determine 
potential causes, such as parasite infections.  
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Pathogenic and physiological changes to intestinal enterocytes include disruption of 
tight junction proteins, ion hypersecretion, apoptosis, luminal fluid accumulation and 
disaccharide deficiencies (Cotton et al., 2011). Large amounts of faecal lactoferrin are 
suggestive of intestinal inflammation, with the host responses to infectious challenges 
inducing lactoferrin secretion as physiological mechanism for modulating immune 
responses to Giardia spp. infections (Legrand et al., 2005). Further work is required to 
confirm findings of this study. Such work may include host genetic traits to determine if 
the host is pre-disposed to Giardia spp. infections and lacks the ability to mount an 
effective response, as described for Irish Setters with granulocytopathy syndrome 
(Renshaw and Davis, 1979). 
The results from proteomic analysis in Chapter 5 identified a range of faecal 
immunoglobulins and IgA has been shown to be present in canine faeces, at four times 
the level circulating in serum (Reynolds and Johnson, 1970). In a more recent study, 
no association was found upon comparison of immunoglobulin content in the serum 
and faeces of gerbils however, the timing of elevated levels of immunoglobulin 
secretion were related (Amorim et al., 2010). Reports in the literature suggest that 
ingestion of bovine lactoferrin by mice causes both innate and humoral responses 
(Debbabi et al., 1998). This study in dogs provides further evidence associating 
lactoferrin with immunoglobulin secretion in the gastro-intestinal tract. 
Recent studies examining G. duodenalis infections in humans suggest that faecal 
lactoferrin levels reduce overtime and maybe associated with protection against 
severity of clinical signs of infection (Kohli et al., 2008). Brock (2012) refers to 
differences in host anti-parasitic mechanisms by the action of lactoferrin for mitigation 
of Giardia spp. parasite infections, rather than by iron deprivation. Recommendations 
for further work to establish the roles of lactoferrin in parasitic infections, as iron is 
known to be a nutritional requirement for G. duodenalis growth and replication have 
been recommended (Davids et al., 2011, Brock, 2012). Earlier studies seeking 
diagnostic methods for distinguishing between inflammatory and non-inflammatory 
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diarrheal infections used faecal lactoferrin as a marker of fecal leukocytes (Guerrant et 
al., 1992). The importance of lactoferrin described by Kanyshkova et al. (2001) as an 
acute phase protein is the use of this glycoprotein as a biomarker of IBD infections in 
humans (Lamb and Mansfield, 2011).  
Whilst the results presented here are from only a small sample size, from a dog owner 
or veterinary practitioners perspective, addressing problems of diarrhoea in dogs is 
important. Due to the presence of asymptomatic infections this may require the 
combination of a rapid copro-antigen test for Giardia spp. with a faecal lactoferrin test, 
where a positive titre >2000pg/ml may indicate an anti-inflammatory response to 
protozoal parasite infections. Those samples positive for Cystoisospora spp. produced 
results indicating consistently high levels of faecal lactoferrin content, even when 
Giardia cysts were not observed. The results of this work confirm the approach of 
seeking routes to assess intestinal disturbances and further understand host-parasite 
interactions. Development of a biomarker panel may be more appropriate for 
confirming Giardia spp. infections in dogs. 
Whilst the exact requirements for iron of this amitochondriate parasite, remain unclear, 
in contrast to T. foetus and T. vaginalis where differences in lactoferrin and transferrin 
requirements as an iron source have been attributed to physiological location with the 
host (Tachezy et al., 1996). Detection of lactoferrin is an indirect measure of 
inflammation, and greater understanding of parasite localization within the digestive 
tract could contribute to improved understanding of sites of inflammation and anti-
inflammatory mechanisms. The bioactive lactoferrin glycoprotein regulates immune 
system responses to infectious challenge. Its structural confirmation also facilitates 
interaction with host cells, in addition to an ability to utilize antimicrobial properties 
within biofilms (Ammons and Copié, 2013). These factors are evidence of a potent ant-
inflammatory role, thus the levels of lactoferrin present and its role in physiological 
processes inversely reflect the measure of inflammation. This study suggests that 
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further investigation into canine lactoferrin is justified, especially as the anti-microbial 
peptides found in canines are uniquely different to those found in humans. 




This study, the first of its kind, has demonstrated the use of proteomic tools in detecting 
parasite proteins of a pathogenic protozoan from infected canine faecal samples, and 
has provided a greater understanding of the dynamics of Giardia spp. infections in 
dogs. In addition, detection of host proteins has enabled tentative comments to be 
made concerning host-parasite interactions and impacts of Giardia spp. infections on 
the canine host. 
This chapter discusses the research findings in six sections, the first of which examines 
results concerning accurate detection of Giardia spp. infections in canine faecal 
samples, including the impact of Giardia spp. infections in dogs with reference to 
patency, polyparasitism and clinical signs of infection. The second section discusses 
the potential zoonotic transmission of Giardia spp. The overall findings from using 
proteomic tools for the phenotypic characterization of Giardia spp. infections in dogs is 
presented in section three. This section comments upon the methods and aspects of 
the unique faecal proteome as an interface between the canine host and this protozoan 
parasite and also reflects on the proteomic information obtained from faecal samples 
and their relevance to the cellular and molecular interactions occurring in the gastro-
intestinal tract. 
The fourth section offers some considerations for the management of Giardia spp. 
infections in dogs, and the final sections includes comments on the limitations to study 
design and suggests areas for further research in the future. 
7.1 Impact of Giardia spp. infections on dogs 
Giardia spp. prevalence rates reported in this study were high, at 29-75% in litters of 
puppies, as shown in Table 2.3.2. If the accepted prevalence rate of 10-20% in dogs 
from other published reports is correct, and includes both symptomatic and 
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asymptomatic infections, this may continue to be an under-estimation if microscopy is 
used as the diagnostic standard (Palmer et al., 2008). 
This study has provided further details of dog (C. familiaris) susceptibility to Giardia spp. 
infections and evidence that enteric protozoan infections can cause both clinical and 
subclinical signs of infection in naturally infected populations. The data supports and 
adds to findings by other researchers that immature dogs are susceptible to Giardia 
spp. and other enteric protozoan infections (Batchelor et al., 2008, Epe et al., 2010, 
Itoh et al., 2011). The pre-patent period of less than 17 days, the earliest recorded 
detection of patent Giardia spp. infection in puppies confirmed during this study, is 
similar to preliminary findings of Barutzki and Schaper (2013) who reported detection of 
Cystoisospora sp. and Giardia spp. in the fourth week of life. The data collected on 
faecal cyst intensity indicates that during the time of patent infection the numbers of 
excreted cysts can be high, which perpetuates infection and re-infection of littermates 
and the maternal dam. The high level of cyst excretion occurs especially at the 
weaning stage (40 - 50 days of age), when the quantity of maternal milk intake reduces, 
along with protective factors in milk such as immunoglobulins (Heddle and Rowley, 
1975). This reduction in dietary intake of immunoglobulins and protective factors is 
accompanied by a reduction in immunoglobulin levels in nasal secretions of puppies 
(German et al., 1998, Schafer-Somi et al., 2005). Thus the potential for resisting 
infectious challenges dramatically changes in the post-weaned canine host. The 
significance of this window of opportunity for parasite infections is a key element in 
transmission routes and also likely to be similar for other mammalian hosts, including 
human infants. 
Whilst the work here investigated Giardia spp. infections in neonatal puppies, it is 
relevant to other hosts of Giardia spp., such as young children. The long-term 
implications of sub-clinical infections have yet to be determined. Signs of Giardia 
infections such as poor appetite, low weight gain or general malaise have been 
reported in both dogs and children (Sackey et al., 2003, Leticia Eligio-Garcia et al., 
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2005). In children there are reports of associated impairment of cognitive function in 
addition to the impact of overt clinical signs reducing attendance at school and thus 
contributing to reduced educational opportunities and barriers to achieving academic 
potential (Thompson, 2001, Berkman et al., 2002, Cotton et al., 2011, Halliez and Buret, 
2013). One of the important results from this study, discussed in section 3.4.5 is the 
demonstration that neonatal infections are likely to be of maternal origin. 
7.1.1 Diagnostic tools  
In a clinical setting it is important for cases presenting with gastro-intestinal signs of 
infection to undergo diagnostic panel tests for parasites, particularly protozoan 
parasites Giardia spp. and coccidian infections, to eliminate these as a source of 
gastro-intestinal signs of infection.  
This study therefore, focused on investigating the impact of Giardia spp. infections in 
dogs with a high risk of infection (Thompson, 2000) as explained more fully in chapter 
2. A number of diagnostic techniques were compared to provide insight into the 
reliability and suitability of their use for identifying Giardia spp. infections in dogs and 
differentiating between host specific and potentially zoonotic infections. 
In the absence of a validated gold standard diagnostic method for Giardia spp., results 
from this study indicate that initial diagnostic screening of canine faecal samples 
should include centrifugal flotation and examination by light microscopy to ensure that 
the presence of all parasitic organisms are recorded. Observation of Giardia cysts is 
the definitive confirmation of patent Giardia spp. infections. However, in instances 
when Giardia cysts are not observed by microscopy, sequential testing using copro-
antigen or molecular methods can be used to accurately confirm Giardia spp. infection 
status, as performed in this study. However, the issue of intermittent cyst shedding 
(Lopez et al., 1980) remains unresolved, and best practice standards of collecting three 
consecutive samples may be impractical in many situations. Liquid or semi-liquid stools 
are difficult to collect, and two of the copro-antigen tests used in this study are both 
portable and practical for collection of samples using dropper or swab, easily 
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overcoming obstacles to traditional faecal sample collection. In situations with limited 
faecal material available diagnosis of Giardia spp. infections may be more conveniently 
confirmed using a copro-antigen test and PCR with DNA sequencing. Nevertheless, 
importantly, this study has demonstrated confirmation that Giardia spp. infections are 
not the exclusive cause of clinical signs. In cases exhibiting diarrhoea or mucus in the 
stool these clinical signs may not be caused solely by Giardia spp., with the potential 
for misdiagnosis. In addition, despite the fact that Giardia spp. infections may not be 
the cause of clinical signs of infection, two thirds of dogs tested were considered 
symptomatic and one third asymptomatic, based upon stool consistency. The data 
presented here conflicts with reports by Barutzki and Schaper (2003) suggesting that 
host specific Giardia spp. assemblages are associated with clinical of clinical signs of 
infection in dogs. This new information is in disagreement over the definitive cause of 
symptomatic cases of diarrhoea in dogs infected with enteric parasites. Limitations 
exist when Giardia spp. diagnosis relies solely on copro-antigen tests. The presence of 
antigen may not indicate active infection, and may overlook other parasitic infections. 
Results from this study suggest that copro-antigen tests may preferentially select for 
particular Giardia spp. genotypes or stages of infection. Whilst manufacturers of the 
copro-antigen tests report 95% sensitivity and 95% specificity, there is no indication in 
the test protocol of the population descriptors used to determine positive predictive 
value and negative predictive value, both of which are affected by prevalence rates. 
The importance of diagnostic validation for infectious disease is one that is equally 
important within veterinary and medical fields (Whitfield et al., 2005, Gardner and 
Greiner, 2006, TDR Diagnostics Evaluation Expert Panel, 2010). 
Moreover, the importance of accurately observing and describing clinical and sub-
clinical signs of infection are critical, both in terms of risks of infection, transmission and 
management strategies. 
In conclusion, whilst a range of diagnostic tests are currently available for confirming 
Giardia spp. infections in canines none of these are capable of determining the 
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infection status, new, active, post-infection or recrudescent infections. This type of 
information, together with identifying markers of Giardia spp. infection are important 
and proteomic tools may provide the next phase of infection information.  
7.1.2 Concurrent Giardia spp. infections and clinical signs of infection 
Results from this study show that faecal coproscopy is important for detection of 
coccidian parasites, and the high prevalence rates are in concordance with results of 
others in Australia and elsewhere (Palmer et al., 2008, Itoh et al., 2011). Diagnostic 
tests for coccidian parasites currently rely mainly upon microscopy techniques, with 
some genetic descriptors using PCR and immuno-antigen based tests. Nonetheless, 
the fact that increased likelihood of clinical symptoms occurs with Cystoisospora spp. 
suggests that development of tests for the specific detection of Cystoisospora spp. 
should be addressed, as this is a common infection in pigs and poultry with multiple 
reports in dogs (Barutzki and Schaper, 2003, Itagaki et al., 2005, Becker et al., 2012, 
Mircean et al., 2012). 
The presence of Sarcocystis spp. in dogs from Western Australia may also be due to 
the geolocality. Earlier evidence has reported that climate regions of high moisture in 
south Western Australia produced high prevalence rates of Sarcocystis spp. in cattle, 
(Savini et al., 1992). Early detailed descriptions and taxonomic classification of 
Coccidians were performed both in terms of morphology and their tissue localization 
(Levine and Ivens, 1965, Levine, 1973). Now, equipped with genetic information it is 
timely to reassess this information at a species level and combine it with genetic data, 
missing from these earlier studies to fully understand the impact of these parasite 
infections in dogs (Tenter et al., 2002). 
The presence of Giardia cysts in faeces indicates an active infection, but is the number 
of cysts important? What is the significance of the cyclic occurrence of cyst excretion? 
Studies in Colombian children divided cyst excretors into three groups (high, low or 
mixed), and although there was limited understanding of what the implications were 
these did highlight the need for multiple samples to confirm an infection. Importantly, 
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this study concluded that clinical symptoms of diarrhoea did not correlate with quantity 
of Giardia cysts or trophozoites excreted in faecal material (Danciger and Lopez, 1975).  
The value of being able to grade levels of cyst excretion is an important reason for 
retaining microscopy as the standard for Giardia spp. diagnostics, at least until the 
significance of different excretion levels is understood. In addition, as this study has 
demonstrated, visualization of parasites by light microscopy provides information on 
other enteric parasites, many of which would otherwise remain undetected if tests 
relied solely on genetic or antigenic factors to confirm or rule out the presence of a 
Giardia spp. infection. 
7.1.3 Significance of coccidian infections 
This study has demonstrated differences in clinical signs of infection, between parasite 
co-infections and the different Giardia spp. genetic assemblages in some populations 
studied, such as the predominance of host specific assemblages. It is a preliminary 
investigation and there are difficulties in assessing phenotypic differences attributed to 
the presence or absence of co-infections. However, all the faecal samples used for the 
proteomic analysis were not infected with any parasites other than Giardia spp. Some 
questions raised in relation to concurrent parasite infections within the dynamics of 
host microbial interactions concern 1) whether interactions occur between different 
species and 2) whether the presence or absence of single or multiple infections are 
influencing phenotypic traits (Bradley and Jackson, 2008). The work presented here 
suggests that co-infections between different parasite species may involve competition. 
The timeline displaying temporal dynamics of patent parasite infections shows that 
some species, including Giardia spp. are present, then absent then reappear again. 
Similar observations reported in the literature concern parasitism of other organisms 
and the potential for manipulative parasites to induce phenotypic changes to favour 
transmission (Leung and Poulin, 2007, Lefèvre et al., 2009, Thomas et al., 2011).  
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7.2 Evidence for zoonotic transmission  
The results of this study suggest that potentially zoonotic assemblages are infective to 
neonatal puppies if there is exposure, such as from the maternal dam or environment. 
Despite the regular sampling used throughout the sampling period, the constraints of 
pooled sample collection from litters of puppies meant that this study was unable to 
confirm if two different genetic assemblages were causing simultaneous infections. 
From all the successfully sequenced DNA samples, only three distinct Giardia spp. 
genotypes were detected in this study, using multiple gene loci. This genetic 
information revealed predominantly host specific genotypes of Giardia assemblages C 
and D. In addition to these host specific infections DNA sequencing results also 
showed evidence of both assemblage A and mixed infections of Giardia spp.   
Evidence for genetic descriptions of assemblage B in this study was lacking, but the 
presence of Assemblage A can be considered to be a potentially zoonotic infection.  
7.2.1 Molecular genetics 
PCR results and genotyping of Giardia spp. infections showed mainly host specific 
infections, although the results are not conclusive, which confirms similar reports by 
Berrilli et al. (2004), Upjohn et al. (2010) and Uehlinger et al. (2013).  
The problems in obtaining consistent results for Giardia spp. genotyping of 
Assemblages A and B despite using multi-locus genotyping are not exclusive to this 
study (Caccio and Ryan, 2008, Wielinga et al., 2011, Huey et al., 2013). A number of 
strategies may be appropriate to resolving the complexities of definitive and consistent 
genotyping of Giardia spp. isolated from canines. These include reconsidering the use 
of additional gene loci or revisiting alternative loci, such as IGS (Hopkins et al., 1999, 
Lee et al., 2006). In addition, improved methods for DNA extraction, as recently 
highlighted by Uda-Shimoda et al. (2014) and for GDH loci (Nantavisai et al., 2007). 
The efficiency of cyst lysis is an important step in molecular genetics and studies have 
indicated that Proteinase K cleaves the peptide bonds of aliphatic and aromatic amino 
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acids which compose the cyst cell wall, although attention to optimal conditions are 
important (Harris and Petry, 1999, Adamska et al., 2011). Moreover, consideration of 
cyst intensity is an important factor for genetic analysis of faecal material and a suitable 
threshold value may be important for obtaining consistent PCR results (Wielinga and 
Thompson, 2007). The promising results from proteomic mapping described in Chapter 
5 have highlighted candidate proteins suitable for further investigation and to explore 
proteomics approaches for genetic characterisation with increased precision (Gupta et 
al., 2008, Ansong et al., 2008, Castellana and Bafna, 2010). 
7.3 Phenotypic expression of Giardia spp. infections in canines  
The proteomic approaches used in this study are unique in attempting to profile 
biological manifestation of parasitic disease. Studying the faecal proteome using mass 
spectrometry techniques is a non-invasive method and captured details of the 
physiology of a single animal at a particular time point. The proteomic approach used 
in this study sought to detect peptides rather than intact proteins. Using the database 
matching software it was possible to match peptide sequences to whole proteins.  
7.3.1 Parasite faecal Proteome  
This research has shown that whole faecal material infected with Giardia cysts can 
provide a useful window into understanding the biology of Giardia spp. lifecycle events. 
The benefits of this novel proteomic approach to examine infected faecal samples by 
following methods for mass spectrometry peptide detection described earlier in this 
thesis, has identified Giardia spp. proteins and peptides. Further work using these 
methods and also Giardia spp. purified cysts directly isolated from faecal material may 
extend this knowledge, especially in light of concerns over the validity of data obtained 
using cysts generated from in vitro cultures (Faghiri and Widmer, 2014). 
Results of the parasite faecal proteome include proteins associated with RNA binding 
and pre-RNA splicing factors that are of particular interest and relevance in potential 
parasite infective mechanisms. Some Giardia spp. are known to be infected with 
Giardia lamblia virus (GLV) a specific double stranded (ds) RNA virus (Wang and 
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Wang, 1986, Tai et al., 1993). Viral infections of axenic cultures of Giardia spp. have 
been shown to occur in isolates from particular geographical areas, and are more 
frequently detected in cultures kept over long time periods, suggesting that a process 
of adaptation may occur (De Jonckheere and Gordts, 1987). Studies of two different 
axenic Giardia spp. cultures, one infected with GLV and a second uninfected isolate 
susceptible to GLV infection showed that an intermediary single strand RNA is present 
functioning as viral mRNA (Furfine et al., 1989). This virus (GLV) may have evolved to 
be a key transporter of genetic material, or alternatively the organism may induce 
expression of a prion (Riesner, 2003, Leiman et al., 2009). GLV may be one factor 
responsible for alteration of transcription processes causing nucleotide substitution at 
intrahost level. The critical importance of this type of selective amino acid changes 
initiated by virus or virus-like particles have been proposed in the context of lateral 
gene transfer mechanisms of RNA viruses and immune evasion strategies (Holmes, 
2009). Single strand RNA is known to be a method of host cell penetration used by 
other organisms, such as plant nematodes or parvovirus (Parrish, 2010, Hewezi et al., 
2012). This type of novel transfer of genetic material has been reported for 
Mycoplasma and Rhizobium species and is considered a transcriptional process 
unique to these organisms (Nakagawa et al., 2010, Liang et al., 2013). There is a 
possibility that there may be some similarities with Giardia spp. infections, with critical 
control points controlled by transcription factors necessary for initiating the transcription 
process. Recently three novel proteins have been implicated as regulatory transcription 
factors during encystation ARID/Bright-like Protein (Wang et al., 2007, Pan et al., 2009, 
Su et al., 2011).  
One hypothetical protein identified in this study was related to RNA binding and pre-
RNA splicing factors, which may be associated with Giardia spp. trophozoite replication, 
or alternatively may be a mechanism for attachment, possibly through a single 
stranded RNA mechanism. Single strand DNA viruses, such as parvovirus are reliant 
upon host DNA polymerase for replication (Holmes, 2009). 
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The factors that are associated with successful trophozoite attachment that causes 
infection remain only partially explained, but this new approach has presented some 
potential explanations. Whilst the understanding of the parasite’s biological system and 
unique attributes of Giardia spp. are evident in the cell wall structure, binuclear and 
tetranuclear cells and cell division processes, the processes of transcription and 
translation of genetic information are only slowly being elucidated. Genes for five 
enzymes associated with cell wall synthesis are induced at the transcriptional level 
(Lopez et al., 2003) and further work is required to fully understand the role of 
transcriptional processes in gene organization and regulation (Teodorovic et al., 2007, 
Padmaja et al., 2010). Outcomes from this research have provided some insight into 
the types of molecular mechanisms that occur, previously existing only as predictions 
from genomic studies. 
Detection of tRNA/rRNA cystosine methylase in this study and the significance of this 
enzyme’s involvement in replication mechanisms in Giardia spp. are yet to be fully 
determined. Bioinformatic analysis of G. duodenalis genome data has failed to identify 
protein arginine methyltransferase genes, despite their presence in other protozoans 
and eukaryotes (Krause et al., 2007, Fisk and Read, 2011). In the absence of these 
proteins the regulatory mechanisms for cellular processing in Giardia spp. is uncertain 
and control of transcription, RNA processing, DNA replication and repair, and signal 
transduction have been suggested to operate under alternative systems, such as 
adenovirus transcription factor (Su et al., 2011). The value of proteomic data greatly 
adds to the genomic dataset that has predicted the existence of genes but where 
confirmed protein expression remains absent. 
7.3.1.1 Giardia spp. life cycle transition between cyst and trophozoite 
Aspects of the Giardia spp. life cycle that remain poorly understood are signalling and 
stages of encystation in human and other host species. This includes the specific 
localization in the digestive tract for potential trophozoite attachment and the 
subsequent encystment processes. Franzen et al. (2009) propose that some Giardia 
Chapter 7 General Discussion  
 239 
spp. genotypes infecting humans are lacking encystation specific genes thus affecting 
excretion numbers, the ability for detection and potential infectivity. This finding 
supports research which reported difficulties encountered with attempts at in vitro 
encystation and excystation (Lauwaet et al., 2007, Ratner et al., 2008). A comparative 
study recommended in vivo methods for Giardia spp. excystation as the method of 
choice (Isaac-Renton et al., 1992). More recently, this was supported in findings from 
transcriptional profiling of Giardia spp. cysts lacking an overlap in results from in vitro 
and in vivo sources of cysts (Faghiri and Widmer, 2014). The approach taken in this 
study has been to examine molecular characteristics of Giardia spp. in situ. The canine 
faecal samples constitute the final stage of in vivo processes containing cysts, the 
infective form of this protozoan parasite. The results reported here complement the 
work of other scholars and advance the knowledge of Giardia spp. proteins. 
7.3.2  Host faecal proteome (Canis familiaris) 
A panel of host (canine) proteins identified in this study are involved with inflammation, 
cell adhesion and immunomodulation, and additional sampling and proteome profiling 
would further extend the current knowledge.  
7.3.2.1  Immune response proteins 
The preliminary dataset (Table 5.8) reported in Chapter 5 confirms earlier work that 
canine faecal material does contain a vast array of immune proteins (Reynolds and 
Johnson, 1970). Further detailed investigations are required to determine the types and 
significance of the immune proteins detected.  
Whilst this study did not collect data concerning the immune status of individual 
animals, such as circulating immunoglobulin levels or types of lymphocytes or 
macrophages, observations can be made about the age when parasite infections 
occurred and potential impacts on growth and development. Considering that samples 
were collected from puppies ingesting maternal milk as the sole nutrient source up until 
the weaning stage it is likely that protective factors are maternally derived. During this 
period microbial colonisation of the digestive tract commences whilst development and 
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maturation of the small intestine are induced by dietary content. Post-weaning, the 
combined effects of growth and dietary changes accompanied by a reduction in 
maternal antibodies stimulates immune function. Internal receptors serve to signal 
presence of ‘foreign’ xenobiotic agents such as parasites and other microflora, 
including viruses and other common canine infections. It is unknown if innate immune 
system reduces immune factors in response to single infectious challenges or in a 
synergistic mechanism.  
Whilst ever increasing information has become available for improved understanding of 
the human and murine immune responses to injury and infectious disease as defence 
mechanisms. There remains limited knowledge for other common species, such as 
companion animals, including dogs (C. familiaris) (Linde et al., 2008). The alpha 
defensins, anti-microbial proteins of the human and murine immune systems, are 
absent in cattle and dogs (Shanahan et al., 2011). To date, the immune system of the 
dog is known to possess three different beta defensins, one cathelicidin (K9CATH) and 
a hormonal peptide canine hepcidin (Fry et al., 2004, Sang et al., 2005, Sang et al., 
2007) but no studies have yet identified any canine intestinal tract anti-microbial 
peptides (AMP).  
In the context of Giardia spp. infection and its ability to infect a wide range of species, 
plus the presence of frequently occurring cross species infections, a detailed 
understanding of the host response mechanisms is essential.  Further studies into anti-
Giardia spp. effector mechanisms in humans suggested by Singer (2011) could also 
include a focus on species-specific host-parasite protein interactions.  
Patil et al. (2004) provided examples of differences and relationships in the types of 
beta-defensins immune responses with evidence for cross-species groupings. His 
phylogenetic study demonstrated distinct evolutionary lineage of AMP between groups, 
one for dog and rodent specific peptides; another for primate and dog specific 
peptides; and a rodent specific and dog specific groups of defensins. This suggests 
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that host specific infectious weaponry may provide a link to understanding the reasons 
for differences between host specific and cross species infections.  
Improved understanding of immune function responses, particularly secretion of 
immunoglobulin A and associated protein production by plasma cells and lymphocytes, 
such as lactoferrin may provide further information about the attachment and disease 
processes of Giardia spp. (Ordaz-Pichardo et al., 2013). Antimicrobial peptides 
including lactoferricin B have been implicated in the depolarization of cell membranes 
in order to penetrate and target intracellular macromolecule synthesis (Ho et al., 2012). 
7.3.2.2  Host microbiome 
Composition of the gut microflora directly affects host physiology (Zoetendal et al., 
2011). This study, whilst concentrating on Giardia spp. proteins also generated 
proteomic information concerning other non-parasite proteins, many matching to 
prokaryotic organisms consistent with normal faecal microbial composition, however 
further analysis of the data is warranted. Studies have demonstrated that molecular 
patterns of microbial and pathogenic organisms (MAMP /PAMP) invoke immune 
responses in colonic epithelial cells of canine hosts (Swerdlow et al., 2006). Molecular 
mechanisms proposed for mammalian innate immune responses to MAMP /PAMP are 
suggested to occur through membrane bound Toll receptors and cytosolic nucleotide 
binding sites with distinctive leucine rich repeats (LRR) (Medzhitov, 2001, Inohara and 
Nunez, 2003, Akira et al., 2006). These LRR are a unique feature of protozoan 
parasites, associated with immune responses (Boceta et al., 2000, Mcguinness et al., 
2003, Kedzierski et al., 2004a, Loftus et al., 2005, Daher et al., 2006) and form an 
integral component of Giardia spp. cell wall proteins (Lujan et al., 1995, Luján et al., 
1997). Expression of IL-7 has shown to be induced in canine cell lines associated with 
LPS of bacterial organisms and glycosylphosphatidylinositol in protozoan parasites 
(Ropert et al., 2001, Swerdlow et al., 2006). 
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7.3.3 Host-parasite interactions 
Results reported here for the Giardia spp. faecal proteome were developed during this 
study seeking to assess the association of clinical signs with Giardia infections. 
Following preliminary results from proteomic analysis one specific protein was selected 
for further study. This protein, lactoferrin, was considered a potential indicator of 
pathogenic infection based upon detection as one component of the canine host faecal 
proteome. Reports in the literature suggest a high likelihood that inflammation is 
occurring as a consequence of parasitic infection. Mammalian host remediation of 
inflammation occurs through secretion of lactoferrin (Vorland, 1999, Farnaud and 
Evans, 2003). Whilst the results from this preliminary study are limited, the results are 
promising and follow up studies should be carried out. These should include a 
reference control group of mature well cared for dogs as a comparative negative 
control group, and triplicate confirmation of control animals being free from Giardia spp. 
And other parasite infections using microscopy, antigen and genetic evidence. More 
importantly, the elevated lactoferrin levels detected in this study need further 
examination to distinguish the causes of any inflammatory processes originating from 
Giardia spp. infection or from the coccidian infections. The early exposure to intestinal 
parasites must affect the developing immune system possibly through tolerance or 
protective immune mechanisms, which may also be affected by different Giardia spp. 
genotypes (Emery et al., 2014). 
7.3.3.1  Lactoferrin 
Studies in humans have demonstrated the immunomodulatory effect of lactoferrin and 
its relationship with secretory IgA (sIgA) in breastfed babies (Hogendorf et al., 2013). 
The immunomodulatory function of lactoferrin in maternal milk promotes t-cell 
proliferation, maturation and differentiation and is involved with B-cell maturation to 
antigen presenting cells (APC). In addition, iron binding by lactoferrin deprives 
pathogenic bacteria of an iron source reducing bacterial infections. Other studies also 
suggest innate immune processes are less likely to be affected by antibodies, and 
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rather that protective functions are conferred by oligosaccharides present in human 
breast milk as fucosyloligosaccharides (Newburg et al., 2004). Humoral immune 
responses to infection have also recently been shown to cause increased leukocyte 
production in human breast milk (Hassiotou et al., 2013). Maternal genotype confers 
variation in the glycoconjugate structures ultimately resulting in tissue wide modification 
of carbohydrate receptor sites. These genetic variations in carbohydrate receptor sites 
arise from polymorphic mutations, partially controlled by Lewis blood group genes in 
utero, in the developing foetus, and consequently provide protective functions to 
suckling neonates by impeding access to intestinal binding sites by pathogenic 
organisms such as Giardia spp. and bacteria (Newburg et al., 2004). Development of 
the canine immune system does not mirror that of Homo sapiens and further studies 
are warranted to determine the relationship between lactoferrin and immune processes. 
7.3.3.2 Secretory IgA 
One important immunoglobulin present in milk and secreted in the small intestine is IgA, 
where the secretory form is bound to a component to prevent proteolysis. Secretory 
IgA is considered to provide passive immune protection and its relationship with 
lactoferrin and lysozyme has been investigated in human subjects (Hennart et al., 
2002). New research has shown that the structure and function of sIgA may vary 
between species (Woof and Russell, 2011). Lagomorphs, such as rabbits possess 
thirteen genes coding for alpha heavy chain constant region immunoglobulin A in 
contrast to the one or two genes found in humans, primates and other mammals (Woof 
and Russell, 2011). Four allelic variants have been detected in the structure of canine 
IgA (Peters et al., 2004). The significance of these genetic – phenotypic differences is 
unclear, although variation between different dog breeds is believed to affect humoral 
immune system responses (Tengvall et al., 2013). 
7.3.3.3 Novel peptides 
This study identified both structural and metabolic proteins. Whilst it is known that 
cytoskeleton components play a role in cell cycle transitions, some of the specific 
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protein expression pathways occurring during excystation and encystation however 
remain undescribed. Consequently, this study is only able to suggest that the structural 
and metabolic proteins detected are associated with Giardia spp. cell cycle regulation. 
Evolution of eukaryotic membrane trafficking mechanisms has been described (Dacks 
and Field, 2007) including functions for specialized GTPases, SNARE and, Rab 
proteins, none of which were identified here. The possibility of a cytoplasmic IFT-
independent mechanism for axoneme assembly and IFT-mediated assembly for 
membrane bound axoneme components of Giardia cytoskeleton (Dawson, 2011a) may 
be associated with the ESV protein packaging and transport mechanism previously 
described by Reiner et al. (1990), Marti and Hehl (2003) and Touz (2012). Movement 
of proteins from ESV to the peripheral vacuole has been illustrated and mobilisation of 
innate immune factors are also associated with the membrane and endoplasmic 
reticulum (Hayakawa et al., 2004, Godfrey et al., 2006, Faso and Hehl, 2011, Wampfler 
et al., 2014). 
Detailed molecular analysis of Giardia cell wall proteins have been published using 
Green Fluorescent Protein (GFP) (Hehl et al., 2000). Fluorescent tagging of IFT 
flagellar proteins combined with measuring rates of protein turnover, as a function of 
flagellar length, can be performed with total internal reflection fluorescence (TIRF) 
microscopy (Engel et al., 2009). This technique has also been used to investigate and 
describe Giardia spp. adhesion (House et al., 2011). Holmberg and Nollen (2013) 
provide the methods and protocols for analysis of protein aggregates using Native 
Agarose Gel Electrophoresis (NAGE) with fluorescent labelling. Future proteomic work 
investigating Giardia proteins or genetics may contribute to advances in knowledge 
when combined with these techniques and other methods used for Giardia spp. cell 
wall protein analysis using species specific DNA probes (Graczyk et al., 2003, 
Erlandsen et al., 2005). 
Fragments of bacterial flagella have been shown to be highly potent immunogens and 
studies using rats have demonstrated induced immune tolerance to flagellin proteins 
Chapter 7 General Discussion  
 245 
(Parish et al., 1969). In cases of canine inflammatory bowel disease one risk factor 
identified is nucleotide polymorphisms affecting TLR 5 signalling. Hyper-
responsiveness to flagellin has been reported for susceptible haplotypes contributing to 
clinical signs of IBD whilst TLR 5 sensing of flagellin may also be a key factor for 
maintaining homeostasis (Kathrani et al., 2012). Conversely, TLR 9 expressed on 
intestinal epithelium cell surfaces play a key signalling role for optimal responses to 
oral infection and vaccination mediated by the DNA of commensal organisms of the gut 
microflora (Hooper et al., 1999, Hall et al., 2008). It remains unclear if similar 
associations between signalling and immune responses are present in response to 
Giardia spp. flagellar protein fragments. 
This study detected seven hypothetical Giardia spp. proteins and seven hypothetical 
proteins of host origin. These were highly confident results with multiple peptides 
detected. One of the hypothetical Giardia spp. proteins (C6LS33) was identified with a 
high protein score and 4 matching peptides, although information is absent for the 
protein domain or cluster and no other related sequences were reported in the 
databases. This indicates the detection of novel peptides therefore making this protein 
and matching peptides of high interest for further investigation. Some of the peptide 
sequences of other hypothetical Giardia spp. proteins showed similarity to related 
sequences for other pathogenic proteins, such as the secretion protein reported for 
Mycobacterium tuberculosis (Alonso et al., 2007, Gong et al., 2012). In addition, other 
examples of the peptides detected matched to proteins with conserved domains, such 
as Lymphocryptovirus that are also related to phage-like glycoproteins, viral 
glycoproteins or penetration protein (Kim et al., 2011). It is unknown if this type of 
Giardia spp. peptide or protein is implicated in attachment to epithelial cells in a similar 
manner to other bacteria or virus found in the reproductive or respiratory tract.  
Results presented here suggesting that Giardia spp. may not be the sole cause of 
clinical signs of infection. Instead a hypothesis is proposed here that Giardia spp. may 
in fact be relatively benign parasites, forming part of the normal gastro-intestinal 
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ecosystem rather than an obligate pathogenic parasite. This status may alter under 
specific conditions when it becomes opportunistic and adhesion to host cells is 
achieved. The parasite utilises a range of pathogenic adaptations and mechanisms to 
survive and replicate at the expense of the host (Cray et al., 2013). The mechanisms 
proposed here may occur in isolation, simultaneously or sequentially, or as optional 
alternatives. This theory proposes that constituents of microbial flora may play an 
active role in facilitating Giardia infections either by enhancing attachment and 
persistence, or by diminishing innate immune responses and the disruption of 
transcription processes. Studies have shown that G.duodenalis does possess some 
mucin degrading enzymes, N-acetylglucosaminidase and N-acetylgalactosaminidase, 
but not the extensive range required for complete breakdown of carbohydrate chains 
as seen in Trichomonad species (Connaris and Greenwell, 1997, Ryan et al., 2011). 
This suggests that metabolism of these mucins may form nutrients for trophozoites or 
that other factors could be associated with digestion of mucins. This study detected 
more than one type of bacterial species capable of digesting the “protective” mucin 
layer, such as Akkermansia mucinphilia or similar species (Collado et al., 2007, 
Ouwerkerk et al., 2013). Giardia spp. secrete proteases capable of digesting collagen, 
and possibly other components of the extracellular matrix, such as elastin, fibronectin 
and laminin. These secreted proteases have been implicated in cell apoptosis and 
leakage at tight junctions. The activation of protease secretion may be a genotype 
specific genetic characteristic as shown by Koh et al. (2012) or may be a common 
feature across all genotypes but requiring stimulus or an initiation factor to induce 
molecular and pathogenic changes.  
7.3.3.4 Differentiation between assemblages requires further validation. 
The proteomic data frequently contained peptide sequences that matched to proteins 
of the G. duodenalis Assemblage B genome, with an overall greater identification of 
Assemblage B proteins than Assemblage A proteins. 
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This proteomic data suggests that differential protein expression between Giardia 
assemblages may occur or that anomalies in genome coverage exist.  
G. duodenalis Assemblage B generally eludes genetic detection, using traditional 
methods, and this finding at the level of protein output is of great interest. Many 
researchers are of the opinion that Assemblage B incorporates high variability and is a 
cause of clinical infections (Kohli et al., 2008, Lebbad et al., 2008, Minvielle et al., 2008, 
Al-Mohammed, 2011). 
Thus, this clearly demonstrates that whilst evidence of genetic descriptions for 
assemblage B in this study was lacking, the proteomic analysis obtained by spectral 
data matching to peptides within existing genomic databases portrays a different 
classification between infections based upon protein identity. 
This could indicate that Giardia spp. genotypes in dogs, host specific assemblages 
have genetic sequences closely related to assemblage B genotypes, although these 
were not detected by PCR. Interestingly high prevalence rates of Assemblage B have 
been reported in faecal samples from humans in Western Australia (Yang et al., 2010). 
A noteworthy trend of increasing detection of Assemblage B infections in humans has 
also been reported from Asian countries (Ajjampur et al., 2009, Singh et al., 2009, 
Boontanom et al., 2011, Laishram et al., 2012). 
7.4 Management of Giardia spp. infections in canines 
The significance of the high numbers of perceived asymptomatic infections found here 
and reported in epidemiology studies are yet to be fully understood. The data 
presented in Chapter 3 showed that earliest patent infections are occurring within the 
first three weeks of life. Studies into these rarely detected or reported asymptomatic 
infections within the wider population should become a higher priority over studies that 
solely report prevalence rates and do not take into consideration molecular 
epidemiology or transmission cycles. Research planning should consider the dynamics 
of Giardia spp. infections over a longitudinal time frame. 
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This study supports the observations concerning risk factors for Giardia spp. that 
communal housing and facility construction are important factors together with types of 
responses to detected infections, such as treatment or quarantine protocols (Ortuna 
and Castella, 2011). Improved routes for management of Giardia infections in dogs and 
reducing transmission to humans and other species should include education about 
responsible dog ownership (Macpherson, 2005, Palmer et al., 2008). 
Understanding the complexities of microbiota and host interactions is a key factor for 
tackling clinical signs of Giardia in dogs. Vaccination against Giardia is unlikely to be 
either cost-effective or appropriate if parasitic populations actually form a component of 
the natural ecosystem of the gastro-intestinal microflora. The consequences of using 
vaccination methods to eliminate Giardia spp. from the gut ecosystem may produce an 
unforseen set of circumstances, particularly in relation to development of the innate 
immune system, digestion of nutrients and neurosignalling mechanisms.  
7.5 Limitations to the design and implementation of this study 
The use of faecal samples from canine subjects infected with Giardia spp. despite the 
lack of directly relevant genomic data for the canine Giardia spp. under study reduced 
the insights into phenotypic variation. The existing genomic data for G. duodenalis did 
however provide useful information on both the types of Giardia spp. proteins and 
differentiation between the two human genotypes. Collection of the evidence for G. 
canis infections (host specific Assemblages C and D) has progressed, and some 
insights into potential transmission routes have been explored.  
Comparison of faecal proteome of symptomatic or asymptomatic cases of canine 
Giardia infection was beyond the scope of this study, whilst the definitive cause of 
signs of gastro-intestinal disorder were shown in this study not to be attributed solely to 
Giardia spp. parasite. For a thorough and comprehensive analysis of host proteomic 
data a broader genomic dataset would be beneficial, or data for specific breed types, 
such as Labrador retriever or miniature schnauzer as used in this study. For 
interpretation of immune protein detection the sex and tissue type is important, the 
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limitations of basing genomic datasets on a single dog breed, sex and tissue type have 
been reported elsewhere (Libert et al., 2010). 
7.6 Future work  
The discovery of unique peptide fragments by proteome mapping confirms the 
usefulness of this technology for further investigation into the potential zoonotic 
transmission of G. duodenalis. Embarking on new studies to examine unconventional 
routes for transmission is timely. 
Further validation of the proposed biomarkers of inflammation may provide new 
insights into host-parasite interactions and the impacts of Giardia spp. on the host 
immune system. 
This work has highlighted the importance of considering canine health from an 
ecosystem approach and consideration of the influence from other microorganisms on 
the pathogenic nature of Giardia spp. demands further investigation in canines and 
other host species. 
7.7 Conclusion 
The limitations of relying on a single method for Giardia spp. diagnosis have been 
identified in this study and shown that traditional methods, such as microscopy, are not 
inferior to technologically advanced methods for determining the causative factors of 
infection. Mass spectrometry results have, for the first time, illustrated a canine faecal 
proteome based upon peptide detection. The differential protein expression profile 
supports evidence for diverse Giardia spp. genotypes in canines. The canine faecal 
proteome has identified potential host responses to Giardia spp. infection and identified 
the value of faecal lactoferrin as a suitable biomarker candidate. The short pre-patent 
period in the neonatal canine reported here, together with temporal dynamics of cyst 
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NCBI National Center for Biotechnology Information 
NPV Negative Predictive value 
PAGE Polyacrylamide Gel Electrophoresis 
PAMP Pathogen Associated Molecular Pattern 
PBS Phosphate Buffered saline 
PCR Polymerase Chain Reaction 
PFOR Pyruvate flavidoxin oxidoreductase 
PP2A Protein phosphatase 2 A 
PPV Positive Predictive Value 
PTM Post-translational Modification 
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RNA  Ribonucleic acid 
sIgA Secretory Immunoglobulin A 
SDS Sodium dodecyl sulphate 
STD Sexually Transmitted Disease 
TCEP Tris (2carboxethyl)phosphine 
TDR Tropical Disease Research 
TEAB triethylammonium bicarbonate 
TIRF Total Internal Reflection Fluorescence 
TLR Toll-like receptor 
TOF Time of Flight 
Tris 2-Amino-2-hydroxymethyl-propane-1,3-diol 
VSP Variant Specific Surface Protein 
WHO World Health Organization 
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Prevalence and diagnostic data Chapters 2 and 3 
2.1 Diagnostic test results for Giardia spp. infections in Labrador retriever 
breeding facilities in Victoria and WA 
Canine faecal samples from Labrador retriever puppies and dogs in Victoria tested for 
Giardia spp. infection using copro-antigen test 1 produced 44 positive results as 
displayed in Table 2.1.1. Negative test results were obtained for 111 samples. True 
Positive (TP) indicates a positive test result for gold standard test and positive for a 
second diagnostic test (positive result for both tests). True negative (TN) indicates a 
negative test result for the gold standard test and a second diagnostic test (negative 
result for both tests). False Positive (FP) indicates a negative test result for gold 
standard test and positive test result for a second diagnostic test. False Negative (FN) 
indicates a positive test result for gold standard test and negative test result for a 
second diagnostic test. 
Samples from WA tested with copro-antigen test 1 gave 12 positive results and 34 
negative results. 
Table 2.1.1 Diagnostic results for three different copro-antigen tests relative to the gold standard  
 Sample source Diagnostic test N TP FP FN TN 
VICTORIA Copro-antigen test 1 155 22 22 12 99 
WA Copro-antigen test 1 46 12 0 8 26 
VICTORIA Copro-antigen test 2 10 5 1 3 1 
WA Copro-antigen test 2 17 9 2 3 3 
VICTORIA ELISA antigen test 22 5 4 10 3 
WA ELISA antigen test 26 9 0 13 4 
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2.2 Giardia spp. infections detected in canine faecal samples - diagnostic test 
results 
Data collected from Western Australia during the first year (2011) were from pooled 
faecal samples from 2 litters of puppies aged 35-49 days old. In the second year, 
(2012) pooled faecal samples were collected from 1 litter of puppies aged 29-50 days 
old. During the third year (2013) individual samples were taken twice weekly (at 3-4 
day intervals) from 1 litter of puppies aged 14 days – 57 days and individual faecal 
samples from the same litter of puppies aged 68-85 days old. 
In 2012 canine faecal samples were collected at weekly intervals whilst the puppies 
were aged between 29 and 50 days old. Twenty-seven samples were tested for 
Giardia spp. infection, using copro-antigen test 1, and 4 positive test results were 
recorded. Three samples positive by microscopy for parasites were negative by copro-
antigen test 1. Two of these samples were Giardia spp. co-infections with 
Cystoisospora spp.  
In 2013 canine faecal samples from one litter of puppies were collected from individual 
puppies over consecutive weeks between the ages of 68-85 days old, a total of 20 
samples. Eight positive test results were recorded using zinc sulphate flotation and 
light microscopy. All samples were also tested with copro-antigen test 1 giving two 
positive test results and six negative test results.  
Table 2.2.1 Giardia spp. diagnostic data obtained using light microscopy gold standard 
Year N Positive Negative Age PREVALENCE (95% CI) 
2011 39 29 10 35-49 73.7%    (0.569-0.866) 
2012 27 8 19 29-50 29.6%    (0.138-0.502) 
2013 20 15 5 68-85 75.0%    (0.509-0.914) 
2011-13 86 52 34 68-85 60.0%    (0.489-0.705) 
 
Table 2.2.2 Diagnostic test results for Copro-antigen test 1 relative to gold standard 
Litter Year N TP FP FN TN 
3 2012 27 4 0 2 21 
4 2013 20 8 0 6 6 
3-4 2012-13 47 12 0 8 27 
 
Table 2.2.3 Diagnostic test results using Copro-antigen Test 2 relative to the gold standard 
Group Year N TP FP FN TN 
Litter 3 2012 3 1 1 1 - 
Litter 4 2013 14 8 1 2 3 
Litter 3-4 2012-13 17 9 2 3 3 
 
Seventy-four samples in total from a shelter population and two Labrador retriever 
breeding facilities (WA and Victoria) were tested using ELISA copro-antigen plate 
assay test. Results are shown in Table 2.2.4 
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Table 2.2.4 Diagnostic test results for ELISA relative to the gold standard for all groups of dogs 
tested 
 N TP FP FN TN 
SHELTER WA 26 1 7 5 13 
LAB RET WA 26 9 0 13 4 
LAB RET VIC 22 5 4 10 3 
ALL GROUPS TESTED 74 15 11 28 20 
Twenty-seven of the canine faecal samples tested positive using ELISA. Eight samples 
were from shelter dogs, ten from Labrador retriever breeding facilities in WA and nine 
from Labrador retriever breeding facilities in Victoria. 
2.3 Molecular genetics – comparison of polymerase chain reaction (PCR) with 
the light microscopy gold standard for Victorian dogs 
Year 1 (2011) 
Thirty-nine pooled faecal samples from two litters of puppies aged 35-49 days old were 
tested by PCR at the 18s gene locus. Fifteen samples were positive giving positive 
results for 38% of all samples tested (and 52% of all samples positive by light 
microscopy). From these positive samples 8 were successfully sequenced and 
genotyping showed 5 samples of mixed assemblage A/D, 2 samples were assemblage 
A and 1 sample was assemblage D. Further PCR testing at BG and GDH loci were 
unsuccessful except for one sample which was genotyped as assemblage D. This 
sample was consistent for all 3 loci. 
Year 2 (2012) 
Twenty-seven faecal samples were collected as pooled samples from one litter of 
puppies, aged 29-49 days old. One of four samples was considered asymptomatic and 
the other 3 symptomatic. 4 samples were positive by PCR at the 18s gene locus which 
is 15% of all samples tested or 40% of all samples confirmed positive by light 
microscopy. There were three samples containing Giardia cysts, confirmed by light 
microscopy, that did not successfully amplify, and one sample, which gave a positive 
PCR result but no Giardia spp. cysts were observed by microscopy. Sequencing of 4 
positive samples was successful for 3 of them, and all were genotyped as Assemblage 
D. Different gene loci were used to determine genotype. All three were confirmed at the 
18s gene locus, one at 18s locus only, one at beta giardin locus only and one at beta 
giardin and GDH loci. 
Year 3 (2013) 
20 faecal samples from individual puppies from this same litter of puppies were 
collected over consecutive weeks between the ages of 68-85 days old. 11 samples 
tested positive by PCR at 18s gene loci. That is 55% of all samples tested, or 73% of 
all light microscopy positive samples. Sequencing was carried out on all 11 samples, 
and 8 were successfully genotyped at the 18s gene locus. Three samples were 
genotyped at single locus, two at 2 loci, and one at 3 loci. One was genotyped as 
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assemblage A (18s) two were assemblage C (18s and GDH) and five were 
assemblage D (3 at 3 loci, 18s, BG, GDH) 1 at 2 loci (18s and GDH) and one at a 
single (18s) loci. One of the assemblage C samples and the assemblage A sample 
(genotyped at 18s locus) were positive for Giardia spp. by light microscopy but 
negative using Copro-antigen tests 1 and 2. PCR was unsuccessful in amplifying 6 
samples (40%) that had been confirmed positive for Giardia cysts by light microscopy. 
Three samples positive by microscopy for parasites were negative by Copro-antigen 
test 1. Two samples were Giardia spp. co-infections with Cystoisospora spp. and two 
of these samples were also tested using Copro-antigen test 2; one gave a positive 
result and one gave a negative result. The sample which was positive with Copro-
antigen test 2 was also positive by PCR at 18s genotype D. One sample was negative 
by both microscopy and Copro-antigen test 1, but positive using Copro-antigen test 2, 
this sample was also PCR positive at 18s, genotype D. 
2.4  Molecular genetics - comparison of PCR test relative to gold standard light 
microscopy for a breeding population in Perth, Western Australia 
Eighty-six canine faecal samples were tested for Giardia spp. over a three year period, 
29 samples were positive for Giardia spp. although 23 samples negative using PCR 
were positive for Giardia spp. cysts by microscopy, as shown in Table 2.4.1.  
Table 2.4.1 PCR Diagnostic test results relative to the gold standard 
 
Appendix 2 
3.1 Cyst intensity 
Table 3.1.1 Frequency of Giardia spp. infections, confirmed by detection of cysts using light 
microscopy, in pooled faecal samples from multiple litters of Labrador retriever puppies 
AGE (days) Giardia spp. cyst intensity TOTAL Low Moderate High 
 +1 +3 +4  
17 1 0 0 2 
26 0 1 0 3 
28 1 0 1 2 
36 0 0 0 3 
35 5 3 0 9 
42 19 0 1 20 
45 2 0 1 7 
67 2 0 0 2 
TOTAL 30 4 3 37 
 
 
Year N TP FP FN TN 
2011 38 15 0 13 10 
2012 27 3 1 3 20 
2013 20 9 1 6 4 
2011-13 85 27 2 22 34 
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Table 3.1.2 Frequency of Giardia spp. infections, confirmed by detection of cysts using 
lightmicroscopy, in pooled faecal samples from Labrador retriever puppies in WA (2013) 
Age (days) 
Giardia spp. (cyst intensity)  
Low Moderate High TOTAL 
 +1 +2 .+3 +4  
68 0 0 0 0 0 
72 3 0 0 1 4 
73 2 0 1 1 4 
75 0 0 2 1 3 
76 0 0 0 1 1 
83 2 1 0 0 3 
84 0 0 0 0 0 
85 1 0 2 0 3 
86 1 0 0 0 1 
TOTAL 9 1 5 4 19 
 
Table 3.1.3 Intensity of infection (cyst) from different Labrador retriever breeding populations 
Location Year Low Moderate High 
WA 2011 24/28 (85%) 3/28 (11% 1/28 (6%) 
WA 2012 2/6 (33%) 2/6 (33%) 2/6 (33%) 
WA 2013 9/19 (47%) 6/19 (32% 4/19 (21% 
VIC 2011-13 30/37 (81%) 4/37 (11% 3/37 (8%) 
 
Table 3.1.4 Frequency of parasite detection in faecal samples from Labrador retriever puppies 
in WA (2013) confirmed positive by microscopy for parasite infections 
Parasite species detected 
Age 
(days) Sarcocystis sp. Cystoisospora sp. Toxocara canis Giardia spp. TOTAL 
15 0 0 0 0 0 
20 0 0 0 0 0 
30 0 0 1 0 1 
32 0 0 0 0 0 
52 0 1 1 0 2 
56 0 1 0 0 1 
68 1 0 0 0 1 
72 3 1 0 4 8 
73 1 1 0 4 6 
75 0 0 0 3 3 
76 0 0 1 1 2 
83 2 0 0 3 5 
84 0 0 0 0 0 
85 1 0 0 3 4 
86 0 0 0 1 1 







Table 3.1.5 Frequency of parasite detection in pooled faecal samples from Labrador 
retriever puppies (2013) in a Victorian breeding facility 
 
Parasite species 
Labrador Retriever (Victoria) 
Frequency Percentage 
Sarcocystis sp. 11 13.6 
Cystoisospora sp. 26 32.1 
Toxocara canis 0 0 
Giardia spp. 30 37.0 
Giardia spp. co-infections 14 17.3 
Total infected 81 
 Total negative 74 
Total tested 155 
 
3.2 Faecal parasites infection and association with clinical signs of 
infection 
Table 3.1.6 Endoparasite infections in faecal samples from Labrador retriever dogs in two 
breeding facilities  























Sample size 38 27 20 85 155 240 
Sarcocystis spp. (only) 0 0 2 2 11 13 
Cystoisospora spp. (only) 0 12 0 12 26 38 
Giardia spp. (only) 27 3 7 37 30 67 
Giardia spp. co-infections 1 5 8* 14 14 28 
No parasitic organisms 10 7 3 20 74 94 
*Figures marked with an asterisk were co-infections with Giardia spp. and 
Toxocara canis. Giardia co-infections were recorded as a separate category, 
addition of figures reported for Giardia spp. and Giardia spp. co-infections gives 
the total number of samples infected with Giardia spp. 
 
Table 3.1.7  Enteric parasite infections and clinical signs in Labrador retriever dogs  
Parasite species Number (N) Symptomatic Asymptomatic 
(Total tested) N  240 122 118 
Sarcocystis spp. 13 6 7 
Cystoisospora spp. 38 29 9 
Giardia spp. 67 38 29 
Giardia co-infections  28 13 15 
No parasitic organisms  94 36 58 
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Appendix 3  
Proteomic data (Chapters 4 and 5) 










































31 E2QS94 Uncharacterized protein  Canis familiaris 3 
34 P06857 
Pancreatic lipase- 
related protein 1  Canis familiaris 2 
40 E2R6T0 Uncharacterized protein  Canis familiaris 2 
50 XP_540774.2 
Mucin-2 precurs 
or (Intestinal mucin 2) Canis familiaris 2 
55 XP_862298.1 
hypothetical protein 




(Down-regulated in colon 
 cancer 1) Canis familiaris 2 
77 E2RF44 Uncharacterized protein  Canis familiaris 1 
85 E2RE31 Uncharacterized protein  Canis familiaris 1 







ENSCAFT00000006667  Canis familiaris 1 
97 Q7M2U3| Gastrotropin (Fragment) Canis familiaris 1 
100 E2RRH4 Uncharacterized protein  Canis familiaris 1 
107 
A9Q6H4 
Trefoil factor family peptide 
2 
 (Fragment)   Canis familiaris 1 







ENSCAFT00000022201  Canis familiaris 1 
114 XP_545265.2 
Sucrase-isomaltase, 
 intestinal   Canis familiaris 1 
119 E2NPK4 30S ribosomal protein S16  
Catenibacterium 
mitsuokai  1 
58 Q98UH8 Calmodulin(Fragment)   Clemmys japonica 1 
66 C5UTM6 Elongation factor Tu  
Clostridium 




corrinoid iron-sulfur protein 
 methyltransferase  
Clostridium 
carboxidivorans  1 
109 P68247 
Troponin I,  





smooth muscle, aorta  Danio rerio 8 
68 Q803M1 
Novel protein  
similar to vertebrate  Danio rerio 4 
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tropomyosin 1 (Alpha)  







ENSDORT00000013505  Dipodomys ordii 9 
28 D6E5E0 Chaperone protein dnaK 2  Eubacterium rectale  3 
99 E2ZFD6 
Ribosomalprotein 
 L4/L1 family protein  
Faecalibacterium cf. 
prausnitzii  1 
116 E2ZK37 Chaperone protein DnaK  
Faecalibacterium cf. 
prausnitzii  1 
103 D4JY68 50S ribosomal protein L29  
Faecalibacterium 
prausnitzii  1 
90 D4K9G0 30Sribosomal protein S19  
Faecalibacterium 
prausnitzii  1 
115 C3W9Q1 Chaperone protein dnaK  
Fusobacterium 














ENSGALT00000015706  Gallus gallus 15 
3 P02604 
Myosin light chain 1,  














ENSGALT00000001420  Gallus gallus 30 
24 P13538 
Myosin heavy chain,  
skeletal muscle, adult  Gallus gallus 25 
27 Q91005 Alpha tropomyosin of brain  Gallus gallus 4 




 light chain 2,  
skeletal muscle isoform  Gallus gallus 5 
36 E1BXB0 Uncharacterized protein  Gallus gallus 2 




micreticulum calcium  
ATPase 1  Gallus gallus 2 
46 P01012 Ovalbumin Gallus gallus 3 
51 P00565 Creatine kinase M-type  Gallus gallus 2 







ENSGALT00000010181  Gallus gallus 1 
65 Q9DGM4 
Fast myosin heavy chain 
 isoform 3  Gallus gallus 32 
101 E1C4M2 Uncharacterized protein  Gallus gallus 1 
110 P17785 Annexin A2  Gallus gallus 1 
111 P00174 Cytochrome b5  Gallus gallus 1 
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10 P04405 Glycinin G2  Glycine max 6 
30 Q9SB11 Glycinin Glycine max 3 
49 P04776 Glycinin G1  Glycine max 6 
73 Q9SB12 Glycinin Glycine max 1 
83 Q948X9 
Beta-conglycinin alpha- 
subunit  Glycine max 1 
5 Q8IAC2 Muscle actin  Halocynthia roretzi 11 
56 C3XE21 Predicted protein  Helicobacter bilis  3 
105 C3XE22 Predicted protein  Helicobacter bilis  1 
4 Q8LPD3 Conlinin Linum usitatissimum 9 























Figure 4.2.1 Annotated ms spectra for peptides matched to G. duodenalis proteins  







Figure 4.2.2 Annotated ms spectra for peptide 1 matched to database entries 




Figure 4.3.1 Annotated ms spectra for peptides matched to G. duodenalis proteins 
Protein 2 Hypothetical protein C6LSL4 
 
 





Figure 4.3.3 Annotated ms spectra for peptide 2  matched to database entries 




Figure 4.4.1 Annotated ms spectra for peptides matched to G. duodenalis proteins 
Protein 3 Axoneme central apparatus protein A8BQ10 
 
Figure 4.4.2 Annotated ms spectra for peptides matched to peptide 1 





Figure 4.5.1 Annotated ms spectra for peptides matched to G. duodenalis proteins 




















Figure 4.5.2 Annotated ms spectra for peptides matched to peptide 1 





Figure 4.5.3 Annotated ms spectra for peptide 2 






Figure 4.6.1 Annotated ms spectra for peptides matched to G. duodenalis proteins 










Figure 4.7.1 Annotated ms spectra for peptides matched to G. duodenalis proteins 
Protein 6 Coiled coil protein C6LY87 
 





Figure 4.8.1 Annotated ms spectra for peptides matched to G. duodenalis proteins 
Protein 7 Hypothetical protein C6LS33 
 




Figure 4.8.3 Annotated ms spectra for peptide 2 matched to database entries 
























Figure 4.9.1 Annotated ms spectra for peptides matched to G. duodenalis proteins  
Protein 8 Histone methyltransferase protein C6LVL9 
 
 
Figure 4.9.2. Annotated ms spectra for peptide 1smatched to database entries 






Figure 4.10.1 Annotated ms spectra for peptides matched to G. duodenalis proteins  







Figure 4.10.2 Annotated ms spectra for peptide 1 matched to database entries 






Figure 4.10.3 Annotated ms spectra for peptide 2 matched to G. duodenalis proteins  









Figure 4.10.4 Annotated ms spectra for peptide 3 matched to database entries  











Figure 4.10.5 Annotated ms spectra for peptide 4 matched to database entries  









Figure 4.11  Annotated ms spectra for peptides  matched to G. duodenalis proteins  




Figure 4.12 Annotated ms spectra for peptides  matched to G. duodenalis proteins  







Figure 4.12.1 Annotated ms spectra for peptide 1  matched to database entries 




Figure 4.13 Annotated ms spectra for peptides matched to G. duodenalis proteins 
Protein 12 Nek kinase protein C6LMX7 
 
Figure 4.13.1  Annotated ms spectra for peptide 1 matched to database entries 
Protein 12 Nek kinase protein C6LMX7 
 
 
